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I. Enantio- and Diastereoselective Organocatalytic Conjugate Additions of 




Enantio- and diastereoselective conjugate addition reactions between nitroethane or 
nitropropane and enone diesters are described. A bifunctional triaryliminophosphorane 
catalyzed the addition reaction with consistently excellent stereoselectivities and yields across 
a wide range of substrates. Using the geminal diester functional handle present in the adducts, 
local desymmetrization via diastereotopic group discrimination was demonstrated and a 
polyfunctionalized lactam with three contiguous stereocenters was synthesized. 
 





An asymmetric sulfa-Michael addition of alkyl thiols to enone diesters is reported. The 
reaction is catalyzed by a bifunctional triaryliminophosphorane-thiourea organocatalyst and 
provides a range of α-sulfaketones in high yields and enantioselectivities. Leveraging the gem-
diester functional handle via a subsequent diastereotopic group discrimination generates 
functionalized lactones with three contiguous stereocenters. 
 
III. Efforts Towards the Reduction of α-Imino Esters via Dynamic Kinetic Resolution 
 
 
Efforts toward the enantioconvergent trichlorosilane-mediated reduction of β-
substituted α-imino esters are described. Chiral Lewis base catalysis enables the synthesis of 
N-aryl unnatural amino esters with β-alkyl or β-halo substitution in moderate yields and 
stereoselectivities. Reactions of β-alkyl α-imino esters provided suffered from poor 
diastereoselectivity, whereas decomposition and product instability plagued the β-halo 
analogs. Additional complicating factors associated with dynamic kinetic resolution and imine 
chemistry are broadly discussed and noted in this work. 
 
IV. Organocatalytic Iso-Pictet-Spengler Reaction for the Enantioconvergent 
Synthesis of Tetrahydro-γ-Carbolines 
 
v 
Progress towards an enantioconvergent iso-Pictet-Spengler reaction using 
thiourea/Brønsted acid co-catalysis is reported. Preliminary control studies demonstrated a 
significant difference in reactivity between α-substituted β-formyl amides and esters, with the 
latter proving amenable for asymmetric reaction development. Optimized conditions provide 
unprotected tetrahydro-γ-carbolines with two contiguous stereocenters, including an exocyclic 
stereogenic center and orthogonal ester functional handle. Finally, promising efforts to expand 
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CHAPTER ONE: ENANTIO- AND DIASTEREOSELECTIVE 




1.1.1 The Development of Enantioselective Superbase Organocatalysis 
Chiral small molecules are intrinsic to life, both biochemically and in our modern world 
as pharmaceuticals, agrochemicals, and materials.1 The importance and applications of 
chirality in naturally occurring compounds have been long investigated, beginning with the 
discovery of molecular chirality by Louis Pasteur and other scientists in the 19th century.1–4 
This revolutionary finding inspired countless new areas of study, but the pursuit of asymmetric 
synthesis remains among the most influential in synthetic chemistry. Over the last two 
centuries, three general approaches for synthesizing chiral non-racemic compounds have been 
established: (1) chiral pool synthesis, (2) asymmetric catalysis, and (3) resolution.5–7  
The first method, chiral pool synthesis, derives structurally and stereochemically 
complex products from a ‘pool’ of naturally abundant enantiopure molecules such as amino 
acids and sugars. Syntheses of countless natural products5,8,9, organocatalysts10, and ligands 
rely on the chiral pool for its dependable stereospecificity. Yet, the limited chemical space 
covered by chiral pool materials inherently restricts the scope and diversity of asymmetric 
products accessible via this approach.11 As a result, the development of alternative methods 
for synthesizing chiral compounds is a significant, ongoing challenge in the field of organic 
                                                 
* Reproduced with permission from Horwitz, M. A.; Fulton, J. L.; Johnson, J. S. Org. Lett. 2017, 19, 5783. 
Copyright 2017 American Chemical Society. 
2 
synthesis. The latter two approaches to the synthesis of chiral non-racemic products, 
asymmetric catalysis and resolution, seek to address that gap. Resolution, and in particular 
dynamic kinetic resolution, will be discussed at length in Chapter 3. Meanwhile, the following 
research falls into the realm of asymmetric catalysis. 
Asymmetric catalysis involves transformation of a racemic or achiral substrate to an 
enantioenriched product via a chiral, non-racemic catalyst. Catalysts take many forms, 
including enzymes12,13, metals14,15, organic molecules16–18, or some cooperative combination 
of the three.19–21 Irrespective of the catalyst the goal remains the same: generate 
enantioenriched product quickly and in high yield without catalyst degradation. The first half 
of my doctoral research focused on developing novel enantioselective transformations via 
organocatalysis, specifically using chiral superbases. 
Organocatalysts have been employed since the late 19th century,22 but their potential 
for enantioinduction were not realized until the late 20th century (Scheme 1-1). Seminal work 
from Hajos and Parrish (Scheme 1-1A), Seebach, and Wynberg established the utility of chiral 
enamine catalysis and asymmetric bifunctional organocatalysis for conjugate additions to 
Michael acceptors;23–25 however, little work was done to expand the field until the 1990’s and 
early 2000’s when the ‘gold rush’ of asymmetric organocatalysis began. From 1998 to 2000, 
pioneers such as and Jacobsen (Scheme 1-1B)26 and MacMillan (Scheme 1-1C)27,28 developed 
novel, robust chiral non-racemic organocatalysts that promoted unexplored asymmetric 
transformations. 
3 
Scheme 1-1. Seminal Organocatalyzed Asymmetric Reactions 
 
In addition to the newly accessible enantioenriched products, these catalytic manifolds 
launched the rapid development of countless other organocatalysts and prompted 
investigations into other unexplored reactions. In 2000, MacMillan coined the term 
‘organocatalysis’ in his first publication on the subject. Five years later, nearly 500 published 
articles referenced the term, and as of the end of 2019 more than 16,000 journal articles discuss 
organocatalysis (Figure 1-1).22 
4 
Figure 1-1. Summation of publications containing the term ‘organocatalysis’ on Reaxys from 
the years 2000 to 2019† 
 
Modern organocatalysis encompasses any small molecule catalyst that does not involve 
an active inorganic species.22 As the field continues to expand, additional classification 
systems have been developed to clarify an organocatalyst’s role and capabilities. The vast 
majority of chiral organocatalysts can be identified as Lewis acids, Lewis bases, Brønsted 
acids, or Brønsted bases.22 While catalysts are generally defined by their most active 
functionality, additional functional handles are frequently employed to activate both the 
nucleophile and electrophile. For example, Cinchona alkaloid-derived thiourea 1.3 is a 
bifunctional Brønsted base organocatalyst which has been employed in numerous asymmetric 
transformations (Figure 1-2).18,29,30 The Brønsted basic quinuclidine deprotonates a 
pronucleophile, while the second functionality, the Lewis acidic thiourea, activates the 
electrophile via hydrogen-bonding.17,31 These identifiers enable organic chemists to better 
                                                 
† Searched for the concept ‘organocatalysis’ in SciFinder. Results were refined to journals, preprints, and reports, 




















understand the proposed function of an organocatalyst and therefore assist in catalyst selection 
when investigating novel transformations.  
Figure 1-2. Bifunctional Brønsted Base Organocatalysis 
 
Although the system above provides nomenclature for central concerns such as 
reactivity and the number of functional handles, it fails to characterize the strength of an 
organocatalyst. For example, quinuclidine 1.3 and iminophosphorane 1.4 function as 
bifunctional Brønsted base organocatalysts (Figure 1-3); however, as the basicity of the 
quinuclidine and iminophosphorane differ by five orders of magnitude, it is unsurprising that 
the two perform quite differently.16 Consequently, to qualitatively differentiate between these 
two classes of Brønsted bases, the community adopted another identifier: superbase.32  
The definition of the term superbase is somewhat arbitrary, but superbases are generally 
uncharged species with a pKBH+ greater than proton sponge (18.2 in MeCN).
16,32 Specifically, 
organosuperbase catalysis takes advantage of the high basicity and poor nucleophilicity of 
these compounds to activate poorly acidic pronucleophiles in previously unproductive 
reactions. Notable classes of chiral organosuperbases include iminophosphoranes (1.4), 
guanidines (1.5), and cyclopropenimines (1.6) (Figure 1-3).16,17,33 Each class is composed of 
structurally diverse catalysts, which span a wide range of basicities. 
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Figure 1-3. Basicities of Common Brønsted Base Organocatalysts 
 
a pKBH+ values obtained in MeCN 
Interest from the Johnson lab in the field of asymmetric superbase organocatalysis dates 
back to 2012, when we collaborated with the Ooi lab to develop a direct aldolization of α-alkyl 
α-hydroxy phosphonoacetate using [5,5]-P-spirocyclic catalyst 1.7 (Scheme 1-2A).34 A 
subsequent collaboration with the Ooi lab employed the same catalyst to enable a reductive 
coupling of isatins and aldehydes (Scheme 1-2B).35 The iminophosphorane catalyst (1.7) 
proved highly effective in both transformations, providing the phosphate products in high 
stereoselectivity and yield. Unfortunately, the synthesis of iminophosphorane 1.7 is 
challenging, and the P-spirocyclic nature of these catalysts generally limits appendage identity, 
thereby prohibiting bifunctional catalysis.36 As such, as our lab considered other underexplored 
transformations, we sought to employ more accessible and diversifiable organosuperbases.  
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Scheme 1-2. Iminophosphorane-Catalyzed Asymmetric Reductive Coupling Between 
Aldehydes and Isatins 
 
In 2013, the lab of Darren Dixon debuted amino acid-derived bifunctional 
iminophosphorane catalyst 1.4.37 Similar to bifunctional Cinchona alkaloid-derived thiourea 
1.3, this catalyst possesses the same Lewis acidic thiourea to coordinate and activate 
electrophiles for addition (Figure 1-4); however, in place of the quinuclidine moiety, this 
catalyst relies on a Brønsted basic triaryliminophosphorane. The catalyst backbone is derived 
from the N-Boc-protected tert-leucine amino alcohol (Scheme 1-3). Subsequent tosylation and 
azide substitution provides the key azido amine intermediate, which undergoes transformation 
at either end to provide a bifunctional organocatalyst. For iminophosphorane 1.4, addition of 
the amine to an aryl isocyanide generated the thiourea moiety, then Staudinger reaction with 
triphenylphosphine yielded the iminophosphorane base.  
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Figure 1-4. Comparison of Bifunctionality for Cinchona Alkaloid Thioureas and 
Iminophosphoranes 
 
Scheme 1-3. Synthesis of Dixon’s Bifunctional Triaryl Iminophosphorane Catalysts 
 
Organocatalyst 1.4 proved highly effective when employed in the addition of 
nitromethane into N-phosphinoyl imines, providing the desired amine in high yield and 
enantioselectivity (Scheme 1-4).37 Notably, quinuclidine catalyst 1.3 failed to provide any 
product, confirming the necessity of the more basic iminophosphorane catalyst. Subsequent 
efforts proved that this same reaction could be catalyzed by immobilized, polystyrene-
supported iminophosphorane 1.8.38 Moreover, the immobilized catalyst 1.8 promoted 
enantioselective additions of malonates and β-keto amides to β-nitrostyrene as well (Scheme 
1-5). 
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Scheme 1-4. Iminophosphorane-Catalyzed Asymmetric Addition of Nitromethane to 
Phosphinoyl Imines 
 
Scheme 1-5. Asymmetric Addition of Dicarbonyls to β-Nitrostyrene by an Immobilized 
Iminophosphorane 
 
One advantage of bifunctional catalysts such as iminophosphorane 1.4 are their 
modularity, which expands opportunities for catalyst tuning and optimization.37,39 Generically, 
this class of catalysts contains three modifiable functionalities (Figure 1-5): (1) amino acid-
derived catalyst backbone (red), (2) the H-bond donor (blue), and (3) the substitution on the 
aryl rings of the triaryliminophosphorane (green). The 2013 publication from Dixon explored 
variations at each of these points, leading to the selection of thiourea 1.4 for their nitro-
Mannich reaction. Altering the triaryliminophosphorane impacted catalyst basicity, with 
electron-donating substitution on the aryl ring increasing the pKBH+ and electron-withdrawing 
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groups decreasing the pKBH+.
37 Altering the H-bond donor or backbone primarily impacted 
stereocontrol. 
Figure 1-5. Modifiable Regions of a Bifunctional Iminophosphorane Organocatalyst 
 
Tuning the basicity of these catalysts and exchanging functionalities can enable new 
chemistry. Recently, Dixon found that exchanging the thiourea for 1-naphthyl amide and 
adding methoxy substitution to the triaryliminophosphorane (1.9) enabled a direct aldol 
addition of aryl ketones to α-fluorinated ketones (Scheme 1-6A).40 Alternatively, amino acid-
derived H-bond donors can provide a second stereogenic center. In 2015, Dixon introduced 
their “second-generation” bifunctional iminophosphorane organocatalyst (1.10), which 
promoted the enantioselective addition of thiols to unactivated α,β-unsaturated esters (Scheme 
1-6B).41,42 Although no stereochemical models have been proposed for either the first or 
second generation catalysts, Dixon had previously observed37 the impact of the H-bond donor 
identity on stereocontrol37, and the second stereogenic center provided a significant boost to 
the stereoselectivity for this reaction.41 
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Scheme 1-6. Modified Iminophosphoranes for Asymmetric Organocatalysis 
 
Intrigued by these catalysts, we investigated the applicability of a bifunctional 
iminophosphorane catalyst to the asymmetric reductive coupling between benzylidene 
pyruvates and aldehydes (Scheme 1-7).43 Catalyst 1.4 successfully promoted the reaction, 
generating complex products with two contiguous stereocenters in high diastereoselectivity 
and enantioselectivity. More recently, we investigated whether bifunctional iminophosphorane 
organocatalysis could enable the stereoselective addition of extended nitroalkanes (Chapter 1) 
and alkyl thiols (Chapter 2) to enone diester electrophiles. 
Scheme 1-7. Asymmetric Reductive Coupling Between Aldehydes and Benzylidene Pyruvates 
 
1.1.2 Organocatalyzed Addition of Nitroalkanes 
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The prevalence of nitrogen-containing acyclic and heterocyclic scaffolds in bioactive 
molecules provides ongoing opportunities for the development of methodologies for their 
efficient construction. Asymmetric organocatalytic conjugate additions of nitroalkanes have 
enabled the rapid construction of small polyads possessing numerous functional handles for 
downstream transformations. Previous approaches utilizing Brønsted base organocatalysis 
have accomplished this transformation in a stereoselective manner.44–49 Although methods 
have been developed for the enantioselective addition of nitromethane, diastereocontrol with 
homologs has proven challenging in many contexts because of prochirality in both reaction 
partners.50–57 Furthermore, substrates bearing both acrylate and enone moieties have been 
found to undergo regioselective addition exclusively at the enone Michael acceptor (Scheme 
1-8A), which limits the scope of products accessible through this reaction. We sought to meet 
the challenges of regioselectivity and stereoselectivity by using a bifunctional organocatalyst 
to orient and unite extended nitroalkanes with acylidene malonates. Herein, we report the 
enantio- and diastereoselective conjugate addition of nitroethane and nitropropane to enone 
diester electrophiles (Scheme 1-8B). 
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Scheme 1-8. Asymmetric Conjugate Addition of Nitroalkanes 
 
 
1.2 Development of a One-Pot Synthesis of Enone Diesters 
With the aim of exploiting these highly activated substrates and delivering useful 
functionality in the derived products, we initiated conjugate addition reaction studies with 
enone diesters. In 2014, Srinivasan published a three-step procedure for accessing aromatic 
enone diesters. Their route proceeded as follows: (1) conjugate addition of a malonate, (2) 
base-promoted halogenation/cyclopropanation, (3) Lewis acid-promoted ring-opening and 
elimination of the nitro group (Scheme 1-9).58 The authors were limited to aryl enone diesters 
as their third step proceeds via formation of a zwitterionic species that relies on resonance 
stabilization of a positive charge at the benzylic carbon. Seeking to expand the scope of enone 
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diesters for our investigations, we opted to investigate alternative routes for accessing these 
substrates. 
Scheme 1-9. Three Step Synthesis of Aryl Enone Diesters (Srinivasan, 2014) 
 
Prior reports indicated that Wittig olefination between a ketomalonate and stabilized 
ylide could rapidly provide the desired enone diester;59–61 however, no examples had been 
reported with the di-tert-butyl ketomalonate. This absence is likely due in part to limited 
commercial availability, and in part to the problematic hydration issues associated with 
isolating the ketomalonate.62–64 This latter fact has necessitated some creative solutions. 
Contemporaneously with our studies, Kürti demonstrated that CAN oxidation of the malonate 
followed by intentional hydration yields a stable crystalline solid which can be employed in 
subsequent operations (Scheme 1-10).65 Although successful, the CAN oxidation is rather 
sluggish, requiring more than 48 h to provide the product in 68% yield. 
Scheme 1-10. Synthesis of Ketomalonate Hydrates via CAN Oxidation (Kürti, 2017) 
 
In an effort to circumvent the hydration issue altogether, we developed a one-pot 
reaction. Di-tert-butyl 2-diazomalonate 1.11 (accessible via the malonate in one step) was 
subjected to oxo transfer under the action of Rh(II)/propylene oxide,66 then the resulting ketone 
underwent Wittig olefination in-situ following addition of the stabilized ylide (Figure 1-6). 
Using this telescoped reaction sequence, we synthesized a variety of enone diesters in good to 
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moderate yields. In addition to tolerating aryl (1.12a-j) substitution, heteroaryl (1.12k-m), and 
alkyl (1.12n-o) substitution were well-tolerated, contrasting with the approach reported by 
Srinivasan.58 
Figure 1-6. Scope of Enone Diesters via One-Pot Procedure 
 
1.3 Asymmetric Addition of Nitroalkenes 
1.3.1 Reaction Optimization for Asymmetric Addition of Nitroalkanes 
Having established a synthetic path to access enone diesters 1.12, we initiated our 
investigation into the stereoselective addition of nitroalkanes. As previously mentioned, 
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Cinchona alkaloid bifunctional organocatalysts are well-precedented in the asymmetric 
conjugate addition of nitroalkanes;48,49,51,54,67,68 however, when thiourea 1.3 was employed in 
the addition of nitromethane (1.13) to enone diesters 1.12, we observed poor yield and little 
enantioinduction for nitro adduct 1.14 (entry 1, Table 1-1). Undeterred, we hypothesized that 
superbase organocatalysis could effect this transformation. Indeed, phenylglycine-derived 
iminophosphorane 1.15 prompted a substantial increase in both enantioselectivity and yield 
(entry 2). Decreasing the temperature and extending the reaction time further improved the 
yield and stereoselectivity (entry 3). Additional catalyst screening commenced with the tert-
leucine-derived thiourea (1.4), as well as a tert-leucine-derived variant of the second-
generation catalyst developed by the Dixon lab bearing two chiral centers (1.16). Although 
iminophosphorane 1.4 provided comparable enantioinduction, the yield was diminished (entry 
4); catalyst 1.16 provided only trace product at -60 °C, and poor yield even at room temperature 
(entries 5, 6). Consequently, optimization continued with the decidedly superior catalyst, 
iminophosphorane 1.15. 
Despite completion of catalyst selection, the reaction provided sub-optimal results at 88:12 
er and 62% NMR yield (entry 3). A brief solvent screen revealed that benzene, 
dichloromethane and ethyl acetate provided diminished enantioselectivities (entries 7-9), while 
other ethereal solvents (Et2O) provided analogous results to THF (entry 10). Switching from 
the ethyl to tert-butyl ester resulted in an increase to enantioselectivity, but yield remained 
consistently low. Despite the moderate yield, the reaction proceeded cleanly as judged by 1H 
NMR spectroscopy, and reaction yield and conversion were well-correlated. Unfortunately, 
diminished yields were of particular concern as tert-butyl enone diester 1.12 and the desired 
product (1.14) were inseparable under standard chromatographic conditions.  
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At present, the cause for poor conversion remains unclear. Increasing the catalyst 
loading to 20 mol % was ineffective at increasing conversion or yield, so we do not believe 
catalyst decomposition is a major factor. In an effort to increase conversion, we elected to 
employ a more acidic nitroalkane. Nitromethane has a pKa of 10.2, while extending the 
nitroalkane to nitroethane decreases the pKa to 8.57.
‡ Although this extended nitroalkane 
presented an additional challenge of diastereocontrol, we hypothesized that the more acidic 
substrate could facilitate reaction. Gratifyingly, we observed excellent diastereocontrol by 
employing catalyst 1.15, along with dramatic improvements to both enantioselectivity and 
yield.  












dr er yielda 
1 H (10.0) Et THF 23 1.3 (0.10) 8 n.a. 55:45 (18) 
2 H (10.0) Et THF 23 1.15 (0.10) 8 n.a. 77:23 (40) 
3 H (10.0) Et THF -60 1.15 (0.10) 21 n.a. 88:12 (62) 
4 H (10.0) Et THF -60 1.4 (0.10) 21 n.a. 13:87 (41) 
5 H (10.0) Et THF -60 1.16 (0.10) 21 n.a. n.d. trace 
6 H (10.0) Et THF 23 1.16 (0.10) 19 n.a. n.d. (30) 
7 H (10.0) Et CH2Cl2 -60 1.15 (0.10) 21 n.a. 78:22 (46) 
8 H (10.0) Et PhH -60 1.15 (0.10) 21 n.a. 81:19 (48) 
9 H (10.0) Et EtOAc -60 1.15 (0.10) 21 n.a. 85.5:14.5 (45) 
10 H (10.0) Et Et2O -60 1.15 (0.10) 21 n.a. 89:11 (54) 
                                                 
‡ pKa values obtained via SciFinder 
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tBu Et2O -60 1.15 (0.20) 24 >20:1 97:3 88 
 
a Yields in parentheses represent 1H NMR yields determined using 1,3,5-trimethoxybenzene as an 
internal standard. b The dr, er, and yield values for this entry are an average of two trials. 
 
1.3.2 Reaction Scope 
When the optimized conditions were applied to the parent substrate 1.12a, the reaction 
proceeded with >20:1 diastereoselection and 97:3 er in 88% isolated yield (Figure 1-7). We 
observed similar reaction outcomes with halogen-substituted arenes 1.14b−d. X-ray 
diffraction analysis of nitro adduct 1.14d allowed us to determine the absolute stereochemical 
outcome of the reaction (Figure 1-8).§ We observed that placing the bromo substituent at the 
ortho position resulted in the formation of an undesired and inseparable byproduct. Other 
electron-deficient enone diesters 1.14e-g provided the desired products in high 
stereoselectivity and yield. When we turned our attention to the electron-donating substituents 
present in 1.14h-j (piperonyl, 4-methoxy, 3-methoxy), we found similar results regardless of 
the specific substitution pattern. A study of furan (1.14k), thiophene (1.14l), and pyridine 
(1.14m) heterocycles also provided products with nearly perfect stereoselectivities and high 
yields. Aliphatic enones 1.14n and 1.14o performed well in the reaction, giving >20:1 dr with 
high enantioselectivities and good yields. Finally, we investigated whether homologous 
nitroalkanes could be employed. A nitropropane addition product was prepared with high 
                                                 
§ CCDC 1563042 contains the supplementary crystallographic data for this structure. These data can be obtained 
free of charge from the Cambridge Crystallographic Centre via www.ccdc.cam.ac.ui/data_request/cif. 
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stereoselectivity and chemical yield (1.14p). On a 1 g scale, the reaction of enone diester 1.12a 
provided product 1.14a with nearly perfect stereoselectivity in 86% isolated yield (Scheme 1-
11). 
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Figure 1-7. Asymmetric Conjugate Addition of Nitroalkanes 
 
a All of the reactions were conducted on a 0.1 mmol scale using 21.0 equiv of EtNO2 or 20.2 equiv of n-PrNO2. 
Isolated yields are shown. All yields and dr and er values are the averages of two trials. b The er of 1.14a was 
determined by derivatization to dimethyl malonate 1.18a 
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Figure 1-8. X-Ray Crystal Structure of para-Bromo Nitro Adduct 1.14d 
 
Scheme 1-11. Gram-Scale Asymmetric Conjugate Addition Reaction 
 
1.4 Local Desymmetrization of Nitro-Adducts 
Seeking to take advantage of the diastereotopic ester groups, we developed a three-step 
local desymmetrization69,70 protocol that enables the formation of a new stereogenic center 
with concomitant lactamization (Scheme 1-12). It was necessary to transform the di-tert-butyl 
malonate substructure into dimethyl malonate 1.18a to achieve ring closure during the nitro 
group reduction. The final lactam 1.19a was obtained with 9.1:1 dr in 45% yield over three 
steps while maintaining the same level of enantiopurity as the starting material 1.14a. On the 
basis of the absence of a H2 −H3 NOE, the three-bond coupling constant (J3) of 7.5 Hz in 
CD3OD (or 8.2 Hz in CDCl3), and strong literature precedent
71–74, the benzoyl group and 
methyl ester were assigned as trans on the γ-butyrolactam ring.  
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In summary, we have developed asymmetric organocatalytic conjugate additions of 
extended nitroalkanes to enone diester electrophiles. A chiral bifunctional iminophosphorane 
enabled the creation of two adjacent stereocenters with high levels of enantio- and 
diastereoselectivity. Through subsequent diastereotopic group selection, the establishment of 
a third stereogenic center during formation of a polyfunctional lactam was demonstrated.  
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1.7 Experimental Details 
Methods: Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform 
infrared spectrometer. Proton and carbon magnetic resonance spectra (1H NMR, 13C NMR, 19F 
NMR) were recorded on a Bruker model DRX 400 or 600 (1H NMR at 400 MHz or 600 MHz, 
13C NMR at 101 MHz or 151 MHz, 19F NMR at 376 MHz with solvent resonance as the internal 
standard (1H NMR: CDCl3 at 7.26 ppm and 
13C NMR: CDCl3 at 77.0 ppm).
 1H NMR data are 
reported as follows: chemical shift, multiplicity (s = singlet, app s = apparent singlet, br s = 
broad singlet, d = doublet, dd = doublet of doublet, t = triplet, m = multiplet), coupling 
constants (Hz), and integration. High resolution mass spectra were obtained with a Thermo 
Fisher Scientific FinniganTM LTQ-ICR FTTM (all samples prepared in methanol). Melting 
points were obtained using a Thomas Hoover UniMelt Capillary Melting Point Apparatus. 
Analytical thin layer chromatography was carried out using Whatman 0.25 mm silica gel 60 
plates, Sorbent Technologies 0.20 mm Silica Gel TLC plates. Visualization was allowed by 
UV light, phosphomolybdic acid in ethanol, or aqueous ceric ammonium nitrate solution. 
HPLC analysis was performed on a Perkin Elmer flexar photodiode array (PDA) system 
equipped with Daicel IA, IC, AD, and OD-H columns. Asymmetric reactions were carried out 
in a Thermo Sigma UCR-150N aluminum block UC reactor with stirring. Purification of the 
reaction products was carried out by using Siliaflash-P60 silica gel (40- 63μm) purchased from 
Silicycle. Yields refer to isolated yields after flash column chromatography; some samples 
contain residual minor diastereomers. Optical rotations of enantioenriched products were taken 
after purification using silica flash column chromatography. Since all asymmetric trial results are 
the averages of two trials, the stereoisomer ratios listed in the text above may not exactly match 
those represented in the NMR and HPLC data below. The relative and absolute 
stereoconfiguration of 1.14d was determined using X-ray diffraction analysis, and the 
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stereochemistry of products 1.14 were assigned by analogy. 
 
Materials: Diethyl ether (Et2O) was passed through a column of neutral alumina under 
nitrogen prior to use. Wittig reagents were prepared according to a literature procedure.75 
Triaryliminophosphorane catalysts 1.4, 1.15-1.16 were prepared according to literature 
procedures.37,41 Commercially available nitroethane and nitropropane were used as received. 
Raney®-Nickel 2800 (W.R. Grace and Co. Raney®) slurry in H2O was used as received. 
 
General procedure for synthesis of enone diesters: 
A modification of literature procedures was used.66,76 A flame-dried 100 mL round-bottomed 
flask equipped with a reflux condenser was charged with Rh2(OAc)4 (0.046 mmol, 0.02 equiv), 
toluene (10 mL), and propylene oxide (22.4 mmol, 10.0 equiv). The mixture was heated to 
85 °C in an oil bath for 10 min. A solution of di-tert-butyl 2-diazomalonate77 (2.25 mmol, 1.0 
equiv) in toluene (2 mL) was added dropwise. An additional volume of toluene (1 mL) was 
used as a rinse to complete the addition of the diazomalonate. The reaction was stirred at 85 °C 
for 1 h then allowed to return to room temperature. The reaction flask was placed in an ice 
bath. MgSO4 (500 mg) was added to the reaction, followed by the appropriate Wittig reagent 
(3.37 mmol, 1.5 equiv). The reaction was allowed to slowly warm to room temperature and 
was stirred for 16 h. The crude mixture was filtered through a short silica plug with CH2Cl2 (to 
remove solids) and concentrated in vacuo. The crude materials thusly obtained were purified 
using flash column chromatography, with the gradient noted below. 
 
Characterization data for enone diesters: 
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Di-tert-butyl 2-(2-oxo-2-phenylethylidene)malonate (1.12a): The 
title compound was prepared on a larger scale according to the general 
procedure. Di-tert-butyl 2-diazomalonate (8.49 g, 35.0 mmol) was 
used and all components of the general procedure were scaled proportionally. The crude 
material was purified using flash column chromatography, with a gradient from 95:5 
hexanes/EtOAc to 85:15 hexanes/EtOAc. Yellow solid (8.53 g, 25.7 mmol, 73%), mp 89-
90 °C; 1H NMR (600 MHz, CDCl3) δ 8.01-7.99 (m, 2H), 7.68 (s, 1H), 7.65-7.62 (m, 1H), 
7.53-7.51 (m, 2H), 1.57 (s, 9H), 1.49 (s, 9H); 13C NMR (151 MHz, CDCl3) δ189.6, 163.7, 
162.2, 138.9, 136.3, 134.0, 133.2, 128.9, 128.9, 83.3, 83.0, 27.9, 27.8. IR (thin film) ν 2979, 
1724, 1673, 1450, 1369, 1278, 1257, 1156, 1069, 866 cm-1. HRMS (ESI): Calcd. For 
C19H24NaO5
+ ([M+Na+]): 355.1516, found 355.1509. TLC (10:90 EtOAc/hexanes): Rf = 0.32. 
 
 Di-tert-butyl 2-(2-(4-fluorophenyl)-2-oxoethylidene)malonate 
(1.12b): The title compound was prepared according to the general 
procedure. The crude material was purified using flash column 
chromatography, with a gradient from pure hexanes to 95:5 hexanes/EtOAc. Yellow oil (544.0 
mg, 1.55 mmol, 69%); 1H NMR (600 MHz, CDCl3) δ 8.04-8.02 (m, 2H), 7.64 (s, 1H), 7.20-
7.18 (m, 2H), 1.56 (s, 9H), 1.50 (s, 9H); 13C NMR (151 MHz, CDCl3) δ188.0, 166.3 (d, J = 
256.8 Hz), 163.6, 162.1, 139.1, 132.9, 132.8 (d, J = 3.0 Hz), 131.6 (d, J = 9.4 Hz), 116.1 (d, J 
= 22.1 Hz), 83.4, 83.1, 27.9, 27.8; 19F NMR (565 MHz, CDCl3) δ -103.18. IR (thin film) ν 
3437, 2980, 1724, 1673, 1598, 1541, 1369, 1279, 1155, 1070 cm-1. HRMS (ESI): Calcd. For 
C19H23FNaO5





(1.12c): The title compound was prepared according to the 
general procedure. The crude material was purified using flash 
column chromatography, with a gradient from pure hexanes to 95:5 hexanes/EtOAc. Yellow 
solid (528.0 mg, 1.44 mmol, 64%), mp 63-64 °C; 1H NMR (600 MHz, CDCl3) δ 7.94 (d, J = 
8.6 Hz, 2H), 7.63 (s, 1H), 7.49 (d, J = 8.6 Hz, 2H), 1.56 (s, 9H), 1.50 (s, 9H); 13C NMR (151 
MHz, CDCl3) δ188.3, 163.6, 162.1, 140.6, 139.4, 134.7, 132.5, 130.2, 129.2, 83.5, 83.2, 27.9, 
27.8. IR (thin film) ν 2979, 2934, 1725, 1673, 1589, 1369, 1258, 1158, 1092, 847 cm-1. HRMS 
(ESI): Calcd. For C19H23ClNaO5
+ ([M+Na+]): 389.1126, found 389.1119. TLC (10:90 
EtOAc/hexanes): Rf = 0.34. 
 
 Di-tert-butyl 2-(2-(4-bromophenyl)-2-
oxoethylidene)malonate (1.12d): The title compound was 
prepared according to the general procedure. The crude material 
was purified using flash column chromatography, with a gradient from pure hexanes to 95:5 
hexanes/EtOAc. Light yellow solid (626.6 mg, 1.52 mmol, 68%), mp 73-74 °C; 1H NMR (600 
MHz, CDCl3) δ 7.85 (d, J = 8.5 Hz, 2H), 7.66 (d, J = 8.5 Hz, 1H), 7.62 (s, 1H), 1.56 (s, 9H), 
1.50 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 188.5, 163.6, 162.0, 139.5, 135.1, 132.4, 132.2, 
130.3, 129.4, 83.5, 83.2, 27.9, 27.8. IR (thin film) ν 2979, 2933, 1725, 1672, 1586, 1569, 1369, 
1278, 1159, 1071 cm-1. HRMS (ESI): Calcd. For C19H23BrNaO5
+ ([M+Na+]): 433.0621, found 




(1.12e): The title compound was prepared according to the 
general procedure. The crude material was purified using flash 
column chromatography, with a gradient from pure hexanes to 90:10 hexanes/EtOAc. Yellow 
solid (407.2 mg, 1.14 mmol, 51%), mp 72-73 °C; 1H NMR (600 MHz, CDCl3) δ 8.08 (d, J = 
8.3 Hz, 2H), 7.83 (d, J = 8.2 Hz, 2H), 7.62 (s, 1H), 1.56 (s, 9H), 1.51 (s, 9H); 13C NMR (151 
MHz, CDCl3) δ 188.3, 163.3, 161.8, 140.4, 139.2, 132.7, 131.6, 129.2, 117.8, 117.1, 83.7, 83.5, 
27.9, 27.8. IR (thin film) ν 2980, 2935, 2232, 1725, 1677, 1370, 1279, 1158, 1071, 847 cm-1. 
HRMS (ESI): Calcd. For C20H23NNaO5
+ ([M+Na+]): 380.1468, found 380.1463. TLC (10:90 
EtOAc/hexanes): Rf = 0.14. 
 
Di-tert-butyl 2-(2-(4-nitrophenyl)-2-oxoethylidene)malonate 
(1.12f): The title compound was prepared according to the 
general procedure. The crude material was purified using flash 
column chromatography, with a gradient from pure hexanes to 85:15 hexanes/EtOAc. Yellow 
solid (598.1 mg, 1.58 mmol, 70%), mp 77-78 °C; 1H NMR (600 MHz, CDCl3) δ 8.37 (d, J = 
8.9 Hz, 2H), 8.16 (d, J = 8.9 Hz, 2H), 7.65 (s, 1H), 1.57 (s, 9H), 1.52 (s, 9H); 13C NMR (151 
MHz, CDCl3) δ 188.0, 163.3, 161.8, 150.7, 140.7, 140.5, 131.5, 129.8, 124.1, 83.8, 83.5, 27.9, 
27.8. IR (thin film) ν 2980, 2360, 1725, 1678, 1530, 1370, 1347, 1278, 1157, 847 cm-1. HRMS 
(ESI): Calcd. For C19H23NNaO7
+ ([M+Na+]): 400.1367, found 400.1358. TLC (10:90 




(trifluoromethyl)phenyl)ethylidene)malonate (1.12g): The 
title compound was prepared according to the general 
procedure. The crude material was purified using flash column chromatography, with a 
gradient from pure hexanes to 90:10 hexanes/EtOAc. Yellow oil (550.6 mg, 1.38 mmol, 61%); 
1H NMR (600 MHz, CDCl3) δ 8.10 (d, J = 8.2 Hz, 2H), 7.79 (d, J = 8.2 Hz, 2H), 7.66 (s, 1H), 
1.60 (s, 9H), 1.51 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 188.6, 163.4, 161.9, 140.0, 139.0, 
135.1 (q, J = 32.8 Hz), 132.0, 129.1, 125.9 (q, J = 3.7 Hz), 123.4 (q, J = 273.0 Hz), 83.6, 83.3, 
27.9, 27.8; 19F NMR (565 MHz, CDCl3) δ -63.19. IR (thin film) ν 2981, 1726, 1678, 1370, 
1326, 1279, 1258, 1161, 1067, 1032 cm-1. HRMS (ESI): Calcd. For C20H23F3NaO5
+ 
([M+Na+]): 423.1390, found 423.1383. TLC (10:90 EtOAc/hexanes): Rf = 0.34. 
 
Di-tert-butyl 2-(2-(benzo[d][1,3]dioxol-5-yl)-2-
oxoethylidene)malonate (1.12h): The title compound was 
prepared according to the general procedure. The crude material 
was purified using flash column chromatography, with a gradient from pure hexanes to 80:20 
hexanes/EtOAc. Yellow solid (506.0 mg, 1.34 mmol, 60%), mp 55-56 °C; 1H NMR (600 MHz, 
CDCl3) δ 7.62 (s, 1H), 7.59 (d, J = 8.2, 1H), 7.48 (s, 1H), 6.89 (d, J = 8.2 Hz, 1H), 6.09 (s, 
2H), 1.56 (s, 9H), 1.51 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 187.5, 163.8, 162.3, 152.7, 
148.6, 138.5, 133.4, 131.3, 126.0, 108.1, 108.1, 102.1, 83.2, 82.9, 27.9, 27.8. IR (thin film) ν 
2979, 2933, 1723, 1664, 1603, 1505, 1446, 1369, 1259, 1161 cm-1. HRMS (ESI): Calcd. For 
C20H24NaO7




oxoethylidene)malonate (1.12i): The title compound was 
prepared according to the general procedure. The crude material 
was purified using flash column chromatography, with a gradient from pure hexanes to 90:10 
hexanes/EtOAc. White solid (612.8 mg, 1.69 mmol, 75%), mp 93-94 °C; 1H NMR (600 MHz, 
CDCl3) δ 7.98 (d, J = 8.8 Hz, 2H), 7.67 (s, 1H), 6.98 (d, J = 8.8 Hz, 2H), 3.91 (s, 3H), 1.56 (s, 
9H), 1.50 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 187.9, 164.3, 163.9, 162.4, 138.3, 133.5, 
131.3, 129.5, 114.1, 83.2, 82.8, 55.6, 27.9, 27.8. IR (thin film) ν 2979, 1724, 1666, 1599, 1512, 
1369, 1281, 1257, 1161, 847 cm-1. HRMS (ESI): Calcd. For C20H26NaO6
+ ([M+Na+]): 
385.1622, found 385.1613. TLC (10:90 EtOAc/hexanes): Rf = 0.14. 
 
Di-tert-butyl 2-(2-(3-methoxyphenyl)-2-oxoethylidene)malonate 
(1.12j): The title compound was prepared according to the general 
procedure. The crude material was purified using flash column 
chromatography, with a gradient from pure hexanes to 90:10 hexanes/EtOAc. Yellow oil (617.3 
mg, 1.70 mmol, 76%); 1H NMR (600 MHz, CDCl3) δ 7.66 (s, 1H), 7.58-7.56 (m, 1H), 7.52-
7.51 (m, 1H), 7.42 (t, J = 8.0 Hz, 1H), 7.19-7.17 (m, 1H), 3.88 (s, 3H), 1.56 (s, 9H), 1.50 (s, 
9H); 13C NMR (151 MHz, CDCl3) δ 189.3, 163.7, 162.2, 160.0, 139.0, 137.7, 133.1, 129.8, 
121.8, 121.0, 112.4, 83.3, 83.0, 55.5, 27.9, 27.8. IR (thin film) ν 2979, 1724, 1672, 1597, 1456, 
1369, 1278, 1157, 1032, 848 cm-1. HRMS (ESI): Calcd. For C20H26NaO6
+ ([M+Na+]): 
385.1622, found 385.1612. TLC (10:90 EtOAc/hexanes): Rf = 0.25. 
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Di-tert-butyl 2-(2-(furan-2-yl)-2-oxoethylidene)malonate (1.12k): 
The title compound was prepared according to the general procedure. 
The crude material was purified using flash column chromatography, 
with a gradient from pure hexanes to 80:20 hexanes/EtOAc. White solid (389.0 mg, 1.21 mmol, 
54%), mp 67-68 °C; 1H NMR (600 MHz, CDCl3) δ 7.69 (m, 1H), 7.58 (s, 1H), 7.36 (d, J = 3.7 
Hz, 1H), 6.62 (dd, J = 3.6 Hz, 1.6 Hz, 1H), 1.59 (s, 9H), 1.55 (s, 9H); 13C NMR (151 MHz, 
CDCl3) δ 175.8, 163.9, 162.0, 152.7, 147.9, 140.0, 129.8, 119.6, 113.0, 83.4, 83.1, 27.9, 27.9. 
IR (thin film) ν 2979, 1732, 1669, 1558, 1465, 1370, 1258, 1158, 1071, 846 cm-1. HRMS 
(ESI): Calcd. For C17H22NaO6
+ ([M+Na+]): 345.1309, found 345.1302. TLC (10:90 
EtOAc/hexanes): Rf = 0.17. 
 
Di-tert-butyl 2-(2-oxo-2-(thiophen-2-yl)ethylidene)malonate 
(1.12): The title compound was prepared according to the general 
procedure. The crude material was purified using flash column 
chromatography, with a gradient from pure hexanes to 90:10 hexanes/EtOAc. Off-white solid 
(485.8 mg, 1.44 mmol, 64%), mp 84-85 °C; 1H NMR (600 MHz, CDCl3) δ 7.83 (dd, J = 3.9, 
1.0 Hz, 1H), 7.76 (dd, J = 4.9, 1.0 Hz, 1H), 7.58 (s, 1H), 7.19 (dd, J = 4.9, 3.8 Hz, 1H), 1.56 
(s, 18H); 13C NMR (151 MHz, CDCl3) δ 180.7, 163.7, 162.1, 144.2, 139.4, 135.8, 133.7, 
131.2, 128.6, 83.4, 83.1, 27.9, 27.9. IR (thin film) ν 2979, 1726, 1656, 1516, 1415, 1369, 1282, 
1257, 1156, 1066 cm-1. HRMS (ESI): Calcd. For C17H22NaO5S
+ ([M+Na+]): 361.1080, found 
361.1073. TLC (10:90 EtOAc/hexanes): Rf = 0.18. 
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 Di-tert-butyl 2-(2-oxo-2-(pyridin-4-yl)ethylidene)malonate 
(1.12m): The title compound was prepared according to the general 
procedure, but better results were obtained on larger scale. Di-tert-
butyl 2-diazomalonate (3.00 g, 12.4 mmol) was used and all components of the general 
procedure were scaled appropriately. The crude material was purified using flash column 
chromatography, with a gradient from 95:5 hexanes/EtOAc to 40:60 hexanes/EtOAc. Low-
melting red-brown solid (2.23 g, 6.70 mmol, 54%); 1H NMR (600 MHz, CDCl3) δ 8.87 (br s, 
2H), 7.78 (br s, 2H), 7.61 (s, 1H), 1.57 (s, 9H), 1.52 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 
188.8, 163.3, 161.8, 151.2, 142.1, 140.7, 130.9, 121.4, 83.8, 83.5, 27.9, 27.8. IR (thin film) ν 
2979, 1725, 1682, 1370, 1279, 1223, 1158, 1072, 1032, 847 cm-1. HRMS (ESI): Calcd. For 
C18H23NNaO5
+ ([M+Na+]): 356.1468, found 356.1452. TLC (40:60 EtOAc/hexanes): Rf = 
0.35. 
 
 Di-tert-butyl 2-(2-oxopropylidene)malonate (1.12n): The title 
compound was prepared according to the general procedure. The crude 
material was purified using flash column chromatography, with a gradient from pure hexanes 
to 95:5 hexanes/EtOAc. Clear oil (282.4 mg, 1.04 mmol, 46%); 1H NMR (600 MHz, CDCl3) 
δ 6.97 (s, 1H), 2.35 (s, 3H), 1.58 (s, 9H), 1.52 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 196.4, 
163.9, 162.0, 138.1, 133.5, 83.4, 83.1, 30.8, 27.9 (2C). IR (thin film) ν 2980, 2935, 1730, 1703, 
1369, 1274, 1254, 1159, 1075, 848 cm-1. HRMS (ESI): Calcd. For C14H22NaO5
+ ([M+Na+]): 
293.1359, found 293.1356. TLC (10:90 EtOAc/hexanes): Rf = 0.24. 
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 Di-tert-butyl 2-(2-cyclopropyl-2-oxoethylidene)malonate (1.12o): 
The title compound was prepared according to the general procedure. 
The crude material was purified using flash column chromatography, with a gradient from pure 
hexanes to 95:5 hexanes/EtOAc. Clear oil (342.4 mg, 1.16 mmol, 51%); 1H NMR (600 MHz, 
CDCl3) δ 7.11 (s, 1H), 2.14-2.09 (m, 1H), 1.56 (s, 9H), 1.53 (s, 9H), 1.22-1.19 (m, 2H), 1.07-
1.04 (m, 2H); 13C NMR (151 MHz, CDCl3) δ 198.7, 164.0, 162.2, 137.4, 133.6, 83.2, 82.9, 
27.9, 27.9, 22.2, 12.6. IR (thin film) ν 2979, 1729, 1686, 1391, 1369, 1256, 1159, 1087, 1062, 
917 cm-1. HRMS (ESI): Calcd. For C16H24NaO5
+ ([M+Na+]): 319.1516, found 319.1510. TLC 
(10:90 EtOAc/hexanes): Rf = 0.29. 
 
Optimization of asymmetric conjugate addition of nitroalkanes: 
General procedure: A test tube was charged with enone diester (0.1 mmol, 1.0 equiv), 
nitroalkane (amount listed in Table 1-1), 1,3,5-trimethoxybenzene (0.1 mmol, 1.0 equiv; 
internal standard), and solvent (listed in Table 1-1). The reaction was cooled to -60 °C and 
catalyst (amount listed in Table 1-1) was added. The reaction was stirred for the listed amount 
of time and then quenched with 50 L of a 0.5 M TFA/toluene solution before flowing it 
through a short plug of SiO2 with diethyl ether. The filtrate was concentrated in vacuo to 
provide the crude product mixture, which was purified via flash column chromatography. 
 
General procedure for asymmetric conjugate addition of nitroalkanes: 
A flame-dried test tube was charged sequentially with enone diester (0.1 mmol, 1.0 equiv), 
Et2O (1.0 mL), and nitroethane (2.1 mmol, 21.0 equiv). The reaction was stirred at -60 °C in a 
cryogenic cooling apparatus for 15 min, then triaryliminophosphorane catalyst 1.15 (0.02 
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mmol, 0.20 equiv) was added. The reaction was then stirred at -60 °C for 24 h. After this period, 
the reaction was quenched with a TFA solution in toluene (50 L, 0.5 M solution) at the same 
temperature. Additional Et2O was used to flush the reaction through a short plug of silica and 
the filtrate was concentrated in vacuo. The crude material thusly obtained was purified using 
flash column chromatography with a gradient from 97.5:2.5 hexanes/EtOAc to 90:10 
hexanes/EtOAc unless otherwise noted. 
 
Gram scale asymmetric conjugate addition reaction: 
A flame-dried 100 mL round-bottomed flask was charged sequentially with enone diester 1.12a 
(1.00 g, 3.01 mmol, 1.0 equiv), Et2O (30.0 mL), and nitroethane (4.50 mL, 62.6 mmol, 20.8 
equiv). The reaction was stirred at -60 °C in a cryogenic cooling apparatus for 15 min, then 
triaryliminophosphorane catalyst 1.15 (401.7 mg, 0.60 mmol, 0.20 equiv) was added. The 
reaction was then stirred at -60 °C for 24 h. After this period, the reaction was quenched with 
a TFA solution in toluene (1.5 mL, 0.5M solution) at the same temperature. Additional Et2O 
was used to flush the reaction through a short plug of silica and the filtrate was concentrated 
in vacuo. The crude material thusly obtained was purified using flash column chromatography 
with a gradient from 97.5:2.5 hexanes/EtOAc to 90:10 hexanes/EtOAc, yielding 1.05 g (86%) 
1.14a as a white solid in >20:1 dr and >99.5:0.5 er. 
 




yl)malonate (1.14a): The title compound was prepared according to 
the general procedure. No minor diastereomer was observed in the 1H 
NMR spectrum of the unpurified product. White solid (34.7 mg, 0.085 mmol, 85%), mp 93-
94 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 7.99 (d, J = 7.4 Hz, 2H), 7.61 (t, 7.4 Hz, 1H), 
7.5 (t, J = 7.8 Hz, 2H), 4.92-4.86 (m, 2H), 3.87 (d, J = 9.8 Hz, 1H), 1.52 (s, 9H), 1.47 (d, 6.7 
Hz, 3H), 1.35 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 197.3, 166.8, 166.2, 137.1, 133.9, 128.8, 
128.6, 83.2, 83.0, 82.4, 55.0, 46.5, 27.8, 27.7, 15.3. IR (thin film) ν 2979, 1729, 1682, 1557, 
1370, 1257, 1143, 842, 734, 692 cm-1. HRMS (ESI): Calcd. For C21H29NNaO7
+ ([M+Na+]): 
430.1842, found 430.1831. HPLC Derivatized to 1.13a for determination of enantiopurity. 
TLC (10:90 EtOAc/hexanes): Rf = 0.25. [α]D = +80.2 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-1-(4-fluorophenyl)-3-nitro-1-
oxobutan-2-yl)malonate (1.14b): The title compound was 
prepared according to the general procedure. The diastereomeric 
ratio was determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the resonances at δ 3.92 (minor diastereomer) and δ 3.86 (major diastereomer). 
The crude material was purified using flash column chromatography, with a gradient from 
97.5:2.5 hexanes/EtOAc to 95:5 hexanes/EtOAc. White solid (34.9 mg, 0.082 mmol, 82%), 
mp 89-90 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 8.02 (dd, J = 8.8, 5.3 Hz, 2H), 7.17 (t, 
J = 8.6 Hz, 2H), 4.88-4.83 (m, 2H), 3.87 (d, J = 9.9 Hz, 1H), 1.53 (s, 9H), 1.48 (d, J = 6 Hz, 
3H), 1.36 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 195.7, 166.7, 166.2, 166.2 (d, J = 256.7 Hz), 
133.6, 131.3 (d, J = 9.1 Hz), 116.0 (d, J = 21.14 Hz), 83.3, 83.1, 82.4, 54.9, 46.4, 27.8, 27.8, 
35 
15.0; 19F NMR (565 MHz, CDCl3) δ -103.8. IR (thin film) ν 2980, 1729, 1683, 1599, 1557, 
1394, 1370, 1257, 1158, 848 cm-1. HRMS (ESI): Calcd. For C21H28FNNaO7
+ ([M+Na+]): 
448.1748, found 448.1729. HPLC Chiralpak AD column, Hex/iPrOH = 98:2, flow rate = 1.0 
mL/min, λ = 210 nm, 9.0 min (minor isomer), 16.4 min (major isomer). TLC (10:90 
EtOAc/hexanes): Rf = 0.16. [α]D = +75.2 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-1-(4-chlorophenyl)-3-nitro-1-
oxobutan-2-yl)malonate (1.14c): The title compound was 
prepared according to the general procedure. The diastereomeric 
ratio was determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the resonances at δ 3.92 (minor diastereomer) and δ 3.87 (major diastereomer). 
The crude material was purified using flash column chromatography, with a gradient from 
97.5:2.5 hexanes/EtOAc to 95:5 hexanes/EtOAc. White solid (39.0 mg, 0.088 mmol, 88%), 
mp 83-84 °C (decomp); 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.6 Hz, 2H), 7.46 (d, J = 
8.6 Hz, 2H), 4.89-4.81 (m, 2H), 3.86 (d, J = 9.9 Hz, 1H), 1.52 (s, 9H), 1.47 (d, J = 6.6 Hz, 3H), 
1.36 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 196.1, 166.6, 166.2, 140.4, 135.5, 130.0, 129.1, 
83.3, 83.1, 82.4, 55.0, 46.4, 27.8, 27.7, 15.1. IR (thin film) ν 2980, 1728, 1683, 1557, 1370, 
1258, 1163, 1093, 846, 736 cm-1. HRMS (ESI): Calcd. For C21H28ClNNaO7
+ ([M+Na+]): 
464.1452, found 464.1435. HPLC Chiralpak AD column, Hex/iPrOH = 98:2, flow rate = 1.0 
mL/min, λ = 210 nm, 9.1 min (minor isomer), 21.8 min (major isomer). TLC (10:90 




oxobutan-2-yl)malonate (1.14d): The title compound was 
prepared according to the general procedure. The diastereomeric 
ratio was determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the resonances at δ 3.92 (minor diastereomer) and δ 3.86 (major diastereomer). 
Some residual minor diastereomer was still present in the isolated material. The crude material 
was purified using flash column chromatography, with a gradient from 97.5:2.5 
hexanes/EtOAc to 95:5 hexanes/EtOAc. White solid (41.1 mg, 0.085 mmol, 85%), mp 80-
81 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 7.85 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.5 Hz, 
2H), 4.88-4.81 (m, 2H), 3.86 (d, J = 10.1 Hz, 1H), 1.52 (s, 9H), 1.48 (d, J = 6.7 Hz, 3H), 1.36 
(s, 9H); 13C NMR (151 MHz, CDCl3) δ 196.4, 166.6, 166.2, 135.9, 132.1, 130.1, 129.3, 83.3, 
83.1, 82.4, 55.0, 46.4, 27.8, 27.7, 15.1. IR (thin film) ν 2979, 1728, 1683, 1557, 1370, 1258, 
1144, 1072, 845, 738 cm-1. HRMS (ESI): Calcd. For C21H28BrNNaO7
+ ([M+Na+]): 508.0947, 
found 508.0928. HPLC Chiralpak AD column, Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ 
= 210 nm, 12.9 min (minor isomer), 32.9 min (major isomer). TLC (10:90 EtOAc/hexanes): 
Rf = 0.31. [α]D = +61.4 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-1-(4-cyanophenyl)-3-nitro-1-
oxobutan-2-yl)malonate (1.14e): The title compound was 
prepared according to the general procedure. No minor 
diastereomer was observed in the 1H NMR spectrum of the unpurified product. The crude 
material was purified using flash column chromatography, with a gradient from 97.5:2.5 
hexanes/EtOAc to 90:10 hexanes/EtOAc. White solid (41.3 mg, 0.95 mmol, 95%), mp 116-
37 
117 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 8.07 (d, J = 8.4 Hz, 2H), 7.80 (d, J = 8.4 Hz, 
2H), 4.86-4.81 (m, 2H), 3.89 (d, J = 10.1 Hz, 1H), 1.54 (s, 9H), 1.50 (d, J = 6.7 Hz, 3H), 1.37 
(s, 9H); 13C NMR (151 MHz, CDCl3) δ 196.5, 166.4, 166.3, 140.1, 132.6, 128.9, 117.9, 116.8, 
83.6, 83.4, 82.3, 55.1, 46.4, 27.8, 27.7, 14.8. IR (thin film) ν 2980, 2360, 1727, 1688, 1557, 
1370, 1294, 1257, 1143, 848 cm-1. HRMS (ESI): Calcd. For C22H28N2NaO7
+ ([M+Na+]): 
455.1794, found 455.1782. HPLC Chiralpak IC column, Hex/iPrOH = 99:1, flow rate = 1.0 
mL/min, λ = 254 nm, 41.1 min (minor isomer), 43.2 min (major isomer). TLC (10:90 
EtOAc/hexanes): Rf = 0.11. [α]D = +47.5 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-3-nitro-1-(4-nitrophenyl)-1-
oxobutan-2-yl)malonate (1.14f): The title compound was 
prepared according to the general procedure. No minor 
diastereomer was observed in the 1H NMR spectrum of the unpurified product. The crude 
material was purified using flash column chromatography, with a gradient from 97.5:2.5 
hexanes/EtOAc to 90:10 hexanes/EtOAc. White solid (42.1 mg, 0.093 mmol, 93%), mp 109-
110 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 8.34 (d, J = 8.8 Hz, 2H), 8.14 (d, J = 8.7 Hz, 
2H), 4.86 (d, J = 8.8 Hz, 2H), 3.90 (d, J = 10.1 Hz, 1H), 1.54 (s, 9H), 1.52 (d, J = 6.7 Hz, 3H), 
1.38 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 196.4, 166.4, 166.3, 150.5, 141.6, 129.6, 123.9, 
83.6, 83.5, 82.3, 55.1, 46.7, 27.8, 27.7, 14.8. IR (thin film) ν 2980, 2936, 2349, 1727, 1530, 
1346, 1258, 1144, 850, 734 cm-1. HRMS (ESI): Calcd. For C21H28N2NaO9
+ ([M+Na+]): 
475.1693, found 475.1681. HPLC Chiralpak OD-H column, Hex/iPrOH = 99:1, flow rate = 
1.0 mL/min, λ = 254 nm, 11.8 min (major isomer), 13.9 min (major isomer). TLC (10:90 




(trifluoromethyl)phenyl)butan-2-yl)malonate (1.14g): The 
title compound was prepared according to the general 
procedure. No minor diastereomer was observed in the 1H NMR spectrum of the unpurified 
product. The crude material was purified using flash column chromatography, with a gradient 
from 97.5:2.5 hexanes/EtOAc to 90:10 hexanes/EtOAc. Yellow solid (46.0 mg, 0.097 mmol, 
97%), mp 68-69 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 8.09 (d, J = 8.2 Hz, 2H), 7.76 
(d, J = 8.16 Hz, 2H), 4.87 (d, J = 7.7 Hz, 2H), 3.89 (d, 9.8 Hz, 1H), 1.53 (s, 9H), 1.50 (d, J = 
6.1 Hz, 3H), 1.37 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 196.7, 166.5, 166.3, 139.8, 134.8 (q, 
J = 33.2 Hz), 128.9, 125.8 (q, J = 3 Hz), 123.5 (q, J = 273.3 Hz), 83.4, 83.3, 82.3, 55.0, 46.6, 
27.8, 27.7, 15.0; 19F NMR (565 MHz, CDCl3) δ -63.2. IR (thin film) ν 2981, 2937, 1728, 1689, 
1558, 1371, 1325, 1169, 1067, 850 cm-1. HRMS (ESI): Calcd. For C22H28F3NNaO7
+ 
([M+Na+]): 498.1716, found 498.1696. HPLC Chiralpak AD column, Hex/iPrOH = 98:2, flow 
rate = 1.0 mL/min, λ = 215 nm, 6.5 min (minor isomer), 20.0 min (major isomer). TLC (10:90 
EtOAc/hexanes): Rf = 0.29. [α]D = +67.1 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-1-(benzo[d][1,3]dioxol-5-yl)-3-nitro-
1-oxobutan-2-yl)malonate (1.14h): The title compound was 
prepared according to the general procedure. The diastereomeric 
ratio was determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the resonances at δ 3.93 (minor diastereomer) and δ 3.85 (major diastereomer). 
The crude material was purified using flash column chromatography, with a gradient from 
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97.5:2.5 hexanes/EtOAc to 90:10 hexanes/EtOAc. White solid (35.8 mg, 0.079 mmol, 79%), 
mp 91-92 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 7.61 (dd, J = 8.3, 1.7 Hz, 1H), 7.45 (d, 
J = 1.6 Hz, 1H), 6.88 (d, J = 8.2 Hz, 1H), 6.08 (s, 2H), 4.88-4.83 (m, 1H), 4.79 (dd, J = 10.2, 
5.3 Hz, 1H), 3.85 (d, J = 10.2 Hz), 1.52 (s, 9H), 1.47 (d, J = 6.8 Hz, 3H), 1.37 (s, 9H); 13C 
NMR (151 MHz, CDCl3) δ 194.9, 166.8, 166.2, 152.6, 148.4, 131.9, 125.4, 108.2, 108.1, 
102.1, 83.2, 82.9, 82.5, 55.0, 46.4, 27.8, 27.7, 15.2. IR (thin film) ν 3443, 2937, 2349, 1728, 
1673, 1556, 1444, 1260, 1144, 1038 cm-1. HRMS (ESI): Calcd. For C22H29NNaO9
+ 
([M+Na+]): 474.1740, found 474.1717. HPLC Chiralpak AD column, Hex/iPrOH = 96:4, flow 
rate = 1.0 mL/min, λ = 205 nm, 13.9 min (minor isomer), 18.5 min (major isomer). TLC (10:90 
EtOAc/hexanes): Rf = 0.22. [α]D = +77.5 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-1-(4-methoxyphenyl)-3-nitro-1-
oxobutan-2-yl)malonate (1.14i): The title compound was 
prepared according to the general procedure. The 
diastereomeric ratio was determined by 1H NMR spectroscopic analysis of the crude reaction 
mixture by comparison of the resonances at δ 5.05-4.99 (minor diastereomer) and δ 4.90-4.83 
(major diastereomer). Some residual minor diastereomer was still present in the isolated 
material. The crude material was purified using flash column chromatography, with a gradient 
from 97.5:2.5 hexanes/EtOAc to 90:10 hexanes/EtOAc. White solid (37.6 mg, 0.086 mmol, 
86%), mp 63-64 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 7.97 (d, J = 8.8 Hz, 2H), 6.96 
(d, J = 8.8 Hz, 2H), 4.89-4.84 (m, 2H), 3.89 (s, 3H), 3.86 (d, J = 9.7 Hz, 1H), 1.52 (s, 9H), 1.47 
(d, J = 6.5 Hz, 3H), 1.34 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 195.3, 166.9, 166.2, 164.2, 
131.0, 130.1, 114.0, 83.1, 82.8, 82.6, 55.5, 54.9, 46.3, 27.8, 27.7, 15.2. IR (thin film) ν 2979, 
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2360, 1729, 1672, 1601, 1556, 1263, 1168, 1030, 846 cm-1. HRMS (ESI): Calcd. For 
C22H31NNaO8
+ ([M+Na+]): 460.1948, found 460.1926. HPLC Chiralpak AD column, 
Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 nm, 20.3 min (minor isomer), 29.0 min 
(major isomer). TLC (10:90 EtOAc/hexanes): Rf = 0.17. [α]D = +77.9 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-1-(3-methoxyphenyl)-3-nitro-1-
oxobutan-2-yl)malonate (1.14j): The title compound was 
prepared according to the general procedure. No minor 
diastereomer was observed in the 1H NMR spectrum of the unpurified product. The crude 
material was purified using flash column chromatography, with a gradient from 97.5:2.5 
hexanes/EtOAc to 90:10 hexanes/EtOAc. White solid (37.1 mg, 0.085 mmol, 85%), mp 80-
81 °C (decomp); 1H NMR (400 MHz, CDCl3) δ 7.58 (d, J = 7.8 Hz, 1H), 7.49 (s, 1H), 7.40 (t, 
J = 8.0 Hz, 1H), 7.15 (dd, J = 8.2, 2.0 Hz, 1H), 4.91-4.84 (m, 2H), 3.88 (s, 3H), 3.85 (d, signal 
overlap prevents J value calculation, 1H), 1.52 (s, 9H), 1.47 (d, J = 6.6 Hz, 3H), 1.35 (s, 9H); 
13C NMR (151 MHz, CDCl3) δ 196.9, 166.8, 166.2, 159.8, 138.3, 129.8, 121.4, 120.6, 112.5, 
83.2, 83.0, 82.4, 55.5, 55.0, 46.7, 27.8, 27.7, 15.4. IR (thin film) ν 2979, 2937, 1729, 1683, 
1557, 1456, 1370, 1270, 1144, 840 cm-1. HRMS (ESI): Calcd. For C22H31NNaO8
+ ([M+Na+]): 
460.1948, found 460.1926. HPLC Chiralpak OD-H column, Hex/iPrOH = 95:5, flow rate = 
1.0 mL/min, λ = 205 nm, 25.3 min (major isomer), 50.5 min (minor isomer). TLC (10:90 




yl)malonate (1.14k): The title compound was prepared according to 
the general procedure. The diastereomeric ratio was determined by 1H 
NMR spectroscopic analysis of the crude reaction mixture by comparison of the resonances at 
δ 3.93 (minor diastereomer) and δ 3.81 (major diastereomer). The crude material was purified 
using flash column chromatography, with a gradient from 97.5:2.5 hexanes/EtOAc to 90:10 
hexanes/EtOAc. White solid (38.0 mg, 0.096 mmol, 96%), mp 88-89 °C (decomp); 1H NMR 
(600 MHz, CDCl3) δ 7.65 (app s, 1H), 7.31 (d, J = 3.6 Hz, 1H), 6.59 (dd, J = 3.5, 2.7 Hz, 1H), 
4.91-4.86 (m, 1H), 4.62 (dd, J = 10.4, 5.1 Hz, 1H), 3.82 (d, J = 10.4 Hz, 1H), 1.52 (d, signal 
overlap prevents J value calculation, 3H), 1.51 (s, 9H), 1.37 (s, 9H); 13C NMR (151 MHz, 
CDCl3) δ 184.6, 166.5, 166.0, 152.5, 147.6, 118.9, 112.9, 83.2, 83.0, 82.3, 54.2, 47.6, 27.8, 
27.7, 15.0. IR (thin film) ν 2980, 2359, 1730, 1674, 1558, 1466, 1296, 1144, 842, 768 cm-1. 
HRMS (ESI): Calcd. For C19H27NNaO8
+ ([M+Na+]): 420.1635, found 420.1623. HPLC 
Chiralpak AD column, Hex/iPrOH = 96:4, flow rate = 1.0 mL/min, λ = 210 nm, 10.4 min 
(minor isomer), 11.8 min (major isomer). TLC (10:90 EtOAc/hexanes): Rf = 0.15. [α]D = +65.2 
(c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-3-nitro-1-oxo-1-(thiophen-2-yl)butan-2-
yl)malonate (1.14l): The title compound was prepared according to 
the general procedure. The diastereomeric ratio was determined by 1H 
NMR spectroscopic analysis of the crude reaction mixture by comparison of the resonances at 
δ 3.93 (minor diastereomer) and δ 3.83 (major diastereomer). The crude material was purified 
using flash column chromatography, with a gradient from 97.5:2.5 hexanes/EtOAc to 90:10 
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hexanes/EtOAc. White solid (39.4 mg, 0.095 mmol, 95%), mp 100-101 °C (decomp); 1H NMR 
(400 MHz, CDCl3) δ 7.79 (dd, J = 3.8, 0.8 Hz, 1H), 7.72 (dd, J = 4.9, 0.9 Hz, 1H), 7.16 (dd, J 
= 4.8, 4.0 Hz, 1H), 4.94-4.87 (m, 1H), 4.66 (dd, J = 10.2, 5.3 Hz, 1H), 3.82 (d, J = 10.2 Hz, 
1H), 1.53 (d, J = 7.2 Hz, 3H), 1.51 (s, 9H), 1.35 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 189.0, 
166.6, 165.9, 144.4 135.7, 133.5, 128.6, 83.3, 83.0, 82.5, 54.6, 48.6, 27.8, 27.6, 15.2. IR (thin 
film) ν 2980, 1730, 1660, 1557, 1415, 1370, 1256, 1144, 838, 733 cm-1. HRMS (ESI): Calcd. 
For C19H27NNaO7S
+ ([M+Na+]): 436.1406, found 436.1394. HPLC Chiralpak AD column, 
Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 215 nm, 14.1 min (minor isomer), 22.6 min 
(major isomer). TLC (10:90 EtOAc/hexanes): Rf = 0.23. [α]D = +80.6 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-3-nitro-1-oxo-1-(pyridin-4-yl)butan-2-
yl)malonate (1.14m): The title compound was prepared according to 
the general procedure. No minor diastereomer was observed in the 
1H NMR spectrum of the unpurified product. The crude material was purified using flash 
column chromatography with a gradient from 90:10 hexanes/EtOAc to 60:40 hexanes/EtOAc. 
White solid (35.3 mg, 0.086 mmol, 86%), mp 95-96 °C (decomp); 1H NMR (600 MHz, CDCl3) 
δ 8.84 (d, J = 4.6 Hz, 2H), 7.76 (d, J = 4.6 Hz, 2H), 4.88-4.84 (m, 1H), 4.79 (dd, J = 10.3, 5.0 
Hz, 1H), 3.88 (d, J = 10.4 Hz, 1H), 1.53 (s, 9H), 1.51 (d, J = 6.9 Hz, 3H), 1.37 (s, 9H); 13C 
NMR (151 MHz, CDCl3) δ 197.3, 166.4, 166.2, 151.0, 143.0, 121.3, 83.5 (2C), 82.3, 55.1, 
46.4, 27.8, 27.7, 15.1. IR (thin film) ν 3438, 2980, 2935, 1727, 1696, 1557, 1370, 1257, 1144, 
845 cm-1. HRMS (ESI): Calcd. For C20H29N2O7
+ ([M+H+]): 409.1974, found 409.1958. HPLC 
Chiralpak IC column, Hex/iPrOH = 95:5, flow rate = 1.0 mL/min, λ = 225 nm, 12.1 min (minor 




Di-tert-butyl 2-((2R,3S)-2-nitro-4-oxopentan-3-yl)malonate (1.14n): 
The title compound was prepared according to the general procedure. 
The diastereomeric ratio was determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture by comparison of the resonances at δ 3.66 (minor 
diastereomer) and δ 3.60 (major diastereomer). The crude material was purified using flash 
column chromatography, with a gradient from 97.5:2.5 hexanes/EtOAc to 95:5 
hexanes/EtOAc. Low-melting white solid (26.3 mg, 0.076 mmol, 76%); 1H NMR (600 MHz, 
CDCl3) δ 4.73-4.69 (m, 1H), 4.02 (dd, J = 10.3, 4.7 Hz, 1H), 3.62 (d, J = 10.4 Hz, 1H), 2.30 
(s, 3H), 1.50 (s, 12H), 1.45 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 205.5, 166.6, 166.4, 83.2, 
83.0, 82.0, 54.6, 52.0, 32.5, 27.8 (2C), 14.7. IR (thin film) ν 2980, 1724, 1557, 1477, 1458, 
1395, 1316, 1144, 1256, 847 cm-1. HRMS (ESI): Calcd. For C16H27NNaO7
+ ([M+Na+]): 
368.1685, found 368.1671. HPLC Chiralpak AD column, Hex/iPrOH = 99:1, flow rate = 1.0 
mL/min, λ = 210 nm, 6.3 min (minor isomer), 10.2 min (major isomer). TLC (10:90 
EtOAc/hexanes): Rf = 0.34. [α]D = +30.8 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-1-cyclopropyl-3-nitro-1-oxobutan-2-
yl)malonate (1.14o): The title compound was prepared according to the 
general procedure. The diastereomeric ratio was determined by 1H 
NMR spectroscopic analysis of the crude reaction mixture by comparison of the resonances at 
δ 3.77 (minor diastereomer) and δ 3.62 (major diastereomer). The crude material was purified 
using flash column chromatography, with a gradient from 97.5:2.5 hexanes/EtOAc to 95:5 
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hexanes/EtOAc. White solid (33.3 mg, 0.090 mmol, 90%), mp 64-65 °C (decomp); 1H NMR 
(600 MHz, CDCl3) δ 4.76-4.72 (m, 1H), 4.32 (dd, J = 10.6, 4.7 Hz, 1H), 3.64 (d, J = 10.7 Hz, 
1H), 2.02-1.98 (m, 1H), 1.50 (s, 9H), 1.48 (d, J = 6.9 Hz, 3H), 1.44 (s, 9H), 1.17-1.12 (m, 1H), 
1.05-1.01 (m, 2H), 0.98-0.95 (m, 1H); 13C NMR (151 MHz, CDCl3) δ 207.2 166.7, 166.3, 
83.1, 82.7, 81.7, 54.2, 53.3, 27.8 (2C), 22.7, 14.6, 13.3, 12.9. IR (thin film) ν 2980, 2359, 1730, 
1556, 1393, 1370, 1294, 1256, 1146, 843 cm-1. HRMS (ESI): Calcd. For C18H29NNaO7
+ 
([M+Na+]): 394.1842, found 394.1826. HPLC Chiralpak AD column, Hex/iPrOH = 99:1, flow 
rate = 1.0 mL/min, λ = 210 nm, 7.9 min (minor isomer), 30.1 min (major isomer). TLC (10:90 
EtOAc/hexanes): Rf = 0.36. [α]D = +36.5 (c = 1.5, CHCl3). 
 
Di-tert-butyl 2-((2S,3R)-3-nitro-1-oxo-1-phenylpentan-2-
yl)malonate (1.14p): The title compound was prepared according to 
the general procedure. No minor diastereomer was observed in the 1H 
NMR spectrum of the unpurified product. The crude material was purified using flash column 
chromatography, with a gradient from 97.5:2.5 hexanes/EtOAc to 90:10 hexanes/EtOAc. 
White solid (41.7 mg, 0.099 mmol, 99%), mp 99-100 °C (decomp); 1H NMR (400 MHz, 
CDCl3) δ 8.00 (d, J = 7.4 Hz, 2H), 7.62 (t, J = 7.4 Hz, 1H), 7.50 (t, J = 7.6 Hz, 2H), 4.79 (dd, 
J = 9.4, 6.0 Hz, 1H), 4.73-4.68 (m, 1H), 3.87 (d, J = 9.4 Hz, 1H), 1.94-1.82 (m, 1H), 1.78-1.68 
(m, 1H), 1.51 (s, 9H), 1.35 (s, 9H), 0.88 (t, J = 7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 
197.3, 166.7, 166.2, 137.2, 133.8, 128.8, 128.6, 89.9, 83.1, 83.0, 55.2, 46.4, 27.8, 27.7, 23.5, 
10.8. IR (thin film) ν 2979, 1741, 1683, 1556, 1370, 1258, 1144, 845, 735, 692 cm-1. HRMS 
(ESI): Calcd. For C22H31NNaO7
+ ([M+Na+]): 444.1999, found 444.1981. HPLC Chiralpak AD 
column, Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 nm, 11.1 min (minor isomer), 
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14.1 min (major isomer). TLC (10:90 EtOAc/hexanes): Rf = 0.27. [α]D = +78.3 (c = 1.5, 
CHCl3). 
 
Procedure for transesterification of 1.14a: 
A one-dram vial with a stir bar was charged with di-tert-butyl ester 1.14a (0.058 mmol, 1.0 
equiv) and trifluoroacetic acid (0.5 mL). The reaction was stirred for 30 min, then placed under 
a stream of nitrogen to evaporate volatiles. The residue was dissolved in 3:2 toluene:MeOH (1 
mL, 0.06 M) and cooled in an ice bath. A solution of TMSCHN2 (2.0 M in Et2O) was added 
dropwise until a yellow color persisted. The reaction was stirred for 30 min at room 
temperature then quenched dropwise with glacial acetic acid; the acid was added until the 
yellow color disappeared. After stirring for 30 min, ethyl acetate was used to dilute the crude 
reaction and the organic layer was washed with an aqueous saturated sodium bicarbonate 
solution. The aqueous layer was extracted twice with ethyl acetate and the combined organic 
layers were dried with sodium sulfate, filtered, and concentrated in vacuo. The crude material 
thusly obtained was purified using flash column chromatography with a gradient from 97.5:2.5 
hexanes/EtOAc to 90:10 hexanes/EtOAc. 
 
Dimethyl 2-((2S,3R)-3-nitro-1-oxo-1-phenylbutan-2-yl)malonate 
(1.18a): The diastereomeric ratio of the isolated material was 
determined by 1H NMR spectroscopic analysis by comparison of the 
resonances at δ 4.22 (minor diastereomer) and δ 4.08 (major diastereomer). Clear oil (16.4 mg, 
0.051 mmol, 87%); 1H NMR (600 MHz, CDCl3) δ 8.02 (d, J = 7.3 Hz, 2H), 7.65-7.63 (m, 1H), 
7.54-7.51 (m, 2H), 4.98 (dd, J = 9.2, 6.5 Hz, 1H), 4.96-4.91 (m, 1H), 4.08 (d, J = 9.2 Hz, 1H), 
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3.80 (s, 3H), 3.69 (s, 3H), 1.47 (d, J = 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 197.3, 
167.8, 167.7, 136.8, 134.1, 128.9, 128.7, 82.3, 53.3, 53.2, 52.6, 46.7, 16.5. IR (thin film) ν 
2956, 1738, 1682, 1596, 1579, 1437, 1281, 1198, 968, 698 cm-1. HRMS (ESI): Calcd. For 
C15H17NNaO7
+ ([M+Na+]): 346.0897, found 346.0893. HPLC Chiralpak IC column, 
Hex/iPrOH = 97:3, flow rate = 1.0 mL/min, λ = 210 nm, 27.3 min (major isomer), 44.1 min 
(minor isomer). TLC (10:90 EtOAc/hexanes): Rf = 0.07. [α]D = +58.8 (c = 0.5, CHCl3). 
 
Local desymmetrization sequence for transesterification/lactamization of 1.14a: 
A scintillation vial with a stir bar was charged with di-tert-butyl ester 1.14a (0.25 mmol, 1.0 
equiv) and cooled in an ice bath. Trifluoroacetic acid (1.25 mL) was added slowly and the 
reaction was stirred for 30 min in the ice bath. The reaction was then placed under a stream of 
nitrogen to evaporate volatiles. The residue was dissolved in 3:2 toluene:MeOH (2.5 mL, 0.1 
M) and cooled in an ice bath. A solution of TMSCHN2 (2.0 M in Et2O) was added dropwise 
until a yellow color persisted. The reaction was stirred for 30 min at room temperature and 
then cooled in an ice bath while it was quenched dropwise with glacial acetic acid; the acid 
was added until the yellow color disappeared. The reaction was allowed to return to room 
temperature and stir for 30 min. Ethyl acetate was used to dilute the crude reaction and the 
organic layer was washed with an aqueous saturated sodium bicarbonate solution. The aqueous 
layer was extracted twice with ethyl acetate and the combined organic layers were dried with 
sodium sulfate, filtered, and concentrated in vacuo. 1H NMR analysis of this crude material 
indicated that it was >20:1 dr. The material was concentrated into a scintillation vial, where it 
was dissolved in EtOH (2.0 mL) and treated with Raney®-Nickel 2800 slurry in H2O (250 
mg). The reaction was placed in a high pressure Parr reactor under H2 (60 psi); the vessel was 
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filled and purged three times before finally refilling and allowing the reaction to stir under H2 
(60 psi) for 24 h at room temperature. The crude reaction was filtered through a Celite® plug 
with EtOH and concentrated in vacuo. The diastereomeric ratio could not be determined from 
the 1H NMR spectrum of the unpurified product. The crude material was purified using flash 
column chromatography, with a gradient from 60:40 hexanes/EtOAc to 40:60 hexanes/EtOAc 
to obtain the lactam product. 
 
Methyl (3S,4S,5R)-4-benzoyl-5-methyl-2-oxopyrrolidine-3-
carboxylate (1.19a): The title compound was prepared according to 
the above procedure. The diastereoselectivity could not be determined 
from the 1H NMR spectrum of the unpurified product. Once isolated, the product was found to 
be 9.1:1 dr, which was determined by comparing the signals in the 1H NMR spectrum at δ 1.38 
(major) and δ 1.34 (minor). Clear oil (29.3 mg, 0.11 mmol, 45%); 1H NMR (600 MHz, 
CD3OD) δ 8.01 (d, J = 7.6 Hz, 2H), 7.70-7.67 (m, 1H), 7.58-5.55 (m, 2H), 4.38 (dd, J = 7.4, 
6.0 Hz, 1H), 3.89 (d, J = 7.5 Hz, 1H), 3.88-3.85 (m, 1H), 3.75 (s, 3H), 1.38 (d, J = 6.2 Hz, 3H); 
13C NMR (151 MHz, CD3OD) δ 197.8, 171.1, 169.8, 135.9, 133.7, 128.7, 128.4, 52.0, 51.9, 
51.7, 51.7, 20.3. IR (thin film) ν 3231, 2954, 2359, 1705, 1596, 1448, 1381, 1264, 1219, 697 
cm-1. HRMS (ESI): Calcd. For C14H15NNaO4
+ ([M+Na+]): 284.0893, found 284.0895. HPLC 
Chiralpak IA column, Hex/iPrOH = 92:8, flow rate = 1.0 mL/min, λ = 210 nm, 16.8 min (minor 
isomer), 22.7 min (major isomer). TLC (50:50 EtOAc/hexanes): Rf = 0.19. [α]D = +3.15 (c = 
1.25, CHCl3).  
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CHAPTER TWO: ASYMMETRIC ORGANOCATALYTIC SULFA-MICHAEL 
ADDITION TO ENONE DIESTERS * 
 
2.1 Background 
The conjugate addition of heteroatom nucleophiles to prochiral Michael acceptors 
offers an atom-economical entry into diverse scaffolds with concomitant construction of 
stereochemical complexity. The application of this reaction manifold to the installation of 
sulfur in organic frameworks has largely been driven by the prominence of sulfur in bioactive 
molecules1–5 and the established utility of thiol- and sulfide-derived functional handles.6–12 To 
that end, noteworthy advances have been made toward the development of the asymmetric 
sulfa-Michael reaction using a variety of catalytic systems.13–17 To advance the art, we sought 
to expand the range of products accessible through this reaction by studying substrates bearing 
multiple electrophilic sites on the Michael acceptor. Previous efforts in this direction have 
demonstrated that Michael acceptors possessing vicinal ester and ketone functionalities (γ-oxo 
acrylates) give addition exclusively at the ester α-carbon, and achieving high stereoselectivities 
remains challenging (Scheme 2-1A).18,19 We viewed this shortcoming of Cinchona alkaloid-
based catalyst stereoselectivity as an opportunity to explore organosuperbase catalysts for this 
transformation. The Dixon group recently developed a tert-leucine and phenylglycine-derived 
triaryliminophosphorane catalyst which promoted the enantioselective addition of alkyl thiols 
to unactivated α,β−unsaturated esters (Scheme 2-1B).20  In addition, phenylglycine-based 
                                                 
* Reproduced with permission from Fulton, J. L.; Horwitz, M. A.; Bruske, E. L.; Johnson, J. S. J. Org. Chem. 
2018, 83, 3385. Copyright 2018 American Chemical Society. 
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triaryliminophosphorane catalyst 2.4, also developed by the Dixon group,21–27 was found to 
mediate the addition of nitroalkanes to enone diesters with high regio- and stereoselectivity 
(Scheme 2-1C).28 By employing this catalyst system we sought to overcome the challenges of 
a highly regio- and enantioselective addition of sulfur nucleophiles to acylidene malonates 
(Scheme 2-1D).  
Scheme 2-1. Asymmetric Conjugate Addition Reactions 
 
 
2.2 Asymmetric sulfa-Michael Addition 
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2.2.1 Reaction Optimization 
We began our investigation by examining the reaction of enone diester 2.1a with benzyl 
thiol 2.2f (Table 2-1). Pleasingly, when triaryliminophosphorane organocatalyst 2.4 was added 
to a mixture of enone diester 2.1a and benzyl thiol at -60°C we obtained the desired product in 
high enantioselectivity, with addition exclusively to the alkylidene malonate (entry 1). Further 
optimization of the catalyst revealed that catalyst 2.4 was uniquely suited to providing 
enantioinduction, whereas use of iminophosphoranes 2.5 and 2.6 resulted in greatly diminished 
selectivities (entries 2-3). The failure of catalyst 2.5 to provide enantioinduction was 
particularly surprising, given its success in other sulfa-Michael additions.20,29 
Further optimization proved necessary to broaden the thiol scope. When employing 
identical reaction conditions to entry 1, addition of ethanethiol yielded product with diminished 
enantioselectivities (entry 4). Moreover, products derived from substituted benzyl thiols such 
as para-chloro-substituted benzyl thiol were racemic (entry 5). Altering the order of addition 
remedied these stereoselectivity issues (see section 2.2.2 for a rationale). By adding the thiol 
after catalyst addition at -60 °C the ethanethiol addition product was obtained in 91:9 er (entry 
6), and the enantiomeric ratio for the product derived from para-chloro-substituted benzyl thiol 
rose to 93:7 (entry 7). Further optimization revealed that isopropyl thiol further increased 
product yield and enantioenrichment (entry 8). Finally, much like the nitroalkane addition, we 
found that replacing the tert-butyl ester with the less bulky ethyl ester resulted in reduced 
enantioselectivity, providing the product in 86:14 er (entry 9). 
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Table 2-1. Optimization of a Sulfa-Michael Addition to Enone Diesters 
 
entry 
thiol addition  
temp (°C) 
R1 (equiv) R2 catalyst er % yielda 
1 23 Bn (5.1) tBu 2.4 90:10 n.d.c 
2 23 Bn (5.1) tBu 2.5 59:41 (88) 
3 23 Bn (5.1) tBu 2.6 55:45 (85) 
4 23 Et (5.4) tBu 2.4 87:13 n.d. 
5 23 4-Cl Bn (5.3) tBu 2.4 50:50 n.d. 
6b -60 Et (5.4) tBu 2.4 91:9 92 
7 b -60 4-Cl Bn (1.5) tBu 2.4 93:7 89 
8b -60 iPr (5.4) tBu 2.4 97:3 93 
9 -60 iPr (5.4) Et 2.4 86:14 n.d. 
a Yields in parentheses represent 1H NMR yields determined using 1,3,5-trimethoxybenzene 
(1.0 equiv) as an internal standard. b The er and yield values for this entry are an average of two 
trials. c n.d. = not determined. 
 
 
2.2.2 Investigation of Side-Product Formation 
Early in our investigations we observed an unexpected side product when thiol was 
added at room temperature, prior to cooling and catalyst addition. The side product was 
identified as the formal alkene reduction of 2.1 to give malonate 2.7 (Table 2-2). Although 
malonate 2.7 was not observed in our initial reactions employing benzyl thiol, substituted 
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benzyl thiols generated varying quantities of side product with concommitant reduction in 
enantioselectivity (entries 1-3). Thiol acidity correlated well with side product formation 
(Figure 2-1), and the increased acidity of benzenethiol provided further evidence for this trend, 
generating the side product in a 1:2.7 ratio with desired product 2.3 (entry 4). Subsequent 
reactions revealed an additional dependence on thiol stoichiometry, with fewer equivalents 
providing less of the side product while maintaining complete conversion of the enone diester 
starting material (entry 5). Notably, we never observed any of malonate 2.7 when employing 
less acidic alkyl thiols (entries 6-7). 
Table 2-2. Formation of an Undesired Malonate in the Presence of Various Thiols 
 
entry 







1 23 4-OMe Bn (4.9) 7.9:1 68:32 
2 23 4-tBu Bn (5.0) 6.5:1 79:21 
3 23 4-Cl Bn (5.3) 5.5:1 50:50 
4 23 Ph (4.9) 2.7:1 n.d. 
5 23 Ph (1.1) 6.7:1 n.d. 
6 23 iPr (5.0) 100:0 95:5 
7 23 nPr (5.0) 100:0 89:11 
8 -60 nPr (5.4) 100:0 92:8 
9 -60 4-Cl Bn (1.5) 100:0 93:7 
10 -60 4-Cl Bn (5.1) 100:0 n.d. 
a Product ratios determined by 1H NMR. Complete consumption of the enone diester 
starting material was observed in all cases (100% conversion). 
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Figure 2-1. Formation of Malonate 2.7 as a Function of Thiol Aciditya 
 
a Predicted pKa values obtained from SciFinder®. 
 
While poor enantioselectivity could presumably result solely from uncatalyzed 
addition of the thiol nucleophile, formation of malonate 2.7 complicated this hypothesis. α-
Thio carbonyls can serve as electrophilic sources of sulfur to generate the disulfide under basic 
conditions.30–32 Consequently, in addition to uncatalyzed thiol addition, we propose that 
pathways A and B could be interfering with enantioenriched product formation (Scheme 2-2). 
Pathway A would generate side product 2.7 via the reported disulfide formation, while 
Pathway B provides an alternative hypothesis for racemic product generation via reversible 








































Scheme 2-2. Proposed Pathways for Diminished Product Yields and Racemization 
  
 
Scheme 2-3. Crossover Experiment Under Optimized Reaction Conditions 
 
 
Addition of the thiol at -60 °C following catalyst addition successfully prevented side 
product formation and improved enantioselectivity for both alkyl thiols (Table 2-2, entry 8) 
and substituted benzyl thiols (entries 9-10). Additionally, we opted to continue with fewer 
equivalents in an attempt to mitigate any potential issues with other benzylic thiols. To further 
assess the impact of this revised procedure, we conducted a crossover experiment (Scheme 2-
3). Pleasingly, exposure of thiol addition product 2.3g to excess para-tbutyl benzyl thiol (2.2i) 
at -60 °C in the presence of iminophosphorane 2.4 failed to provide either the reduction product 
(2.7) or crossover product (2.3i) after 24 hours. Consequently, we confirmed that pathway B 
is inactive at cryogenic temperatures. 
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2.2.3 Sulfa-Michael Addition Scope 
With our optimized conditions in hand, we first examined the scope of the thiol 
nucleophile (Figure 2-2). Branched alkyl thiols (2.3a−c) performed well, providing the desired 
product in high yield and enantioselectivity. Products derived from linear alkyl thiols (2.3d−e) 
were obtained in similarly high yield, although enantioselectivity was slightly diminished. 
Benzyl thiols (2.2f−2.2i) also proved to be competent reaction partners when fewer equivalents 
of the thiol were used in accordance with the findings reported above. Employing benzyl thiol 
2.2f, the desired product (2.3f) was obtained in 91:9 er and 90% yield. Probing the impact of 
various para-substituents on the aromatic ring of the benzyl thiol, electron-withdrawing groups 
led to an increase in enantioselectivity (2.3g), while electron-donating groups had the opposite 
effect (2.3h−i).  
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Figure 2-2. Asymmetric Conjugate Addition of Alkyl Thiols to Enone Diester 2.2a 
 
All of the reactions were conducted on a 0.1 mmol scale using 1.5−5.5 equiv of alkyl thiol 2. Isolated yields are 
shown. All yields and er values are the average of two trials. 
 
Next, we investigated the scope of enone diesters that could be employed in this 
reaction (Figure 2-3). Enone diesters bearing an electron-releasing acyl substituent (2.1j−k, 
4-methoxy, 3-methoxy, piperonyl) provided the desired products in excellent yield and 
enantioselectivity regardless of substitution pattern. Halogen-substituted arenes (2.1m−o) 
were similarly successful under these reaction conditions, as were other electron-poor enone 
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diesters (2.1p−q). Cyclopropyl enone diester 2.1r provided the desired product (2.3r) in 96% 
yield, although with diminished enantioselectivity (83.5:16.5 er). An exploration of 
heteroaromatic enone diesters revealed that furan 2.3s, thiophene 2.3t, and pyridine 2.3u could 
all be obtained in good yield and enantioselectivity. When examining the scalability of this 
transformation, we observed that on 1 g scale thiol 2.2a engaged acylidene malonate 2.1a, 
affording 1.21 g of α-sulfaketone 2.3a without any negative impact on yield or stereoselectivity 
(Scheme 2-4). 
Figure 2-3. Asymmetric Conjugate Addition of 2-Propanethiol to Enone Diesters 
 
All of the reactions were conducted on a 0.1 mmol scale using 5.4 equiv of alkyl thiol 2.2a. Isolated yields are 
shown. All yields and er values are the average of two trials. 
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Scheme 2-4. Gram-Scale Asymmetric Sulfa-Michael Reaction 
 
2.3 Derivatization of Sulfa-Michael Addition Products 
Seeking to explore the synthetic utility of these products, we developed a two-step local 
desymmetrization that takes advantage of the diastereotopic ester groups (Scheme 3).33,34 
Beginning with enantioenriched thioether 2.3a, reduction of the ketone with sodium 
borohydride35,36 provided the syn-hydroxy sulfide 2.8a in >20:1 dr and 89% yield. Subsequent 
acid-promoted cyclization provided lactone 2.9a with three contiguous stereocenters in >20:1 
dr and 70% yield. Analogous results were obtained using benzyl thioether 2.3f, with both the 
reduction and lactonization proceeding in good diastereoselectivity and yield. Finally, an X-
ray diffraction study revealed the absolute and relative stereochemistry of lactone 2.9f.†   
                                                 
† CCDC 1587179 contains the supplementary crystallographic data for this paper. These data can be obtained free 
of charge from the Cambridge Crystallographic Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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Scheme 2-5. Local Desymmetrization via Diastereoselective Reduction and Lactonization 
 
2.4 Conclusion 
In conclusion, we have developed an asymmetric organocatalyzed addition of alkyl 
thiols to enone diesters with unique regioselectivity that enables access to an unexplored class 
of enantioenriched sulfa-Michael adducts. The diester products were further manipulated via 
diastereoselective reduction and subsequent diastereotopic group selection to form 
stereochemically dense lactone products. 
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2.6 Experimental Details 
Methods: Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform 
infrared spectrometer. Proton and carbon magnetic resonance spectra (1H NMR, 13C NMR, 19F 
NMR) were recorded on a Bruker model DRX 400 or 600 (1H NMR at 400 MHz or 600 MHz, 
13C NMR at 101 MHz or 151 MHz, 19F NMR at 376 MHz with solvent resonance as the internal 
standard (1H NMR: CDCl3 at 7.26 ppm and 
13C NMR: CDCl3 at 77.0 ppm).
 1H NMR data are 
reported as follows: chemical shift, multiplicity (s = singlet, br s = broad singlet, d = doublet, 
dd = doublet of doublet, t = triplet, m = multiplet), coupling constants (Hz), and integration. 
High resolution mass spectra were obtained with a Thermo Fisher Scientific FinniganTM LTQ-
ICR FTTM (all samples prepared in methanol). Melting points were obtained using a Thomas 
Hoover UniMelt Capillary Melting Point Apparatus. Analytical thin layer chromatography was 
carried out using Whatman 0.25 mm silica gel 60 plates, Sorbent Technologies 0.20 mm Silica 
Gel TLC plates. Visualization was allowed by UV light, phosphomolybdic acid in ethanol, or 
aqueous ceric ammonium nitrate solution. HPLC analysis was performed on a Perkin Elmer 
flexar photodiode array (PDA) system equipped with Daicel IA, IC, and AD columns. 
Asymmetric reactions were carried out in a Thermo Sigma UCR-150N aluminum block UC 
reactor with stirring. Purification of the reaction products was carried out by using Siliaflash-
P60 silica gel (40- 63μm) purchased from Silicycle. Yields refer to isolated yields after flash 
column chromatography. Optical rotations of enantioenriched products were taken after 
purification using silica flash column chromatography. Since all asymmetric trial results are the 
averages of two trials, the stereoisomer ratios listed in the text above may not exactly match 
those represented in the NMR and HPLC data below. The relative and absolute 
stereoconfiguration of 2.9f was determined via X-ray diffraction analysis, and the 
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stereochemistry of all other structures was assigned by analogy. 
 
Materials: Diethyl ether (Et2O) was passed through a column of neutral alumina under 
nitrogen prior to use. The thiols employed were obtained from commercial sources and used 
as received. Enone diesters were prepared according to a literature procedure.28 
Triaryliminophosphorane catalysts 2.4-2.6 were prepared according to a literature 
procedure.21,24 Racemic samples were obtained by employing the general procedure and using 
2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine (BEMP) in 
place of organocatalyst 2.4. 
 
Procedures employed during reaction optimization 
General procedure A – Thiol addition at 23°C: A flame-dried test tube was charged 
sequentially with enone diester (0.1 mmol, 1.0 equiv), thiol (thiol identity and equivalents 
listed in table), and Et2O (1.0 mL). The reaction was stirred at -60 °C in a cryogenic cooling 
apparatus for 15 min, then the triaryliminophosphorane catalyst (0.01 mmol, 0.10 equiv) was 
added. The reaction was stirred at -60 °C for 24 h then quenched with a TFA solution in toluene 
(50 L, 0.5 M solution) at the same temperature. The solvent was removed in vacuo, and the 
crude material was purified using flash column chromatography. 
General procedure B – Thiol addition at -60°C: A flame-dried test tube was charged 
sequentially with enone diester (0.1 mmol, 1.0 equiv) and Et2O (1.0 mL). The reaction was 
stirred at -60 °C in a cryogenic cooling apparatus for 15 min, then triaryliminophosphorane 
catalyst 2.4 (0.01 mmol, 0.10 equiv) was added, followed by thiol (thiol identity and 
equivalents listed in table). The reaction was stirred at -60 °C for 24 h then quenched with a 
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TFA solution in toluene (50 L, 0.5 M solution) at the same temperature. The solvent was 
removed in vacuo, and the crude material was purified using flash column chromatography. 
Optimized general procedure for the asymmetric conjugate addition of alkyl thiols. A 
flame-dried test tube was charged sequentially with enone diester 2.1 (0.1 mmol, 1.0 equiv) 
and Et2O (1.0 mL). The reaction was stirred at -60 °C in a cryogenic cooling apparatus for 15 
min, then triaryliminophosphorane catalyst 2.4 (0.01 mmol, 0.10 equiv) was added, followed 
by thiol 2.2 (see below for thiol identity and equivalents). The reaction was stirred at -60 °C 
for 24 h then quenched with a TFA solution in toluene (50 L, 0.5 M solution) at the same 
temperature. The solvent was removed in vacuo, and the crude material was purified using 
flash column chromatography with 97.5/2.5 hexanes/EtOAc unless otherwise noted. 
 
Gram scale asymmetric conjugate addition reaction with propane-2-thiol. A flame-dried 
test tube was charged sequentially with enone diester 2.1a (1.00 g, 3.01 mmol, 1.0 equiv) and 
Et2O (30 mL). The reaction was stirred at -60 °C in a cryogenic cooling apparatus for 15 min, 
then triaryliminophosphorane catalyst 2.4 (201 mg, 0.30 mmol, 0.10 equiv) was added, 
followed by propane-2-thiol (1.51 mL, 16.3 mmol, 5.38 equiv). The reaction was stirred at -
60 °C for 24 h then quenched with a TFA solution in toluene (1.5 mL, 0.5 M solution) at the 
same temperature. The solvent was removed in vacuo, and the crude material was purified 
using flash column chromatography with 97.5/2.5 hexanes/EtOAc to yield 1.21 g (93%) of a 




(2.3a). The title compound was prepared using propane-2-thiol (0.05 mL, 
0.54 mmol, 5.38 equiv) according to the general procedure. Low-melting 
white solid (38.3 mg, 0.093 mmol, 93%); 1H NMR (600 MHz, CDCl3) δ 8.05 (d, J = 7.9 Hz, 
2H; 7.58 (t, J = 7.3Hz, 1H), 7.49 (t, J = 7.6 Hz, 2H), 4.76 (d, J = 11.6 Hz, 1H), 4.17 (d, J = 
11.6 Hz, 1H), 2.96-2.89 (m, 1H), 1.55 (s, 9H), 1.39 (s, 9H), 1.23 (t, J = 6.8 Hz, 3H), 1.10 (t, J 
= 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ194.8, 167.0, 166.9, 135.9, 133.0, 128.7, 128.6, 
82.4, 82.2, 55.8, 45.7, 34.6, 28.0, 27.8, 24.8, 24.2. IR (thin film) ν 3430, 2977, 2360, 1729, 
1679, 1369, 1299, 1252, 1140, 690 cm-1. HRMS (ESI): Calcd. For C22H32O5SNa
+ ([M+Na+]): 
431.1868, found 431.1858. HPLC Chiralpak IC column, Hex/iPrOH = 98:2, flow rate = 1.0 
mL/min, λ = 210 nm, tR (minor) 11.5 min, tR (major) 15.4 min. TLC (10/90 EtOAc/hexanes): 
Rf = 0.41. [α]D
25
 = -65.9 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(1-(tert-butylthio)-2-oxo-2-phenylethyl)malonate 
(2.3b). The title compound was prepared using 2-methylpropane-2-thiol 
(0.06 mL, 0.53 mmol, 5.32 equiv) according to the general procedure. 
White solid (43.5 mg, 0.010 mmol, 100%), mp 76-78 °C (decomp); 1H NMR (600 MHz, 
CDCl3) δ 8.06 (d, J = 7.7 Hz, 2H), 7.56 (t, J = 7.3 Hz, 1H), 7.49 (t, J = 7.6 Hz, 2H), 4.76 (d, J 
= 11.8 Hz, 1H), 4.17 (d, J = 11.8 Hz, 1H), 1.55 (s, 9H), 1.38 (s, 9H), 1.18 (s, 9H); 13C NMR 
(151 MHz, CDCl3) δ 198.2, 167.1 (2C), 136.9, 132.7, 129.1, 128.4, 82.5, 82.1, 57.0, 45.6, 45.4, 
31.5, 28.0, 27.8. IR (thin film) ν 2979, 2360, 1739, 1682, 1368, 1290, 1252, 1138, 855, 695 
cm-1. HRMS (ESI): Calcd. For C23H34O5SNa
+ ([M+Na+]): 445.2025, found 445.2016. HPLC 
Chiralpak IC column, Hex/iPrOH = 96:4, flow rate = 1.0 mL/min, λ = 210 nm, tR (minor) 7.6 
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min, tR (major) 10.4 min. TLC (10/90 EtOAc/hexanes): Rf = 0.42. [α]D
25




(2.3c). The title compound was prepared using cyclohexanethiol (0.06 mL, 
0.49 mmol, 4.90 equiv) according to the general procedure. White solid 
(43.7 mg, 0.097 mmol, 97%), mp 53-55 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 8.04 (d, 
J = 7.9 Hz, 2H), 7.57 (t, J = 7.3 Hz, 1H), 7.49 (t, J = 7.6 Hz, 2H), 4.76 (d, J = 11.6 Hz, 1H), 
4.15 (d, J = 11.6 Hz, 1H), 2.71-2.67 (m, 1 H), 1.95-1.89 (m, 1H), 1.73-1.64 (m, 2H), 1.63-1.57 
(m, 1H), 1.55 (s, 9H), 1.53-1.48 (m, 1H), 1.38 (s, 9H), 1.32-1.26 (m, 2H), 1.25-1.19 (m, 1H), 
1.18-1.11 (m, 2H); 13C NMR (151 MHz, CDCl3) δ 194.7, 167.0, 166.9, 135.9, 133.0, 128.7, 
128.6, 82.4, 82.1, 55.8, 45.3, 42.4, 34.8, 34.4, 28.0, 27.8, 26.1, 26.0, 25.4.  IR (thin film) ν 
2978, 2931, 2853, 2360, 1741, 1680, 1369, 1299, 1139, 857 cm-1. HRMS (ESI): Calcd. For 
C25H36O5SNa
+ ([M+Na+]): 471.2181, found 471.2171. HPLC Chiralpak IC column, 
Hex/iPrOH = 96:4, flow rate = 1.0 mL/min, λ = 230 nm, tR (minor) 6.8 min, tR (major) 9.8 min. 
TLC (10/90 EtOAc/hexanes): Rf = 0.39. [α]D
25
 = -64.3 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(1-(ethylthio)-2-oxo-2-phenylethyl)malonate (2.3d). 
The title compound was prepared using ethanethiol (0.04 mL, 0.56 mmol, 
5.52 equiv) according to the general procedure. Clear oil (36.5 mg, 0.092 
mmol, 92%); 1H NMR (600 MHz, CDCl3) δ 8.05 (d, J = 7.9 Hz, 2H), 7.58 (t, J = 7.3 Hz, 1H), 
7.50 (t, J = 7.5 Hz), 4.73 (d, J = 11.5 Hz, 1H), 4.14 (d, J = 11.5 Hz, 1H), 2.63-2.58 (m, 1H), 
2.39-2.33 (m, 1H), 1.55 (s, 9H), 1.39 (s, 9H), 1.14 (t, J = 7.5 Hz, 3H); 13C NMR (151 MHz, 
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CDCl3) δ 193.1, 167.0, 166.8, 135.5, 133.1, 128.7, 128.6, 82.5, 82.2, 54.8, 44.9, 28.0, 27.8, 
22.9, 13.8. IR (thin film) ν 3431, 2978, 1741, 1679, 1369, 1300, 1259, 1140, 856, 689 cm-1. 
HRMS (ESI): Calcd. For C21H30O5SNa
+ ([M+Na+]): 417.1708, found 417.1701. HPLC 
Chiralpak IC column, Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 nm, tR (minor) 9.5 
min, tR (major) 14.8 min. TLC (10/90 EtOAc/hexanes): Rf = 0.39. [α]D
25




(2.3e). The title compound was prepared using propane-1-thiol (0.05 mL, 
0.54 mmol, 5.36 equiv) according to the general procedure. Clear oil (39.5 
mg, 0.096 mmol, 96%); 1H NMR (600 MHz, CDCl3) δ 8.05 (d, J = 7.7 Hz, 2H), 7.58 (t, J = 
7.3 Hz, 1H), 7.49 (t, J = 7.6 Hz, 2H), 4.73 (d, J = 11.5 Hz, 1H), 4.13 (d, J = 11.5 Hz, 1H), 2.58-
2.53 (m, 1H), 2.33-2.29 (m, 1H), 1.55 (s, 9H), 1.52-1.46 (m, 2H), 1.39 (s, 9H), 0.90 (t, J = 7.4 
Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 193.2, 166.9, 166.8, 135.5, 133.0, 128.7, 128.6, 82.4, 
82.1, 54.8, 44.7, 30.6, 28.0, 27.8, 22.3, 13.6. IR (thin film) ν 3431, 2978, 2360, 1740, 1680, 
1369, 1299, 1139, 856, 668 cm-1. HRMS (ESI): Calcd. For C22H32O5SNa
+ ([M+Na+]): 
431.1868, found 431.1858. HPLC Chiralpak IC column, Hex/iPrOH = 98:2, flow rate = 1.0 
mL/min, λ = 210 nm, tR (minor) 6.6 min, tR (major) 9.4 min. TLC (10/90 EtOAc/hexanes): Rf 
= 0.41. [α]D
25
 = -54.0 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(1-(benzylthio)-2-oxo-2-phenylethyl)malonate 
(2.3f). The title compound was prepared using phenylmethanethiol (0.02 
mL, 0.17 mmol, 1.71 equiv) according to the general procedure. Low-
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melting white solid (40.4 mg, 0.091 mmol, 91%); 1H NMR (600 MHz, CDCl3) δ 7.98 (d, J = 
7.9 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.47 (t, J = 7.6 Hz, 2H), 7.29-7.22 (m, 5H), 4.79 (d, J = 
11.4 Hz, 1H), 4.26 (d, J = 11.4 Hz, 1H), 3.86 (d, J = 11.8 Hz, 1H), 3.55 (d, J = 11.8 Hz, 1H), 
1.58 (s, 9H), 1.40 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 193.2, 166.9 (2C), 136.2, 135.4, 
133.1, 129.4, 128.7, 128.6, 128.5, 127.3, 82.6, 82.3, 55.0, 45.3, 33.7, 28.0, 27.8. IR (thin film) 
ν 3431, 2978, 2360, 1727, 1678, 1369, 1300, 1252, 1157, 691 cm-1. HRMS (ESI): Calcd. For 
C26H32O5SNa
+ ([M+Na+]): 479.1868, found 479.1858. HPLC Chiralpak IC column, 
Hex/iPrOH = 99:1, flow rate = 1.0 mL/min, λ = 210 nm, tR (major) 10.8 min, tR (minor) 12.3 
min. TLC (10/90 EtOAc/hexanes): Rf = 0.36. [α]D
25
 = -50.6 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(1-((4-chlorobenzyl)thio)-2-oxo-2-
phenylethyl)malonate (2.3g). The title compound was prepared using (4-
chlorophenyl)methanethiol (0.02 mL, 0.15 mmol, 1.51 equiv) according 
to the general procedure. Low-melting white solid (44.4 mg, 0.089 mmol, 
89%); 1H NMR (600 MHz, CDCl3) δ 7.94 (d, J = 7.9 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.47 
(t, J = 7.7 Hz, 2H), 7.21 (d, J = 8.3 Hz, 2H), 7.15 (d, J = 8.2 Hz, 2H), 4.76 (d, J = 11.5 Hz, 
1H), 4.23 (d, J = 11.5 Hz, 1H), 3.81 (d, J = 12.1 Hz, 1H), 3.51 (d, J = 12.1 Hz, 1H), 1.57 (s, 
9H), 1.38 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 193.2, 166.8 (2C), 135.3, 134.9, 133.2, 133.1, 
130.7, 128.7, 128.6 (2C), 82.7, 82.4, 55.0, 45.1, 33.1, 28.0, 27.8. IR (thin film) ν 3431, 2979, 
2360, 1739, 1678, 1491, 1369, 1301, 1140, 690 cm-1. HRMS (ESI): Calcd. For 
C26H31ClO5SNa
+ ([M+Na+]): 513.1479, found 513.1469. HPLC Chiralpak IC column, 
Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 nm, tR (major) 9.1 min, tR (minor) 12.2 
min. TLC (10/90 EtOAc/hexanes): Rf = 0.41. [α]D
25




phenylethyl)malonate (2.3h). The title compound was prepared using (4-
methoxyphenyl)methanethiol (0.03 mL, 0.21 mmol, 2.15 equiv) according 
to the general procedure. The crude material was purified via flash column 
chromatography using a gradient from 97.5/2.5 hexanes/EtOAc to 95/5 hexanes/EtOAc. Low-
melting white solid (45.2 mg, 0.094 mmol, 94%); 1H NMR (600 MHz, CDCl3) δ 7.97 (d, J = 
7.9 Hz, 2H), 7.58 (t, J = 7.3 Hz, 1H), 7.46 (t, J = 7.6 Hz, 2H), 7.14 (d, J = 8.4 Hz, 2H), 6.79 
(d, J = 8.4 Hz, 2H), 4.76 (d, J = 11.5 Hz, 1H), 4.26 (d, J = 11.5 Hz, 1H), 3.82 (d, J = 11.8 Hz, 
1H), 3.78 (s, 3H), 3.50 (d, J = 11.8 Hz, 1H), 1.58 (s, 9H), 1.40 (s, 9H); 13C NMR (151 MHz, 
CDCl3) δ 193.2, 166.9 (2C), 158.8, 135.4, 133.0, 130.5, 128.7, 128.6, 128.0, 113.9, 82.5, 82.3, 
55.2, 54.5, 45.3, 33.2, 28.0, 27.8. IR (thin film) ν 3431, 2978, 2360, 1777, 1738, 1512, 1251, 
1139, 833, 690 cm-1. HRMS (ESI): Calcd. For C27H34O6SNa
+ ([M+Na+]): 509.1974, found 
509.1967. HPLC Chiralpak IC column, Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 
nm, tR (major) 14.8 min, tR (minor) 18.1 min. TLC (10/90 EtOAc/hexanes): Rf = 0.25. [α]D
25
 = 
-49.9 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(1-((4-(tert-butyl)benzyl)thio)-2-oxo-2-
phenylethyl)malonate (2.3i). The title compound was prepared using (4-
tert-butylphenyl)methanethiol (0.03 mL, 0.16 mmol, 1.60 equiv) 
according to the general procedure. Clear oil (44.4 mg, 0.086 mmol, 86%); 
1H NMR (600 MHz, CDCl3) δ 7.98 (d, J = 7.8 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.47 (t, J = 
7.5 Hz, 2H), 7.28 (d, J = 7.9 Hz, 2H), 7.15 (d, J = 7.9 Hz, 2H), 4.79 (d, J = 11.4 Hz, 1H), 4.26 
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(d, J = 11.5 Hz, 1H), 3.86 (d, J = 11.8 Hz, 1H), 3.53 (d, J = 11.7 Hz, 1H), 1.59 (s, 9H), 1.41 (s, 
9H), 1.30 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 193.2, 166.9 (2C), 150.2, 135.5, 133.0 (2C), 
129.0, 128.7, 128.6, 125.4, 82.5, 82.3, 54.9, 45.4, 34.5, 33.2, 31.3, 28.0, 27.8. IR (thin film) ν 
3431, 2970, 2360, 1728, 1678, 1368, 1300, 1253, 1139, 851 cm-1. HRMS (ESI): Calcd. For 
C30H40O5SNa
+ ([M+Na+]): 535.2494, found 535.2491. HPLC Chiralpak AD column, 
Hex/iPrOH = 99:1, flow rate = 1.0 mL/min, λ = 254 nm, tR (minor) 7.7 min, tR (major) 9.5 min. 
TLC (10/90 EtOAc/hexanes): Rf = 0.39. [α]D
25
 = -48.3 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(1-(isopropylthio)-2-(4-methoxyphenyl)-2-
oxoethyl)malonate (2.3j). The title compound was prepared 
according to the general procedure using propane-2-thiol (0.05 mL, 
0.54 mmol, 5.38 equiv). The crude material was purified via flash column chromatography 
using a gradient from 97.5/2.5 hexanes/EtOAc to 95/5 hexanes/EtOAc. Clear oil (43.6 mg, 
0.099 mmol, 99%); 1H NMR (600 MHz, CDCl3) δ 8.04 (d, J = 8.9 Hz, 2H), 6.97 (d, J = 8.9 
Hz, 2H), 4.73 (d, J = 11.6 Hz, 1H), 4.16 (d, J = 11.5 Hz, 1H), 3.89 (s, 3H), 2.97-2.90 (m, 1H), 
1.55 (s, 9H), 1.38 (s, 9H), 1.24 (d, J = 6.8 Hz, 3H), 1.10 (d, J = 6.8 Hz, 3H); 13C NMR (151 
MHz, CDCl3) δ 193.5, 167.1, 167.0, 163.5, 131.0, 128.6, 113.8, 82.3, 82.1, 55.8, 55.5, 45.3, 
34.4, 28.0, 27.8, 24.8, 24.2. IR (thin film) ν 3431, 2978, 2360, 1739, 1669, 1602, 1369, 1260, 
1142, 860 cm-1. HRMS (ESI): Calcd. For C23H34O6SNa
+ ([M+Na+]): 461.1974, found 
461.1964. HPLC Chiralpak IA column, Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 
nm, tR (major) 9.8 min, tR (minor) 10.7 min. TLC (10/90 EtOAc/hexanes): Rf = 0.29. [α]D
25
 = 




oxoethyl)malonate (2.3k). The title compound was prepared according to 
the general procedure using propane-2-thiol (0.05 mL, 0.54 mmol, 5.38 
equiv). The crude material was purified via flash column chromatography using a gradient 
from 97.5/2.5 hexanes/EtOAc to 95/5 hexanes/EtOAc. Clear oil (42.3 mg, 0.096 mmol, 96%); 
1H NMR (600 MHz, CDCl3) δ 7.64 (d, J = 7.7 Hz, 1H), 7.56 (dd, J = 2.4 Hz, 1.6 Hz, 1H), 7.40 
(t, J = 8.0 Hz, 1H), 7.12 (dd, J = 8.2 Hz, 2.6 Hz, 1H), 4.73 (d, J = 11.6 Hz, 1H), 4.16 (d, J = 
11.6 Hz, 1H), 2.96-2.89 (m, 1H), 1.55 (s, 9H), 1.39 (s, 9H), 1.23 (d, J = 6.8 Hz, 3H), 1.12 (d, 
J =6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 194.6, 166.9 (2C), 159.8, 137.3, 129.6, 121.2, 
119.5, 113.1, 82.5, 82.2, 55.8, 55.4, 45.7, 34.7, 28.0, 27.8, 24.7, 24.2. IR (thin film) ν 3432, 
2978, 2360, 1729, 1679, 1583, 1369, 1288, 1159, 761 cm-1. HRMS (ESI): Calcd. For 
C23H34O6SNa
+ ([M+Na+]): 461.1974, found 461.1963. HPLC Chiralpak IA column, 
Hex/iPrOH = 96:4, flow rate = 1.0 mL/min, λ = 210 nm, tR (minor) 8.2 min, tR (major) 12.7 
min. TLC (10/90 EtOAc/hexanes): Rf = 0.35. [α]D
25
 = -74.5 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(2-(benzo[d][1,3]dioxol-5-yl)-1-(isopropylthio)-
2-oxoethyl)malonate (2.3l). The title compound was prepared 
according to the general procedure using propane-2-thiol (0.05 mL, 
0.54 mmol, 5.38 equiv). The crude material was purified via flash column chromatography 
using a gradient from 97.5/2.5 hexanes/EtOAc to 95/5 hexanes/EtOAc. Clear oil (42.3 mg, 
0.093 mmol, 93%); 1H NMR (600 MHz, CDCl3) δ 7.68 (dd, J = 8.2 Hz, 1.7 Hz, 1H), 7.51 (d, 
J = 1.7 Hz, 1H), 6.89 (d, J = 8.2 Hz, 1H), 6.06 (s, 2H), 4.67 (d, J = 11.6 Hz, 1H), 4.14 (d, J = 
11.5 Hz, 1H), 2.97-2.90 (m, 1H), 1.54 (s, 9H), 1.38 (s, 9H), 1.24 (d, J = 6.9 Hz, 3H), 1.11 (d, 
77 
J = 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 193.0, 167.0, 166.9, 151.8, 148.1, 130.4, 
124.8, 108.7, 108.0, 101.9, 82.4, 82.1, 55.9, 45.4, 34.5, 28.0, 27.8, 24.8, 24.2. IR (thin film) ν 
3431, 2978, 1727, 1672, 1442, 1258, 1139, 1038, 850, 734 cm-1. HRMS (ESI): Calcd. For 
C23H33O7S
+ ([M+H+]): 453.1948, found 453.1940. HPLC Chiralpak IA column, Hex/iPrOH = 
95:5, flow rate = 1.0 mL/min, λ = 210 nm, tR (major) 5.5 min, tR (minor) 6.2 min. TLC (10/90 
EtOAc/hexanes): Rf = 0.30. [α]D
25
 = -51.8 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(2-(4-bromophenyl)-1-(isopropylthio)-2-
oxoethyl)malonate (2.3m). The title compound was prepared 
according to the general procedure using propane-2-thiol (0.05 mL, 
0.54 mmol, 5.38 equiv). White solid (46.8 mg, 0.096 mmol, 96%), mp 73-75 °C (decomp); 1H 
NMR (600 MHz, CDCl3) δ 7.92 (d, J = 8.6 Hz, 2H), 7.64 (d, J = 8.6 Hz, 2H), 4.69 (d, J = 11.6 
Hz, 1H), 4.15 (d, J = 11.6 Hz, 1H), 2.94-2.87 (m, 1H), 1.55 (s, 9H), 1.39 (s, 9H), 1.24 (d, J = 
6.8 Hz, 3H), 1.09 (d, J = 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 193.8, 167.0, 166.8, 
134.7, 131.9, 130.2, 128.1, 82.6, 82.3, 55.7, 45.7, 34.7, 28.0, 27.8, 24.8, 24.2. IR (thin film) ν 
3430, 2978, 2360, 1729, 1679, 1586, 1369, 1309, 1251, 1139 cm-1. HRMS (ESI): Calcd. For 
C22H31BrO5SNa
+ ([M+Na+]): 509.0974, found 509.0963. HPLC Chiralpak IC column, 
Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 nm, tR (minor) 5.8 min, tR (major) 8.0 min. 
TLC (10/90 EtOAc/hexanes): Rf = 0.50. [α]D
25
 = -41.3 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(2-(4-chlorophenyl)-1-(isopropylthio)-2-
oxoethyl)malonate (2.3n). The title compound was prepared 
according to the general procedure using propane-2-thiol (0.05 mL, 
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0.54 mmol, 5.38 equiv). White solid (43.6 mg, 0.098 mmol, 98%), mp 64-66 °C (decomp); 1H 
NMR (600 MHz, CDCl3) δ 7.99 (d, J = 8.6 Hz, 2H), 7.47 (d, J = 8.6 Hz, 2H), 4.69 (d, J = 11.6 
Hz, 1H), 4.15 (d, J = 11.6 Hz, 1H), 2.94-2.87 (m, 1H), 1.55 (s, 9H), 1.39 (s, 9H), 1.24 (d, J = 
6.8 Hz, 3H), 1.09 (d, J = 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 193.6, 167.0, 166.8, 
139.4, 134.2, 130.1, 128.9, 82.6, 82.3, 55.7, 45.7, 34.6, 27.9, 27.8, 24.8, 24.2. IR (thin film) ν 
3430, 2979, 1740, 1680, 1590, 1369, 1309, 1140, 1093, 861 cm-1. HRMS (ESI): Calcd. For 
C22H31ClO5SNa
+ ([M+Na+]): 465.1479, found 465.1469. HPLC Chiralpak IC column, 
Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 nm, tR (minor) 5.7 min, tR (major) 7.5 min. 
TLC (10/90 EtOAc/hexanes): Rf = 0.47. [α]D
25
 = -53.0 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(2-(4-fluorophenyl)-1-(isopropylthio)-2-
oxoethyl)malonate (2.3o). The title compound was prepared according 
to the general procedure using propane-2-thiol (0.05 mL, 0.54 mmol, 
5.38 equiv). White solid (39.2 mg, 0.093 mmol, 93%), mp 71-73 °C (decomp); 1H NMR (600 
MHz, CDCl3) δ 8.10-8.07 (m, 2H), 7.17 (at, J = 8.6 Hz, 2H), 4.71 (d, J = 11.6 Hz, 1H), 4.16 
(d, J = 11.5 Hz, 1H), 2.95-2.88 (m, 1H), 1.55 (s, 9H), 1.39 (s, 9H), 1.24 (d, J = 6.8 Hz, 3H), 
1.09 (d, J = 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 193.3, 167.0, 166.8, 165.7 (d, J = 
254.7 Hz), 132.2 (d, J = 3.0 Hz), 131.3 (d, J = 9.2 Hz), 115.7 (d, J = 21.9 Hz), 82.5, 82.2, 55.7, 
45.7, 34.6, 27.9, 27.8, 24.8, 24.2; 19F NMR (376 MHz, CDCl3)δ -105.41. IR (thin film) ν 3431, 
2979, 2360, 1728, 1678, 1598, 1369, 1308, 1157, 862 cm-1. HRMS (ESI): Calcd. For 
C22H31FO5SNa
+ ([M+Na+]): 449.1774, found 449.1764. HPLC Chiralpak IC column, 
Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 nm, tR (minor) 5.6 min, tR (major) 6.8 min. 
TLC (10/90 EtOAc/hexanes): Rf = 0.43. [α]D
25




oxoethyl)malonate (2.3p). The title compound was prepared 
according to the general procedure using propane-2-thiol (0.05 mL, 
0.54 mmol, 5.38 equiv). Clear oil (42.0 mg, 0.093 mmol, 93%); 1H NMR (600 MHz, CDCl3) 
δ 8.34 (d, J = 8.9 Hz, 2H), 8.20 (d, J = 8.9 Hz, 2H), 4.70 (d, J = 11.5 Hz, 1H), 4.16 (d, J = 11.5 
Hz, 1H), 2.94-2.87 (m, 1H), 1.56 (s, 9H), 1.41 (s, 9H), 1.24 (d, J = 6.8 Hz, 3H), 1.10 (d, J = 
6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 193.1, 167.1, 166.6, 150.2, 141.1, 129.7, 123.8, 
82.9, 82.5, 55.6, 46.4, 34.9, 27.9, 27.8, 24.8, 24.1. IR (thin film) ν 3439, 2978, 2931, 1738, 
1685, 1530, 1307, 1139, 850, 702 cm-1. HRMS (ESI): Calcd. For C22H31NO7SNa
+ ([M+Na+]): 
476.1719, found 476.1712. HPLC Chiralpak IC column, Hex/iPrOH = 98:2, flow rate = 1.0 
mL/min, λ = 210 nm, tR (minor) 9.6 min, tR (major) 13.0 min. TLC (10/90 EtOAc/hexanes): Rf 
= 0.39. [α]D
25
 = -46.6 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(2-(4-cyanophenyl)-1-(isopropylthio)-2-
oxoethyl)malonate (2.3q). The title compound was prepared 
according to the general procedure using propane-2-thiol (0.05 mL, 
0.54 mmol, 5.38 equiv). The crude material was purified via flash column chromatography 
using a gradient from 97.5/2.5 hexanes/EtOAc to 95/5 hexanes/EtOAc. White solid (38.8 mg, 
0.091 mmol, 91%), mp 83-85 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 8.13 (d, J = 8.4 Hz, 
2H), 7.80 (d, J = 8.5 Hz, 2H), 4.67 (d, J = 11.6 Hz, 1H), 4.15 (d, J = 11.6 Hz, 1H), 2.92-2.86 
(m, 1H), 1.55 (s, 9H), 1.40 (s, 9H), 1.23 (d, J = 6.8 Hz, 3H), 1.09 (d, J = 6.8 Hz, 3H); 13C NMR 
(151 MHz, CDCl3) δ 193.3, 167.0, 166.6, 139.4, 132.4, 129.1, 118.0, 116.1, 82.8, 82.5, 55.6, 
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46.1, 34.8, 27.9, 27.8, 24.8, 24.1. IR (thin film) ν 2978, 2231, 1727, 1685, 1369, 1298, 1162, 
1140, 866, 755 cm-1. HRMS (ESI): Calcd. For C23H31NO5SNa
+ ([M+Na+]): 456.1821, found 
456.1815. HPLC Chiralpak IC column, Hex/iPrOH = 96:4, flow rate = 1.0 mL/min, λ = 210 
nm, tR (minor) 11.0 min, tR (major) 12.9 min. TLC (10/90 EtOAc/hexanes): Rf = 0.30. [α]D
25
 = 
-51.0 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(2-cyclopropyl-1-(isopropylthio)-2-
oxoethyl)malonate (2.3r). The title compound was prepared according to 
the general procedure using propane-2-thiol (0.05 mL, 0.54 mmol, 5.38 
equiv). Low-melting white solid (33.2 mg, 0.092 mmol, 92%); 1H NMR (600 MHz, CDCl3) δ 
4.07 (d, J = 11.6 Hz, 1H), 3.88 (d, J = 11.6 Hz, 1H), 2.98-2.91 (m, 1H), 2.26-2.22 (m, 1H), 
1.51 (s, 9H), 1.43 (s, 9H), 1.31 (d, J = 6.8 Hz, 3H), 1.22 (d, J = 6.8 Hz, 3H), 1.13-1.09 (m, 1H), 
1.09-1.05 (m, 1H), 1.01-0.96 (m, 2H); 13C NMR (151 MHz, CDCl3) δ 204.7, 166.7, 166.7, 
82.2, 82.0, 55.3, 51.2, 34.8, 27.9, 27.8, 24.8, 24.1, 19.5, 12.1, 11.2. IR (thin film) ν 3445, 2979, 
2931, 1732, 1609, 1369, 1255, 1141, 1054, 851 cm-1. HRMS (ESI): Calcd. For C19H32O5SNa
+ 
([M+Na+]): 395.1868, found 395.1858. HPLC Chiralpak AD column, Hex/iPrOH = 98:2, flow 
rate = 1.0 mL/min, λ = 210 nm, tR (major) 5.0 min, tR (minor) 10.5 min. TLC (10/90 
EtOAc/hexanes): Rf = 0.40. [α]D
25
 = -103.6 (c = 1.5, CHCl3). 
 
Di-tert-butyl (S)-2-(2-(furan-2-yl)-1-(isopropylthio)-2-
oxoethyl)malonate (2.3s). The title compound was prepared according to 
the general procedure using propane-2-thiol (0.05 mL, 0.54 mmol, 5.38 
equiv). The crude material was purified via flash column chromatography using a gradient 
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from 97.5/2.5 hexanes/EtOAc to 95/5 hexanes/EtOAc. White solid (36.9 mg, 0.091 mmol, 
91%), mp 103-105 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 7.62 (d, J = 0.9 Hz, 1H), 7.32 
(d, J = 3.5 Hz, 1H), 6.58 (dd, J = 3.5 Hz, 1.6 Hz, 1H), 4.59 (d, J = 11.8 Hz, 1H), 4.11 (d, J = 
11.8 Hz, 1H), 3.10-3.03 (m, 1H), 1.54 (s, 9H), 1.38 (s, 9H), 1.26 (d, J = 6.8 Hz, 3H), 1.19 (d, 
J = 6.7 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 183.9, 166.8, 166.7, 151.3, 146.3, 118.0, 112.6, 
82.5, 82.2, 55.3, 45.8, 35.1, 27.9, 27.8, 24.4, 24.0. IR (thin film) ν 3430, 2979, 2360, 1737, 
1659, 1468, 1366, 1311, 1165, 1138 cm-1. HRMS (ESI): Calcd. For C20H30O6SNa
+ ([M+Na+]): 
421.1661, found 421.1650. HPLC Chiralpak IC column, Hex/iPrOH = 96:4, flow rate = 1.0 
mL/min, λ = 210 nm, tR (minor) 12.1 min, tR (major) 17.5 min. TLC (10/90 EtOAc/hexanes): 
Rf = 0.27. [α]D
25
 = -56.2 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(2-(furan-2-yl)-1-(isopropylthio)-2-
oxoethyl)malonate (2.3t). The title compound was prepared according to 
the general procedure using propane-2-thiol (0.05 mL, 0.54 mmol, 5.38 
equiv). The crude material was purified via flash column chromatography using a gradient 
from 97.5/2.5 hexanes/EtOAc to 95/5 hexanes/EtOAc. White solid (39.5 mg, 0.095 mmol, 
95%), mp 71-73 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 7.86 (dd, J = 3.8 Hz, 1.1 Hz, 
1H), 7.67 (dd, J = 4.9 Hz, 1.0 Hz, 1H), 7.17 (dd, J = 4.9 Hz, 3.8 Hz, 1H), 4.58 (d, J = 11.6 Hz, 
1H), 4.13 (d, J = 11.6 Hz, 1H), 3.08-2.99 (m, 1H), 1.55 (s, 9H), 1.38 (s, 9H), 1.27 (d, J = 6.8 
Hz, 3H), 1.16 (d, J = 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 187.9, 166.8, 166.7, 142.4, 
133.8, 132.4, 128.2, 82.5, 82.2, 55.7, 47.1, 34.7, 27.9, 27.8, 24.7, 24.2. IR (thin film) ν 3431, 
2978, 1730, 1659, 1415, 1369, 1304, 1161, 849, 724 cm-1. HRMS (ESI): Calcd. For 
C20H30O5S2Na
+ ([M+Na+]): 437.1433, found 437.1423. HPLC Chiralpak IC column, 
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Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 210 nm, tR (minor) 10.7 min, tR (major) 15.7 
min. TLC (10/90 EtOAc/hexanes): Rf = 0.33. [α]D
25
 = -60.5 (c = 2.0, CHCl3). 
 
Di-tert-butyl (S)-2-(1-(isopropylthio)-2-oxo-2-(pyridin-4-
yl)ethyl)malonate (3.3u). The title compound was prepared according to 
the general procedure using propane-2-thiol (0.05 mL, 0.54 mmol, 5.38 
equiv). The crude material was purified via flash column chromatography using a gradient 
from 90/10 hexanes/EtOAc to 85/15 hexanes/EtOAc. White solid (37.3 mg, 0.090 mmol, 
90%), mp 69-71 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 8.82 (d, J = 5.9 Hz, 2H), 7.82 
(dd, J = 4.4 Hz, 1.6 Hz, 2H), 4.64 (d, J = 11.6 Hz, 1H), 4.13 (d, J = 11.6 Hz, 1H), 2.92-2.85 
(m, 1H), 1.54 (s, 9H), 1.40 (s, 9H), 1.23 (d, J = 6.8 Hz, 3H), 1.10 (d, J = 6.8 Hz, 3H); 13C NMR 
(151 MHz, CDCl3) δ 193.8, 167.0, 166.5, 150.8, 142.5, 121.7, 82.9, 82.5, 55.4, 46.1, 34.9, 
27.9, 27.8, 24.7, 24.1. IR (thin film) ν 3431, 2979, 2360, 1728, 1691, 1369, 1301, 1141, 861, 
667 cm-1. HRMS (ESI): Calcd. For C21H32NO5S
+ ([M+H+]): 410.2002, found 410.1990. HPLC 
Chiralpak IA column, Hex/iPrOH = 98:2, flow rate = 1.0 mL/min, λ = 225 nm, tR (major) 7.2 
min, tR (minor) 8.5 min. TLC (25/75 EtOAc/hexanes): Rf = 0.32. [α]D
25
 = -65.5 (c = 2.0, 
CHCl3). 
 
General procedure for the reduction of 2.3. A vial under an N2 atmosphere was charged with 
α-sulfaketone 2.3 (0.15 mmol, 1.0 equiv) followed by MeOH (1.5 mL). The reaction mixture 
was cooled to -20 °C, NaBH4 (10.3 mg, 1.75 equiv) was added, and stirring was continued at 
-20 °C. After quenching with 1 M HCl (1.5 mL), the product was extracted with DCM (3x), 
dried with Na2SO4, and concentrated in vacuo. The crude material was purified via column 
83 
chromatography using a gradient from 97.5/2.5 hexanes/EtOAc to 95/5 hexanes/EtOAc. 
 
Di-tert-butyl 2-((1S,2S)-2-hydroxy-1-(isopropylthio)-2-
phenylethyl)malonate (2.8a). The product was synthesized according to the 
general procedure, and quenched after 1 h. White solid (53.7 mg, 0.131 mmol, 87%), mp 85-
87 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 7.46 (d, J = 7.5 Hz, 2H), 7.37 (t, J = 7.6 Hz, 
2H), 7.29 (t, J = 7.3 Hz, 1H), 4.89 (d, J = 3.4 Hz, 1H), 3.54-3.49 (m, 2H), 2.39-2.32 (m, 1H), 
1.52 (s, 9H), 1.51 (s, 9H), 1.11 (d, J = 6.7 Hz, 3H), 0.95 (d, J = 6.7 Hz, 3H); 13C NMR (151 
MHz, CDCl3) δ 167.7, 167.0, 142.1, 128.2, 127.6, 126.1, 82.6, 82.0, 76.8, 73.0, 57.2, 53.5, 
37.4, 28.0, 23.3 (2C). IR (thin film) ν 3434, 2979, 2089, 1725, 1645, 1454, 1628, 1251, 1155, 
1139 cm-1. HRMS (ESI): Calcd. For C22H34O5SNa
+ ([M+Na+]): 433.2025, found 433.2012. 
HPLC Chiralpak IA column, Hex/iPrOH = 97:3, flow rate = 1.0 mL/min, λ = 210 nm, tR (major) 
7.3 min, tR (minor) 8.8 min. TLC (10/90 EtOAc/hexanes): Rf = 0.29. [α]D
25




phenylethyl)malonate (2.8f). The product was synthesized according to the 
general procedure, and quenched after 3 h. White solid (49.6 mg, 0.108 mmol, 74%), mp 81-
83 °C (decomp); 1H NMR (600 MHz, CDCl3) δ 7.43 (d, J = 7.4 Hz, 2H), 7.38 (t, J = 7.6 Hz, 
2H), 7.32 (t, J = 7.3 Hz, 1H), 7.26-7.20 (m, 3H), 7.08 (d, J = 6.5 Hz, 2H), 4.94 (d, J = 1.9 Hz, 
1H), 3.53-3.48 (m, 3H), 3.44 (br s, 1H), 3.29 (d, J = 12.2 Hz, 1H), 1.52 (s, 9H), 1.51 (s, 9H); 
13C NMR (151 MHz, CDCl3) δ 167.7, 166.9, 141.9, 137.4, 129.0, 128.4, 128.3, 127.7, 127.2, 
126.1, 82.7, 82.2, 73.0, 57.0, 54.3, 38.6, 28.0 (2C). IR (thin film) ν 3459, 2979, 2359, 2341, 
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1731, 1455, 1369, 1254, 1140, 700 cm-1. HRMS (ESI): Calcd. For C26H34O5SNa
+ ([M+Na+]): 
481.2025, found 481.2011. HPLC Chiralpak IA column, Hex/iPrOH = 97:3, flow rate = 1.0 
mL/min, λ = 210 nm, tR (major) 10.2 min, tR (minor) 14.4 min. TLC (10/90 EtOAc/hexanes): 
Rf = 0.27. [α]D
25
  = +18.4 (c = 2.0, CHCl3). 
 
tert-Butyl (3S,4S,5S)-4-(isopropylthio)-2-oxo-5-phenyltetrahydrofuran-3-
carboxylate (2.9a). A vial under an atmosphere of N2 was charged with 2.8a 
(41.3 mg, 0.10 mmol, 1.0 equiv) and 1,4-dioxane (0.1 M). Then, 4 M HCl in 1,4-dioxane (0.1 
M) was added dropwise at room temperature. The reaction was stirred for 5 h, then diluted 
with Et2O and H2O. The layers were separated, and the aqueous layer was extracted with Et2O. 
The combined organic layers were dried with Na2SO4 and concentrated in vacuo. The crude 
material was then purified with flash column chromatography using 50/50 DCM/hexanes to 
give an off-white solid (25.5 mg, 0.075 mmol, 75%), mp 70-72 °C (decomp); 1H NMR (600 
MHz, CDCl3) δ 7.43-7.39 (m, 3H), 7.29-7.28 (m, 2H), 5.81 (d, J = 7.4 Hz, 1H), 4.32 (t, J = 7.7 
Hz, 1H), 3.68 (d, J = 7.9 Hz), 2.74-2.68 (m, 1H), 1.56 (s, 9H), 1.22 (d, J = 6.6 Hz, 3H), 1.18 
(d, J = 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 170.9, 165.9, 134.9, 129.0, 128.3, 126.6, 
83.7, 82.5, 55.5, 46.8, 35.5, 27.9, 23.5, 23.2. IR (thin film) ν 3436, 1783, 1732, 1647, 1636, 
1456, 1135, 1271, 1034, 978 cm-1. HRMS (ESI): Calcd. For C18H24O4SNa
+ ([M+Na+]): 
359.1293, found 359.1285. HPLC Chiralpak IC column, Hex/iPrOH = 96:4, flow rate = 1.0 
mL/min, λ = 210 nm, tR (minor) 11.4 min, tR (major) 12.6 min. TLC (10/90 EtOAc/hexanes): 
Rf = 0.34. [α]D
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carboxylate (2.9f). A vial under an atmosphere of N2 was charged with 2.8f 
(41.3 mg, 0.10 mmol, 1.0 equiv) and 1,4-dioxane (0.05M). The reaction was stirred for 2 h, 
then diluted with Et2O and H2O. The layers were separated, and the aqueous layer was 
extracted with Et2O. The combined organic layers were dried with Na2SO4 and concentrated 
in vacuo. The crude material was then purified with flash column chromatography using 50/50 
DCM/hexanes to give an off-white solid (25.5 mg, 0.067 mmol, 67%), mp 94-96 °C (decomp); 
1H NMR (600 MHz, CDCl3) δ 7.43-7.41 (m, 3H), 7.33 (t, J = 7.2 Hz, 2H), 7.29-7.27 (m, 3H), 
7.21 (d, J = 7.0 Hz, 2H), 5.73 (d, J = 7.0 Hz, 1H), 4.11 (t, J = 6.8 Hz, 1H), 3.69 (d, J = 6.7 Hz, 
1H), 3.49 (d, J = 13.1 Hz, 1H), 3.45 (d, J = 13.1 Hz, 1H), 1.55 (s, 9H); 13C NMR (151 MHz, 
CDCl3) δ 170.6, 165.6, 136.8, 134.7, 129.1, 128.9, 128.7, 128.3, 127.5, 126.5, 83.8, 82.3, 55.3, 
47.8, 36.2, 27.9. IR (thin film) ν 3437, 1783, 1731, 1636, 1456, 1370, 1138, 1004, 979, 699 
cm-1. HRMS (ESI): Calcd. For C22H24O4SNa
+ ([M+Na+]): 407.1293, found 407.1286. HPLC 
Chiralpak IC column, Hex/iPrOH = 96:4, flow rate = 1.0 mL/min, λ = 210 nm, tR (major) 16.0 
min, tR (minor) 18.2 min. TLC (10/90 EtOAc/hexanes): Rf = 0.29. [α]D
25
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CHAPTER THREE: EFFORTS TOWARDS THE REDUCTION OF α-IMINO 
ESTERS VIA DYNAMIC KINETIC RESOLUTION 
 
3.1 Overview of Dynamic Kinetic Resolution 
 As discussed in chapter 1, an ongoing demand exists for enantiopure molecules with 
ever-increasing stereocomplexity. While chiral pool synthesis and asymmetric catalysis are 
essential methods for generating novel chiral structures, resolution remains a robust and widely 
used process for isolating enantioenriched compounds.1 Resolution involves the physical 
separation of enantiomers from a racemic mixture, and encompasses a broad array of 
approaches for accessing enantioenriched products (Scheme 3-1).2 Chief among these methods 
is classical resolution, which relies on stoichiometric quantities of a resolving agent (Scheme 
3-1A). These resolving agents are generally chiral pool materials and bond either covalently 
or non-covalently to a racemic substrate to generate a pair of diastereomers. Following 
separation of the diastereomers, chemical-mediated decomplexation provides the 
enantioenriched material. Classical resolution is frequently employed, particularly in industry; 
however, the scope of substrates is generally limited to those which form ion pairs or who can 
engage in facile covalent connection and removal. Consequently, other methods of resolution 
have been developed to obviate formal complexation and decomplexation of the resolving 
agent.  
Chiral chromatography is another effective means of resolution, whereby a chiral 
stationary phase (CSP) enables separation of the two enantiomers (Scheme 3-1B).3,4 Similar 
to classical resolution, the CSP interacts with the substrate non-covalently to form transient 
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diastereomers and promote separation of enantiomers. The nature of the interaction eliminates 
any need for subsequent decomplexation and CSPs can be reused for extensive periods of time. 
Unfortunately, although CSPs are currently the most efficient means for quantitatively 
analyzing enantiomeric ratios, the broader utility of this process is limited to due to the high 
cost of even small scale CSP-packed columns, as well as the need for large quantities of solvent 
and long separation times. 
Scheme 3-1. Example Methods for the Resolution of Racemic Substrates 
 
A third general strategy within the resolution manifold is kinetic resolution. For 
example, the Sharpless asymmetric epoxidation kinetic resolution enables isolation of highly 
enantioenriched allylic alcohols (Scheme 3-1C).5 While the former two approaches require 
stoichiometric quantities of resolving agent or struggle with scale limitations, kinetic 
resolutions can proceed catalytically and are well-suited to large scale transformations. In a 
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kinetic resolution, enantiomers of a racemic substrate (S) are transformed at different rates (kR 
and kS) to a product (P) (Scheme 3-2A).
2,6 A successful kinetic resolution converts one 
enantiomer of substrate to product, while the other enantiomer is collected as unreacted 
substrate. The success of a kinetic resolution, or the ability to isolate highly enantioenriched 
material, is directly related to the difference in energy between the diastereomeric transition 
states (ΔΔG‡). Additionally, enantioenrichment changes as a function of conversion; therefore, 
optimal kinetic resolution involves full conversion of one enantiomer and no conversion of the 
opposite enantiomer. In this ideal scenario enantioenrichment is maximized, but the theoretical 
yield of one enantiomer of product is capped at 50%  much like classical resolution and 
chromatographic resolution. Moreover, separation of the resolved starting material and product 
can be challenging. 
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Scheme 3-2. Key Differences Between Kinetic Resolution and Dynamic Kinetic Resolution 
 
 Despite the reliability of resolution as a means for accessing enantioenriched material, 
a maximum theoretical yield of 50% limits the utility of this process and results in the 
abandonment of valuable material. Dynamic kinetic resolution (DKR) overcomes this barrier, 
by following the same general principles as kinetic resolution, but with simultaneous 
equilibration between the two enantiomers of starting material (Scheme 3-2B).2,6 Equilibration 
can proceed through a variety of means: chemical, enzymatic, or spontaneous.6 With 
sufficiently rapid racemization, the racemic substrate can be funneled through the faster 
asymmetric pathway, increasing the theoretical yield of a single enantiomer of product to 
100%. Along with this significant improvement come some equally important requirements 
for success. The rate of equilibration (kinv) is crucial to this process. At a minimum, this rate 
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must be greater than the rate of reaction for the slower enantiomer (kinv > kR) as per Curtin 
Hammett kinetics.1,6 Moreover, an optimal DKR requires that the rate of equilibration be 
greater than the rate of reaction for the faster enantiomer (kinv > kS), otherwise the demands on 
enantioselectivity for the reaction increase dramatically (kS >>> kR).
1,6 Finally, the resolution 
must be irreversible and the product cannot undergo racemization under the reaction 
conditions. These final two restrictions are true of any resolution, but particularly applicable 
to KR and DKR.  
 When the criteria outlined above are satisfied, dynamic kinetic resolutions can quickly 
and effectively provide enantioenriched product in high yield. Consequently, DKR has been a 
research area of interest for academia and industry alike. Perhaps the most influential and well-
known DKR is Noyori’s development of a ruthenium-catalyzed hydrogenation of α-substituted 
β-keto esters.7,8 Noyori contributed key theoretical and practical advances to the art of DKR 
through mathematical models9 and other studies10. Additionally, their initial 1989 publication 
included the stereoselective synthesis of a key intermediate of L-threo-3,4-
dihydroxyphenylserine (L-DOPS), a norepinephrine prodrug that has been studied for more 
than three decades for the treatment of neurodegenerative diseases (Scheme 3-3A).7,11–14 
Subsequent advances enabled chemical manufacturer Takasago to stereoselectively 
manufacture 4-acetoxyazetidinones – precursors in carbapenem antibiotic synthesis – on the 
scale of 150 tons/year (Scheme 3-3B).10,15  
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Scheme 3-3. Transfer Hydrogenation DKR of β-Keto Esters 
 
For more than a decade, the Johnson lab has studied dynamic asymmetric processes. In 
particular, we have recently focused our pursuits on the dynamic kinetic resolutions of α-keto 
esters as a means for accessing diverse glycolate scaffolds.16 Initial efforts involved ruthenium-
catalyzed asymmetric transfer hydrogenations (ATH), inspired by Noyori’s seminal DKR 
work with configurationally labile β-keto esters.7,8 We envisioned reducing the ketone of 
racemic α-keto ester 3.1 to generate alcohol 3.2 with two contiguous stereocenters (Scheme 3-
4). In 2012, we reported a DKR-ATH of malonate substrate 3.1a to generate alcohol 3.2a, 
which spontaneously cyclized after reduction to provide lactone 3.3a with a third contiguous 
stereocenter.17,18 This transformation proved to be extremely robust throughout subsequent 
investigations, generating chemically diverse and stereochemically complex products (3.2b-d) 
under nearly identical reaction conditions for all substrates.17–19  
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Scheme 3-4. Ruthenium-Catalyzed Transfer Hydrogenation DKR of α-Keto Esters 
 
Following our DKR-ATH work, we began exploring C-C bond forming reactions for 
the enantioconvergent synthesis of increasingly complex glycolic acid scaffolds. The Johnson 
lab successfully adapted a variety of organocatalyzed and transition-metal catalyzed reactions 
to our α-keto ester DKR manifold, including the cross-benzoin condensation (Scheme 3-5A),20 
alkyne addition (Scheme 3-5B),21 and Hayashi-Miyaura arylation (Scheme 3-5C),22 among 
others. 
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Scheme 3-5. Advances in DKR with Configurationally Labile α-Keto Esters 
 
 While continuing our investigations into α-keto ester dynamic kinetic resolutions, our 
ambitions also expanded to other substrate classes. In 2015, we published a DKR employing 
α-substituted β-formyl amides, which were novel substrates for asymmetric catalytic 
transformation.23 Although these substrates resemble their β-keto ester counterparts, they are 
notable for their increased acidity at the α-position, particularly following enamine formation. 
Careful substrate optimization was required to promote equilibration of the enamine to the 
imine. Ultimately, combination of these substrates with an allyl primary amine and chiral 
phosphoric acid catalyst yielded the aza-Cope rearrangement product in good yield and 
stereoselectivity (Scheme 3-6A). More recently, we  published a stereoconvergent addition of 
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arylboronic acids to α-angelica lactone derivatives to provide enantioenriched γ-butyrolactones 
with two contiguous stereocenters (Scheme 3-6B).24 Racemization of the α-Angelica lactone 
proceeded via formation of the dienolate ‒ a novel racemization approach for our lab. This 
DKR also overcame several obstacles, including polymerization, dimerization, and hydrolysis 
of the lactone.  
Scheme 3-6. DKRs with Underexplored Substrates 
 
Motivated and informed by these past efforts, we have sought to develop novel DKRs 
which provide access to stereochemically complex amines. The remainder of this chapter 
discusses my efforts to synthesize unnatural amino acids containing vicinal stereocenters via 
DKR transformation of β-substituted α-imino esters (Scheme 3-7A). Subsequently, Chapter 4 
discloses the successful development of an enantioconvergent iso-Pictet Spengler reaction with 
α-alkyl β-formyl esters to provide γ-carbolines with two contiguous stereocenters (Scheme 3-
7B). 
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Scheme 3-7. Generating Amines via Dynamic Kinetic Resolution  
 
3.2 Motivation & Background 
3.2.1 Applications of Unnatural Amino Acids 
 The synthesis of unnatural amino acids (UAAs) is of great import to both the biological 
and chemical communities. Chemically, UAAs are often employed as chiral small molecule 
building blocks. For example, many asymmetric ligands and organocatalysts derive their chiral 
backbone from UAAs such as the commercially available25 UAA D-phenylglycine (Scheme 
3-8).26–28 UAAs are also uniquely suited for myriad biological applications. Canonically, 22 
amino acids (cAAs) comprise the vast majority of peptides and proteins, enabling fundamental 
cell functions.29 This small set of building blocks limits the scope of small molecules, peptides, 
and proteins, and as a result there is an ongoing impetus for the synthesis of novel amino acids. 
The demand for UAAs arises from their unique biological properties and activities that enable 
bio-orthogonal chemistry, metabolic studies, studies on protein function and structure-activity 
relationships, and use as molecular probes.27,28,30–34 Finally, drug discovery efforts employ 
UAAs as protein-small molecule linkages for antibody-drug complexes33,35, as well as in 
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peptidomimetic therapeutics such as Saralsin (hypertension) and Carbetocin (postpartum 
hemorrhaging).36   
Scheme 3-8. Unnatural Amino Acids in Organocatalyst Synthesis 
 
3.2.2 Synthetic Approaches to Unnatural Amino Acids 
Numerous methods have been developed for the synthesis of enantioenriched UAAs. 
The most robust syntheses of enantiopure unnatural amino acids diversify one of the canonical 
natural amino acids. Shi and Yu have both developed palladium-catalyzed methods for 
carrying out C-H functionalization of amino acids; although conversion of the AA’s carboxylic 
acid to a designer amide is required prior to reaction (Scheme 3-9A).37–41 Impressively, high 
diastereoselectivity is observed when installing the vicinal stereogenic center. White further 
expanded the library of amino acid-derived UAAs with their publication of an iron-catalyzed 
oxidative diversification of amino acids and peptides (Scheme 3-9B).42 While the utility of 
these approaches is undeniable, this chemistry relies on enantioenriched starting materials such 
as cAAs.  
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Scheme 3-9. C-H Functionalization of Natural Amino Acids 
 
 Biocatalytic approaches are an effective means of achieving excellent 
enantioselectivity in the synthesis of UAAs;30 however, establishing two stereocenters has 
proven extremely challenging. Engineered methylaspartate ammonia lyase (MAL) enzymes 
have found some application in the synthesis of aspartic acid analogs, but the substrate scope 
and yields were quite limited – a common issue for enzymes (Scheme 3-10A).43,44 Given the 
broader biochemical importance of enzymes, and particularly of transaminases, organic 
chemists have long sought to develop analogous processes using small molecule 
organocatalysis. Yet, organocatalytic asymmetric transamination has proven quite challenging 
and the literature contains relatively few examples. In 2011, Shi reported an asymmetric 
transamination of α-keto esters via a quinine-derived catalyst (Scheme 3-10B).45 Subsequent 
efforts improved the scope and enantioselectivity of this transformation.46–49 Spearheaded by 
102 
Dr. Blane Zavesky, our lab attempted to adapt this chemistry to the dynamic kinetic resolution 
of β-substituted α-keto esters, but these efforts did not bear fruit. More recently, Maruoka 
published an organocatalyzed transamination employing phase-transfer catalysis; but, this 
transformation was plagued by moderate enantioselectivities.50, a 2016 publication from Zhao 
disclosed a transamination of α-keto acids to generate unprotected, unnatural amino acids in a 
single step (Scheme 3-10C).51 Although my efforts focused on α-keto and α-imino esters, 
future work by members of the Johnson lab may seek to adapt these conditions to our synthetic 
interests. 
Scheme 3-10. Synthesis of UAAs via Bio- or Organocatalysis 
 
Historically, the vast majority of methods for synthesizing UAAs have proceeded via 
transformation of an α-imino ester. Initial efforts involved use of auxiliaries such as Ellman’s 
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sulfinamide or (R)-1-phenylethylamine;52 however, the evolution of asymmetric catalysis 
dramatically augmented the array of reactions employing achiral imine protecting groups. 
Rhodium-catalyzed hydrogenation of enamides is one of the oldest examples of asymmetric 
catalysis, dating back to Knowles in 1972.53 Only a few years later, advances in ligand 
development enabled the formation of two contiguous stereocenters with excellent 
enantioselectivity and diastereoselectivity (Scheme 3-11).54 Today, these Rh-catalyzed 
enamide hydrogenations tolerate a staggering array of substitution patterns and protecting 
groups;55,56 yet, as is common in transition metal chemistry, tolerance for substrates containing 
halogens is low. With an ever-growing list of halogen-dependent cross-coupling 
transformations57, enantioenriched β-halo-substituted unnatural amino acids could prove 
valuable.  
Scheme 3-11. Rhodium-Catalyzed Asymmetric Hydrogenation of Enamides 
 
Organocatalytic transfer hydrogenations with Hantzsch esters and benzothiazolines 
sought to overcome this substrate limitation, and specifically eliminate the need for precious 
transition metals and high pressures of H2. Despite achieving excellent results with aryl α-
imino esters, these transformations exhibit low tolerance for aliphatic substitution (Scheme 3-
12A).52,58,59 Seeking to apply this chemistry to configurationally labile β-substituted α-imino 
esters, our preliminary investigations were fraught with poor reactivity and decomposition 
(Scheme 3-12B). Consequently, we turned to a distinctly different approach to imine 
reduction: chiral Lewis-base activated trichlorosilane hydrosilylation. 
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Scheme 3-12. Hantzsch Ester Reduction of α-Imino Esters 
 
3.2.3 Asymmetric Reductions with Trichlorosilane 
Trichlorosilane is a well-established hydride source for the enantioselective reduction 
of C=N bonds.60 Predominantly used by the organosilicon industry, the clear, colorless liquid 
is a cheap, commodity chemical.60 As a reagent, trichlorosilane is not sufficiently hydridic to 
reduce carbonyls and imines on its own.61 Rather, dual coordination of a Lewis base (LB) 
generates a hypervalent, hexacoordinate silicate species, which is the active reductant (Scheme 
3-13).62  
Scheme 3-13. Reduction of Imines by Hexacoordinate Silicates  
 
The racemic reduction of imines via trichlorosilane dates back to 1982, when Benkeser 
and Snyder synthesized N-benzyl anilines in refluxing acetonitrile.63 In 1996, Kobayashi 
identified trichlorosilane-DMF as an effective reducing reagent of ketones and confirmed the 
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presence of a six-coordinate silicon species via 29Si NMR.64 A catalytic reduction was 
subsequently reported by Matsumura using chiral formamide 3.10 (Figure 3-1), first to reduce 
ketones in 1999, then ketimines in 2001.65,66 Neither reaction exhibited good 
enantioselectivity, but the proof-of-concept prompted research and development of more 
effective chiral Lewis bases. 
Independent contributions over the last two decades from Matsumura, Kocovsky, Sun, 
and Benaglia have given rise to a diverse library of chiral Lewis base organocatalysts;60–62 
although very few have achieved broad substrate scopes with high levels of enantioinduction 
(>90:10 er). A select number have successfully effected the asymmetric reduction of aryl α-
imino esters and/or aliphatic ketimines, both of which were considered reasonable model 
substrates for our interests. In 2007, Zhang reported that ephedrine-based picolinamide 3.11 
could asymmetrically reduce a variety of ketimines, including para-methoxy phenyl (PMP)-
protected α-imino ester 3.18 and aliphatic ketimine 3.20 (Scheme 3-14).67 Unfortunately, 
stereoselectivities varied greatly (80:20 to 98:2 er), and products 3.18 and 3.20 were obtained 
with only modest enantioenrichment. Despite these mixed results, the ease with which this 
catalyst is synthesized prompted further optimization. Subsequent work from Benaglia 
demonstrated that chlorinated pyridyl 3.12 improved yields and stereoselectivities for a variety 
of ketimines.68 Related structure-activity investigations also informed the proposed 
stereochemical model, wherein the picolinamide activates trichlorosilane, while the secondary 
benzylic alcohol hydrogen bonds with the imine (Scheme 3-15).  
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Figure 3-1. Select Chiral Organocatalysts for the Trichlorosilane Reduction of α-Imino Esters 
and Aliphatic Ketimines 
 
Scheme 3-14. Formamide-Activated Trichlorosilane Reduction of Imines (Zhang, 2007) 
 
Scheme 3-15. Proposed Stereochemical Model for Ephedrine-Trichlorosilane Reduction of N-
Aryl Ketimines 
 
Non-ephedrine-based systems have also shown great promise, although extended 
reaction sequences to arrive at the target structure have hampered attempts to expand the utility 
of these catalysts. Prolinols have long been employed as backbones for organocatalysts, and in 
107 
2008 Zhang developed a proline-derived picolinamide catalyst for the asymmetric reduction 
of β-enamino esters.69 The following year, Jones exchanged the pyridine for N-methyl 
imidazole to generate catalyst 3.14, which provided aliphatic amine 3.21 in high yield and 
good enantioselectivity.70 Finally, catalysts 3.15-3.17 all achieved excellent yields and 
enantioselectivities with 3.18.71–73 Unfortunately, 3.17 demonstrated very poor 
enantioselectivity with an aliphatic α-imino ester71, and our attempts to synthesize 3.16 were 
unsuccessful.73 As such, we settled on ephedrine, prolinol, and Cinchona alkaloid-derived 
Lewis bases for our initial studies. 
 
3.3 Challenges to Dynamic Kinetic Resolution with α-Imino Esters 
With this prior literature front of mind, we sought to advance the art of dynamic kinetic 
resolution and expand the library of synthetically accessible unnatural amino acids by 
developing a DKR reduction of configurationally labile α-imino esters using trichlorosilane. 
When initially considering this transformation, several key challenges quickly arose which 
required our attention as we moved forward. Naturally, all of the standard challenges of 
dynamic kinetic resolution were present, such as access to β-substituted α-imino ester 
substrates, rate of racemization, and stereoselective catalyst control; however, several 
additional complications arise when carrying out DKR with imines (Figure 3-2).  
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Figure 3-2. Challenges in Dynamic Kinetic Resolution with α-Imino Esters 
 
The first complication is imine reactivity and stability, as these characteristics vary 
greatly with substrate structure and electronics. α-Imino esters are more electrophilic than 
ketimines due to the electron-withdrawing nature of the ester, and the pKa values for these two 
substrates reflects this difference.74 Consequently, α-imino esters benefit from heightened 
reactivity, as well as an increased propensity for racemization. As a result, we hypothesized 
that these substrates would be well-suited for DKR; however, this increased reactivity also 
amplifies the α-imino ester’s sensitivity to hydrolysis and other undesirable decomposition 
pathways. Careful tailoring of the N-protecting group and β-substituents is generally required 
to ensure sufficient stability of the α-imino ester starting material. 
In addition to imine stability, the presence and equilibration of E/Z isomers for N- 
protected imines adds another challenging element. Sun and Hoveyda have independently 
observed that aliphatic ketimines and α-imino esters exist as a mixture of E/Z isomers.74,75 The 
two isomers readily interconvert, and the authors propose that selective reaction of a single 
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isomer is required for enantioselective transformation. Jacobsen noted a similar trend during 
mechanistic investigations of their enantioselective Strecker reaction, where the catalyst 
binding occurred exclusively with the Z-imine.76 Consequently, an ideal DKR would involve 
rapid E/Z imine equilibration as well as facile interconversion at the β-stereogenic center 
(Scheme 3-16). Moreover, the optimal catalyst would select for only one of these four reactive 
species to stereoselectively provide product. This intense reliance on conformational control 
makes cyclic imines excellent candidates for asymmetric functionalization, and dynamic 
kinetic resolution in particular.77–81 A few impressive DKRs of cyclic β-imino esters and 
ketimines have been developed; however, unfortunately, no methods currently exist for the 
synthesis of cyclic α-imino esters and our attempts to develop a robust, accessible process 
proved unsuccessful. 
Scheme 3-16. Generic Proposed DKR of α-Imino Esters 
 
Ultimately, the factors above rely heavily on the identity of the nitrogen protecting 
group. A wide selection of amine protecting groups exist in the literature, and asymmetric 
catalysis has employed nearly all of them at one time or another; however, the vast majority of 
reactions accomplish enantioinduction with only a single class (e.g. carbamates, phosphinoyl, 
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sulfonyl, etc.) and broad tolerance is rarely observed. This is due to the unique electronic and 
structural features that each protecting group possesses to enable or disable reactivity and 
stereoselectivity.82,83 Additionally, many asymmetric transformations utilize amine 
substituents such as alkyl groups which are challenging, if not impossible, to remove. If the 
end goal of this endeavor is to synthesize UAAs, we must limit ourselves to amines that can 
be deprotected. All of these challenges must be overcome to develop a successful DKR 
transformation of α-imino esters with high yields and stereoselectivities. 
 
3.4 Results & Discussion 
3.4.1 Synthesis of β-Substituted α-Imino Esters 
Our first task in developing an enantioconvergent trichlorosilane-mediated reduction 
of imines was accessing the requisite β-substituted α-imino ester starting material. In 
accordance with prior literature, we identified the para-methoxyphenyl (PMP) N-protecting 
group for the imine. Although these protecting groups are considerably more difficult to 
remove than alternatives such as carbamates, an abundance of trichlorosilane literature 
employs this protecting group.60 Moreover, the electron-donation of the PMP group serves to 
stabilize the imine C=N bond74 – a feature deemed critical for success after preliminary studies 
with electron-withdrawing groups (Cbz, Ts, Acyl) showed little to no isomerization of the 
enamide to the imine.  
Traditionally, the synthesis of α-imino esters proceeds via condensation of a primary 
amine onto the α-keto ester. While this reaction is facile for aldimine synthesis, ketimine 
generation is considerably slower, and especially so when sterically encumbered (e.g. by β-
substitution).74 Accordingly, the transformation generally suffers from long reaction times and 
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moderate yields. We sought to identify a faster, higher yielding method for accessing the 
desired starting material. In 2008, Hoveyda adapted a procedure from Palacios84 to generate 
aliphatic α-imino esters from aryl azides and α-keto esters via Staudinger reduction (Scheme 
3-17A).74* Gratifyingly, we found that we could apply identical reaction conditions to generate 
β-methyl, β-phenyl α-imino ester 3.22 in similarly high yield and a 5:1 E/Z ratio of imine 
isomers (Scheme 3-17B).  
Scheme 3-17. Staudinger Reaction for the Efficient Synthesis of α-Imino Esters 
 
 
3.4.2 Trichlorosilane-Mediated Reduction and DKR of β-Alkyl α-Imino Esters 
 With our desired starting material in hand, we established proof of concept using DMF 
as an achiral ligand64 in the presence of trichlorosilane and PMP-protected imino ester 3.22 
(Scheme 3-18). DMF is considerably less activating than designer chiral ligands, but still 
succeeded in generating the desired amine (3.23) in 3.8:1 dr and 45% conversion after 21 h. 
Following these encouraging results we opted to synthesize and screen an array of chiral 
organocatalysts.   
                                                 
* Hoveyda synthesized these imines for an asymmetric, Zr-catalyzed dialkyl zinc addition to generate quaternary 
stereocenters. Attempts to apply this to our system proved unsuccessful, resulting in uncatalyzed, racemic addition 
at the nitrogen center of the C=N bond. The reaction was abandoned in favor of more promising transformations. 
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Scheme 3-18. Racemic Reduction of a β-Substituted α-Imino Ester via DMF-HSiCl3 
 
 Applying catalyst ent-3.11 to our system, we observed promising enantioselectivity and 
diastereoselectivity despite moderate to low yield (Scheme 3-19). The 4-chloropicolinic acid 
derivative 3.12 provided a substantial increase in yield, but no dramatic improvements to 
stereoselectivity. Cinchona alkaloid catalyst 3.17 improved diastereoselectivity to 9:1 dr, but 
diminished enantioselectivity negated any advantages of exploring this ligand further. Finally, 
we observed racemic product when screening Sun’s tert-butyl sulfinamide catalyst (3.24).85 
Ultimately, as in many reactions, the ephedrine-based ligands proved most promising. As such, 
we initiated optimization of that catalytic manifold. 
 We selected two areas of investigation for catalyst optimization: (1) the stereochemistry 
of the catalyst backbone, and (2) the nitrogen heterocycle. Like ephedrine, its diastereomers 
(R,R) and (S,S)-pseudoephedrine are commercially available. Exchanging the backbone 
generated catalysts (R,R)-3.25 and (S,S)-3.26. Application of 3.25 and 3.26 in the model 
reaction resulted in increased yields and similar enantioselectivities relative to results obtained 
with 3.11. Catalyst 3.25 also increased the diastereoselectivity from 3.6:1 dr to 4:1 dr. 
Simultaneous investigation of the N-heterocycle was motivated by differences observed 
between the unsubstituted (3.11) and 4-chloro (3.12) picolinic catalysts. We hypothesized that 
other nitrogen heterocycles could further improve stereoselectivities and yields. Unfortunately, 
both quinolyl ligand 3.27 and indole ligand 3.28 provided racemic product, and poor yields 
and diastereoselectivities.  
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Scheme 3-19. Initial Ligand Screening for HSiCl3 DKR Reduction 
 
a Determined by 1H NMR analysis of the crude reaction mixture using an internal standard. 
 
 Although improvements to both yield and stereoselectivity were observed upon catalyst 
structure variation, the reaction outcomes remained suboptimal. Given that our 
enantioselectivity was thus far limited to 80:20 er, we hypothesized that perhaps the rate of 
racemization (krac) was not sufficiently fast. Traditionally, DKR of α-keto esters requires base 
to facilitate racemization, so we hypothesized that the DKR of α-imino esters could be enabled 
by the addition of acid or base. Reagent grade trichlorosilane generally contains trace quantities 
of HCl, and spontaneously reacts with water to generate hydrochloric acid and silicon 
polymer.86 Although distillation is possible, the presence of HCl in trichlorosilane reactions is 
somewhat inevitable.86,87 Kočovsky’s 2008 DKR synthesis of β-amino acids found that acetic 
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acid acted as a buffer to promote enamine/imine isomerization and improve reactivity.86 In an 
effort to strike a similar balance, we employed catalytic quantities of acids and bases (Table 
3-1). Acetic acid performed as suspected by improving the yield dramatically, however 
stereoselectivity was slightly diminished (entry 2). In contrast, cesium carbonate had little 
effect (entry 3), while trialkylamines shutdown the reaction (entry 4) – likely due to 
displacement of the activating ligand by the amine61. Additives conclusively affected 
reactivity, yet poor stereoselectivity remained a serious issue. 
Table 3-1. Additive Effects on Trichlorosilane-Mediated DKR 
 
entry additive dr er yielda 
1 none 3.6:1 81:19 48% 
2 AcOH 3.4:1 77:23 89% 
3 Cs2CO3 3.4:1 80:20 48% 
4 DIPEA 2.4:1 - 20% 
a Determined by 1H NMR analysis of the crude reaction 
mixture using an internal standard. 
 
3.4.3 Trichlorosilane-Mediated Enantioconvergent Reduction of β-Halo α-Imino Esters 
 Concurrently with our additive screen, we began investigating whether β-halo α-imino 
esters might be more effective substrates in this transformation. Synthesis of β-bromo β-benzyl 
α-imino ester 3.30 was accomplished using the same procedure as the β-alkyl substrates 
(Scheme 3-20A). Subsequent exposure of the imine to the asymmetric trichlorosilane 
reduction conditions gave the desired secondary amine (3.31) in 20:1 dr and 80:20 er, although 
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yield was poor (Scheme 3-20B). Despite the moderate enantioselectivity and yield, the 
substantial improvement to diastereoselectivity led us to continue investigations exclusively 
with the β-halo substrates. 
Scheme 3-20. Synthesis of and Initial Hit with β-Bromo α-Imino Ester 
 
 Although the β-halo α-imino esters proved synthetically accessible and sufficiently 
reactive, the improvements to diastereoselectivity were quickly accompanied by two new 
challenges. First, we found that this substrate was more susceptible to temperature-dependent 
decomposition. While preliminary trials 0 °C provided the product in moderate yield, warming 
the reaction to room temperature diminished the yield significantly (Scheme 3-21). 
Additionally, the reaction conditions generated varying quantities (~5-10%) of dehalogenated 
side-product 3.32 (Scheme 3-22). This side product was observed in equal quantities at 0 °C 
and room temperature, suggesting additional pathways are responsible for the diminished 
yields at elevated temperature. We propose that initial aziridine formation could be followed 
by trichlorosilane-mediated reduction. No studies have previously reported this reactivity but 
we understand this outcome to be a logical outgrowth based on fundamental organic reactivity. 
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Scheme 3-21. Side Product Formation and Temperature Dependence 
 
 
Scheme 3-22. Hypothetical Mechanism for Dehalogenated Side Product Formation 
 
 
With these challenges in mind, we sought to minimize these decomposition pathways 
and maximize stereoselectivity by initiating a catalyst screen with β-bromo α-imino ester 3.30 
(Scheme 3-23). Ephedrine and pseudoephedrine-derived catalysts ent-3.11, 3.25, and 3.26 all 
provided nearly identical results with regards to both stereoselectivity and yield, with 
enantioselectivity limited to 70:30 er. Inspired by a mechanistic investigation of trichlorosilane 
reductions from Jones in 2017, we began synthesizing ligands 3.33-3.36.88 Jones proposed that 
methylating the alcohol of their prolinol catalyst (3.36) could facilitate catalyst turnover; 
however, methylation of the pseudoephedrine-based catalyst to generate 3.33 proved less 
productive, diminishing product yield. Jones also found that their system benefited from the 
additional hydrogen-bonding capability of the imidazole relative to the picolinic functional 
group. However, our system performed quite differently when exposed to N-methylimidazole 
catalyst 3.34, with less than 15% NMR yield after stirring overnight. Proline-derived catalysts 
3.35 and 3.36 provided further evidence of the stereochemical importance of the pyridine 
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moiety in this catalyst, while also indicating that stereoselectivity was not heavily dependent 
on the ephedrine-derived backbone.  
Scheme 3-23. Ligand Screen for the DKR Reduction of a β-Bromo α-Imino Ester 
 
a Determined by 1H NMR analysis of the crude reaction mixture using an internal standard. 
 
Disheartened by these results, we made a final push to overcome the many obstacles of 
this transformation by attempting to synthesize alternative β-halo α-imino esters (Scheme 3-
24). Unfortunately, imine stability proved debilitating. Both β-chloro- and β-bromo-β-phenyl 
α-iminoesters were observed to decompose under Staudinger reduction as reported for β-alkyl-
β-phenyl substrates (vide infra). Evidently, imine 3.30 was uniquely stable, and our initial 
concerns regarding β-halo imine instability were justified.  
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Scheme 3-24. Synthesis of Diverse β-Substituted α-Imino Esters 
 
This final synthetic challenge proved insurmountable, and given the general 
complications this project faced, we opted to move away from this dynamic kinetic resolution. 
With our improved understanding of asymmetric imine chemistry, we initiated an investigation 




 In conclusion, we have reported efforts toward realizing a dynamic kinetic resolution 
of β-substituted α-imino esters. Ultimately, instability of both the imine starting material and 
β-halogenated products diminished the yields of this transformation, while we suspect that 
slow racemization and suboptimal catalyst selectivity contributed to poor enantioenrichment. 
Despite a lack of positive, publishable results, we identified two important lessons for 
application to future imine work: (1) Significant differences in diastereoselectivity were 
observed between the β-alkyl and β-halo α-imino esters, likely due to more facile group 
differentiation. (2) Our broader efforts to investigate the utility of PMP-protected imines, as 
well as other imines and enamides, in dynamic kinetic resolution shed light on the reactivity 
of α-imino esters. Other imine protecting groups (tosyl, acyl, carbamate) failed to generate any 
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product even under forcing conditions. PMP-protected imino esters successfully afforded the 
desired α-amino esters, but the nascent stereogenic centers were generated in poor selectivity. 
The synthesis of unnatural amino acids via dynamic kinetic resolution is a challenging task, 
but a worthy one. We remain optimistic that our efforts will provide useful insight for future 
endeavors. 
 
3.6 Experimental Details 
Methods: Proton magnetic resonance spectra (1H NMR) were recorded on a Bruker model 
DRX 400, 500, or 600 (1H NMR at 400 MHz, 500 MHz, or 600 MHz). 1H NMR data are 
reported as follows: chemical shift, multiplicity (s = singlet, app s = apparent singlet, br s = 
broad singlet, d = doublet, dd = doublet of doublet, t = triplet, m = multiplet), coupling 
constants (Hz), and integration. Analytical thin layer chromatography was carried out using 
Whatman 0.25 mm silica gel 60 plates, Sorbent Technologies 0.20 mm Silica Gel TLC plates. 
Visualization was allowed by UV light, phosphomolybdic acid in ethanol, aqueous ceric 
ammonium nitrate solution, ninhydrin solution, or KMnO4. HPLC analysis was performed on 
a Perkin Elmer flexar photodiode array (PDA) system equipped with a Daicel Chiralpak IC 
column. Asymmetric reactions at temperatures below 23 °C were carried out in a Thermo 
Sigma UCR-150N aluminum block UC reactor with stirring. Purification of the reaction 
products was carried out by using Siliaflash-P60 silica gel (40- 63μm) purchased from 
Silicycle. Yields refer to isolated yields after flash column chromatography. NMR yields were 
obtained using phenanthrene as an internal standard. Racemic traces were obtained using DMF 
as a racemic ligand (1 equiv as opposed to 10 mol %).  
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Materials: Solvents were passed through a column of neutral alumina under nitrogen prior to 
use. Reagents were obtained from Millipore Sigma, Fischer Scientific, or Oakwood Chemical 
Supply and used as received. 
 
Catalyst Synthesis 
(R)-N-(2-hydroxybenzyl)-2-methylpropane-2-sulfinamide (3.24): The 
title compound was synthesized as reported by Sun, et al.85 1H NMR 
spectroscopic data matches those reported.  
 
(S)-(2-(hydroxydiphenylmethyl)pyrrolidin-1-yl)(1-methyl-1H-imidazol-2-
yl)methanone (3.36): The title compound was synthesized as reported by Jones, 
et al.70 1H NMR spectroscopic data matches those reported. 
 
Ephedrine-Based Catalysts (ent-3.11, 3.12, 3.25-3.28): The catalysts below were synthesized 
via a modified procedure from Benaglia, et al.68   
 
N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylpicolinamide 
(ent-3.11): Picolinic acid (300 mg, 2.43 mmol, 1 equiv) was added to a flame-
dried round bottom flask, then dissolved in SOCl2 (2.5 mL). The reaction was refluxed at 80 °C 
for 2 hours, then the solvent was removed in vacuo. In a separate flask, (1R,2S)-ephedrine (402 
mg, 1 equiv) was dissolved in THF, followed by addition of triethylamine (1.02 mL, 3 equiv). 
The acid chloride was dissolved in THF, added to the flask, and the reaction mixture was stirred 
at reflux overnight. The reaction was quenched with satd. aq. NaHCO3. The aqueous layer was 
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discarded, then the organics were washed with brine. The organics were collected and dried 
over Na2SO4, filtered, and concentrated. The crude material was purified using flash column 
chromatography (1% to 2.5% MeOH:DCM) to give a white solid. 1H NMR spectroscopic data 
matches those reported.68 
 
N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylpicolinamide 
(3.25): Picolinic acid (123 mg, 1.00 mmol, 1 equiv) was added to a flame-
dried round bottom flask, then dissolved in SOCl2 (1.0 mL). The reaction was refluxed at 80 °C 
for 2 hours, then the solvent was removed in vacuo. In a separate flask, (1S,2S)-
pseudoephedrine (198 mg, 1.2 equiv) was dissolved in THF (3 mL), followed by addition of 
triethylamine (0.42 mL, 3 equiv). The acid chloride was dissolved in THF (2 mL) + DMF (2 
drops), added to the flask, and the reaction mixture was stirred at reflux overnight. The reaction 
was quenched with satd. aq. NaHCO3. The aqueous layer was discarded, then the organics 
were washed with brine. The organics were collected and dried over Na2SO4, filtered, and 
concentrated. The crude material was purified using flash column chromatography (1% to 
2.5% MeOH:DCM) to provide the product as a white solid (85 mg, 0.31 mmol, 31%). The 
product appeared as a 10:1 mixture of rotamers in the NMR spectrum. Major Rotamer: 1H 
NMR (500 MHz, Chloroform-d) δ 8.73 (d, J = 4.8 Hz, 1H), 7.96 (td, J = 7.7, 1.7 Hz, 1H), 7.89 
(d, J = 7.8 Hz, 1H), 7.53 (ddd, J = 7.6, 4.9, 1.3 Hz, 1H), 7.37 – 7.31 (m, 2H), 7.29 (d, J = 5.7 
Hz, 3H), 4.61 (dd, J = 10.1, 8.4 Hz, 1H), 4.21 (dq, J = 10.2, 6.7 Hz, 1H), 3.19 (s, 3H), 0.95 (d, 




(3.26): The title compound was synthesized in the same manner as reported 
for enantiomer 3.25. The product was obtained as a white solid (90 mg, 0.35 mmol, 35%), and 
appeared as a 10:1 mixture of rotamers in the NMR spectrum. Major Rotamer: 1H NMR (500 
MHz, Chloroform-d) δ 8.73 (d, J = 4.8 Hz, 1H), 7.96 (td, J = 7.7, 1.7 Hz, 1H), 7.89 (d, J = 7.8 
Hz, 1H), 7.53 (ddd, J = 7.6, 4.9, 1.3 Hz, 1H), 7.37 – 7.31 (m, 2H), 7.29 (d, J = 5.7 Hz, 3H), 
4.61 (dd, J = 10.1, 8.4 Hz, 1H), 4.21 (dq, J = 10.2, 6.7 Hz, 1H), 3.19 (s, 3H), 0.95 (d, J = 6.7 
Hz, 3H). The alcohol proton was not observed. 
 
N-((1S,2S)-1-methoxy-1-phenylpropan-2-yl)-N-methylpicolinamide 
(3.33): The title compound was synthesized via a modified procedure from 
Benaglia.68 NaH was was added to a flame dried flask under N2. THF (5 mL, 0.17 M) was 
added, followed by addition of picolinamide 3.25 (215 mg, 0.80 mmol, 1 equiv) in a single 
portion. The mixture was stirred at room temperature for 2 h, then MeI (0.10 mL, 2 equiv) was 
added. The reaction was stirred for 20 h at room temperature, then quenched with satd. aq. 
NH4Cl. The product was extracted with DCM (3x), then organics dried over Na2SO4, filtered, 
and concentrated in vacuo. The crude material was purified using flash column 
chromatography (50% to 70% EtOAc:Hex) to provide the product as a clear, viscous oil (87 
mg, 0.31 mmol, 39%). The product appeared as a 2.4:1 mixture of rotamers in the NMR 
spectrum. Major Rotamer: 1H NMR (400 MHz, Chloroform-d) δ 8.54 (d, J = 4.8 Hz, 1H), 7.74 
(m, 1H), 7.39 (m, 2H), 7.36 – 7.21 (m, 5H), 4.12 (p, J = 7.2 Hz, 1H), 4.01 (d, J = 8.2 Hz, 1H), 
3.13 (d, J = 2.0 Hz, 3H), 3.09 (d, J = 1.9 Hz, 3H), 1.14 – 1.06 (m, 3H). Minor Rotamer: 1H 
NMR (400 MHz, Chloroform-d) δ 8.61 (d, J = 4.8 Hz, 1H), 7.74 (q, J = 7.9, 7.0 Hz, 1H), 7.48 
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(d, J = 7.9 Hz, 1H), 7.39 (m, 1H) 7.04 – 6.92 (m, 5H), 4.99 (bs, 1H), 4.32 (d, J = 8.4 Hz, 1H), 
3.23 (d, J = 2.0 Hz, 3H), 2.91 (s, 3H), 1.14 – 1.06 (m, 3H). 
 
4-chloro-N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-
methylpicolinamide (3.12): A flame-dried round bottom flask was charged 
with 4-chloro picolinic acid (158 mg, 1.00 mmol, 1 equiv), followed by SOCl2 
(1 mL). The reaction was refluxed at 80 °C for 2 hours, then the solvent was removed in vacuo. 
In a separate flask, (1R,2S)-ephedrine (198 mg, 1.2 equiv) was dissolved in THF (3 mL), 
followed by addition of triethylamine (0.42 mL, 3 equiv). The acid chloride was dissolved in 
THF (2 mL) + DMF (2 drops), added to the flask, and the reaction mixture was refluxed 
overnight before aqueous quenching with satd. aq. NaHCO3. The aqueous layer was discarded, 
then the organics were washed with brine. The combined organics were collected and dried 
over Na2SO4, filtered, and concentrated. The crude material was purified using flash column 
chromatography (2% MeOH:DCM) to provide the product as a white solid (250 mg, 0.82 
mmol, 82%). The product appeared as a 1.4:1 mixture of rotamers in the NMR spectrum. 1H 
NMR spectroscopic data matches those reported. 
 
N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylquinoline-2-
carboxamide (3.27): Quinoline 2-carboxylic acid (123 mg, 0.711 mmol, 
1 equiv) was added to a flame-dried round bottom flask, then dissolved in SOCl2 (0.71 mL). 
The reaction was refluxed at 80 °C for 3 hours, then the solvent was removed in vacuo. In a 
separate flask, (1R,2S)-ephedrine (141 mg, 1.2 equiv) was dissolved in THF (3 mL), followed 
by addition of triethylamine (0.30 mL, 3 equiv). The acid chloride was dissolved in THF (2 
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mL) + DMF (2 drops), added to the flask, and the reaction mixture was stirred at reflux 
overnight. The reaction was quenched with satd. aq. NaHCO3. The aqueous layer was 
discarded, then the organics were washed with brine. The organics were collected and dried 
over Na2SO4, filtered, and concentrated. The crude material was purified using flash column 
chromatography (1 to 3% MeOH:DCM) to give the product as a white solid (189 mg, 0.59 
mmol, 83%). The product appeared as a 1.8:1 mixture of rotamers in the NMR spectrum. Major 
Rotamer: 1H NMR (400 MHz, Chloroform-d) δ 8.30 (d, J = 8.6 Hz, 1H), 8.19 (d, J = 8.5 Hz, 
1H), 7.91 (d, J = 8.2 Hz, 1H), 7.87-7.74 (m, 1H), 7.71-7.61 (m, 2H), 7.59-7.49 (m, 1H), 7.44 
– 7.30 (m, 4H), 6.16 (bs, 1H), 4.93 (d, J = 4.6 Hz, 1H), 4.70 – 4.53 (m, 1H), 2.74 (s, 3H), 1.31 
(d, J = 6.9 Hz, 3H). Minor Rotamer: 1H NMR (400 MHz, Chloroform-d) δ 8.27 (d, J = 8.6 Hz, 
1H), 8.12 (d, J = 8.4 Hz, 1H), 7.87-7.74 (m, 2H), 7.71-7.61 (m, 1H), 7.59-7.49 (m, 1H), 7.46 




carboxamide (3.28): Indole 2-carboxylic acid (322 mg, 2.00 mmol, 1 
equiv) was added to a flame-dried round bottom flask, then dissolved in 
DCM (10 mL, 0.2 M). Oxalyl chloride (0.52 mL, 3 equiv) was added followed by 2 drops 
DMF. The reaction was refluxed at 45 °C for 2 hours, then the solvent was removed in vacuo. 
In a separate flask, (1R,2S)-ephedrine (397 mg, 1.2 equiv) was dissolved in THF (6 mL), 
followed by addition of triethylamine (0.30 mL, 3 equiv). The acid chloride was dissolved in 
THF (4 mL) + DMF (2 drops), added to the flask, and the reaction mixture was stirred at reflux 
overnight. The reaction was quenched with satd. aq. NaHCO3. The aqueous layer was 
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discarded, then the organics were washed with brine. The organics were collected and dried 
over Na2SO4, filtered, and concentrated. The crude material was purified using flash column 
chromatography (30 to 40% EtOAc:Hex) to provide the product as a white solid (482 mg, 1.56 
mmol, 78%). 1H NMR (500 MHz, Chloroform-d) δ 9.35 (s, 1H), 7.68 (d, J = 8.1 Hz, 1H), 7.44 
(d, J = 8.3 Hz, 3H), 7.38 – 7.29 (m, 4H), 7.16 (ddd, J = 8.0, 6.9, 1.0 Hz, 1H), 6.84 (app s, 1H), 
5.03 (app s, 1H), 4.73 (bs, 1H), 4.42 (s, 1H), 3.14 (app s, 3H), 1.40 (s, 3H). 
 
N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-N,1-dimethyl-1H-
imidazole-2-carboxamide (3.34): N-methyl imidazole carboxylic acid (42 
mg, 0.33 mmol, 1 equiv) was dissolved in DMF (1 mL, 0.33 M), and HBTU (126 mg, 1 equiv), 
DIPEA (0.12 mL, 2.0 equiv), and (1R,2S)-ephedrine were added sequentially. The reaction 
was stirred overnight at room temperature, then quenched with water. The mixture was 
extracted with EtOAc (3x), then the organics were washed with brine (2x), dried over Na2SO4, 
and concentrated in vacuo. The crude material was purified using flash column 
chromatography (2% to 4% MeOH:DCM) to provide the product as a white solid (65 mg, 0.24 
mmol, 71%). The product appeared as a 3:1 ratio of rotamers in the NMR spectrum. Major 
Rotamer: 1H NMR (600 MHz, Chloroform-d) δ 7.38 – 7.19 (m, 4H), 7.02 (s, 1H), 6.91 (s, 1H), 
5.10 (dt, J = 12.0, 6.0 Hz, 1H), 4.75 (d, J = 4.9 Hz, 1H), 3.66 (s, 3H), 2.51 (s, 3H), 1.30 (d, J 
= 7.0 Hz, 3H). Minor Rotamer: 1H NMR (600 MHz, Chloroform-d) δ 7.42 (d, J = 6.9 Hz, 3H), 
7.38 – 7.18 (m, 1H), 6.94 (s, 1H), 6.88 (s, 1H), 4.95 (app s, 1H), 4.60 (app s, 1H), 3.70 (s, 3H), 




(3.35): The title compound was synthesized via a modified procedure from Jones, 
et al.88 Picolinic acid (300 mg, 2.44 mmol, 1.25 equiv) was added to a flame dried 
flask under N2 and dissolved in DCM (7.4 mL). Oxalyl chloride (0.63 mL, 3.8 equiv) was 
added dropwise and the reaction was stirred at rt for 4 h. The volatiles were removed in vacuo, 
then the residual material was dissolved in DCM (9.8 mL). In a separate flask, (S)-diphenyl 
prolinol (494 mg, 1.95 mmol, 1.0 equiv) was dissolved in toluene (9.8 mL), then the solution 
of acid chloride in DCM was added slowly. The reaction mixture was stirred overnight, then 
quenched with satd. aq. NH4Cl. The layers were separated, and the product was extracted with 
EtOAc (3x). The combined organics were dried over Na2SO4, filtered and concentrated in 
vacuo. The crude material was purified via flash column chromatography (column 1: 80% to 
100% EtOAc:Hex, column 2: 1.5% to 3% MeOH:DCM) to provide the product as a white solid 
(138 mg, 0.39 mmol, 16%). 1H NMR spectroscopic data matches those reported.88  
 
N-((R)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)picolinamide (3.17): The quinidine 
primary amine was synthesized as reported by Melchiorre, et al.89 The 
picolinic acid derivative was synthesized using a modified procedure from Benaglia, et al.90 
Picolinic acid (123 mg, 1.00 mmol, 1 equiv) was added to a flame dried flask, dissolved in 
SOCl2 (1 mL), and refluxed at 80 °C for 2 hours. The solution was concentrated in vacuo and 
the acid chloride was dissolved in THF (5.6 mL). The solution was cooled to 0 °C, then TEA 
(0.17 mL, 1.2 equiv) was added, followed by dropwise addition of a solution of primary amine 
(257 mg, 0.83 equiv) in THF (5.5 mL). The reaction was warmed to room temperature and 
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stirred overnight before quenching with satd. aq. NaHCO3 (3 mL). The biphasic solution was 
rotary evaporated to remove THF, then DCM was added and the layers were separated. The 
aqueous phase was extracted with DCM (5x), then the combined organics were dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude material was purified using flash 
column chromatography (100% DCM to 15% MeOH:DCM) to provide the product as a light 
brown solid (~95% purity) (308 mg, 0.72 mmol, 87%). 1H NMR spectroscopic data matches 
those reported.90 
 
Synthesis of α-imino esters 
1-azido-4-methoxybenzene: The title compound was synthesized as reported by 
Fokin, et al.91 The crude material was purified via flash column chromatography (5% 
to 10% EtOAc:Hex) to provide the product as a red oil (10.0g, 68 mmol, 90% yield). 
The product was stored in the freezer in a vial wrapped with aluminum foil to mitigate safety 
concerns. 1H NMR (600 MHz, Chloroform-d) δ 6.98 (d, J = 9.0 Hz, 2H), 6.92 (d, J = 8.9 Hz, 
2H), 3.82 (s, 3H). 
 
ethyl 2-oxo-3-phenylbutanoate: The title compound was prepared as reported 
by Johnson, et al.21 1H NMR spectroscopic data matches those reported. 
 
ethyl 3-bromo-2-oxo-4-phenylbutanoate: Prepared as reported by 
Hoffman, et al.92 1H NMR spectroscopic data matches those reported. 
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General procedure for PMP-protected imines: A flame dried flask was charged with 1-
azido-4-methoxybenzene (1 equiv) and placed under N2. Dry DCM (0.05 M) was added, and 
the reaction was cooled to 0 °C. Trimethylphosphine (1.0 M in PhMe, 1 equiv) was added 
dropwise, then the reaction was warmed to room temperature and stirred for 30 minutes. A 
solution of α-keto ester (0.5 M in dry DCM, 1 equiv) was subsequently added to the pale 
yellow, room temperature solution of iminophosphorane. Stirring was continued for 1 hour, 
then the reaction was quenched with H2O. The organic layer was separated, and the aqueous 
layer was extracted with DCM (3x). The combined organics were dried over Na2SO4, filtered, 
and concentrated. The crude material was purified using flash column chromatography.   
 
Ethyl 2-((4-methoxyphenyl)imino)-3-phenylbutanoate (3.22): The title 
compound was synthesized from ethyl 2-oxo-3-phenylbutanoate (413 mg, 
2.0 mmol, 1 equiv). The crude material was purified using flash column 
chromatography (2.5% to 5% EtOAc:Hex) to provide the product as a bright yellow oil (527 
mg, 1.69 mmol, 85%). The product was obtained as a 5:1 ratio of E/Z isomers, which was 
calculated using proton resonances at 1.69 ppm (major) and 1.62 ppm (minor). 1H NMR (400 
MHz, Chloroform-d) δ 7.34 (d, J = 2.8 Hz, 1H), 7.33 (app s, 2H), 7.28 (app s, 2H), 6.84 (app 
s, 4H), 4.13 (q, J = 7.0 Hz, 1H), 3.82 (d, J = 7.1 Hz, 2H), 3.80 (s, 3H), 1.62 (d, J = 7.0 Hz, 3H), 
0.80 (t, J = 7.1 Hz, 3H). 
 
 Ethyl 3-bromo-2-((4-methoxyphenyl)imino)-4-phenylbutanoate 
(3.30): The title compound was synthesized from ethyl 3-bromo-2-oxo-4-
phenylbutanoate (570 mg, 2.0 mmol, 1 equiv). The crude material was 
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purified using flash column chromatography (2.5% EtOAc:Hex) to provide the product as a 
bright orange solid (709 mg, 1.82 mmol, 91%). The product was obtained as a 2.6:1 ratio of 
E/Z isomers, which was calculated using proton resonances at 1.05 ppm (major) and 1.48 ppm 
(minor). 1H NMR (400 MHz, Chloroform-d) δ 7.36 (app s, 7.36) 7.35 (app s, 2H), 7.31-7.28 
(m, 1H), 6.86 (d, J = 8.9 Hz, 2H), 6.78 (d, J = 8.8 Hz, 2H), 5.07 (dd, J = 8.5, 6.6 Hz, 1H), 4.12 
(q, J = 7.1 Hz, 2H), 3.82 (s, 3H), 3.79 (dd, J = 16.3, 8.2 Hz, 5H), 3.43 (dd, J = 14.5, 8.5 Hz, 
1H), 1.05 (t, J = 7.1 Hz, 3H). 
 
General procedure for the asymmetric trichlorosilane-mediated reduction of PMP-
protected imines: The title compounds were synthesized via a modified procedure from 
Hoveyda, et al.74 PMP-protected imine (0.10 mmol, 1 equiv) was added to a flame dried vial, 
placed under N2, and dissolved in dry DCM (1 mL, 0.1 M). The reaction was cooled to the 
appropriate temperature (see tables above for conditions), then catalyst (0.01 mmol, 10 mol %) 
was added, followed by HSiCl3 (30L, 0.30 mmol, 3 equiv). After stirring overnight at the 
same temperature, the reaction was quenched with satd. aq. NaHCO3. The mixture was 
extracted with DCM (3x), then the combined organics were dried over Na2SO4, filtered, and 
concentrated in vacuo. The crude material was purified using flash column chromatography. 
 
Ethyl 2-((4-methoxyphenyl)amino)-3-phenylbutanoate (3.23): The 
title compound was obtained using PMP-protected imino ester 3.22. The 
diastereomeric ratio was calculated using proton resonances at 3.30 ppm 
(minor) and 3.19 ppm (major). 1H NMR (500 MHz, Chloroform-d) δ 7.38 – 7.22 (m, 5H), 6.75 
(d, J = 8.9 Hz, 2H), 6.56 (d, J = 8.9 Hz, 2H), 4.07 (d, J = 6.9 Hz, 1H), 3.96 (q, J = 6.9 Hz, 2H), 
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3.75 (s, 3H), 3.19 (p, J = 7.0 Hz, 1H), 1.48 (d, J = 7.1 Hz, 3H), 1.03 (t, J = 7.1 Hz, 3H). HPLC 
(98:2 hexanes:iPrOH, Daicel Chiralpak IC Column, flow rate = 1.0 mL/min, λ = 210 nm): tR 
(major diastereomer) = 13.5, 14.5 min, tR (minor diastereomer) = 10.5 min, 12.2 min. 
 
Ethyl 3-bromo-2-((4-methoxyphenyl)amino)-4-phenylbutanoate 
(3.31): The title compound was obtained using PMP-protected imino ester 
3.30. The crude material was purified using flash column chromatography 
(60 to 70% DCM:Hexanes). 1H NMR (500 MHz, Chloroform-d) δ 7.42 – 7.36 (m, 2H), 7.36 
– 7.30 (m, 3H), 6.76 – 6.70 (m, 2H), 6.49 – 6.41 (m, 2H), 4.48 (td, J = 7.7, 2.8 Hz, 1H), 4.37 
– 4.26 (m, 2H), 4.27 – 4.23 (m, 1H), 3.75 (s, 3H), 3.54 (dd, J = 14.1, 7.7 Hz, 1H), 3.31 (dd, J 
= 14.2, 7.6 Hz, 1H), 1.37 (t, J = 7.1 Hz, 3H). HPLC (97:3 hexanes:iPrOH, Daicel Chiralpak 
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CHAPTER FOUR: ORGANOCATALYTIC ISO-PICTET-SPENGLER REACTION 




Carbolines represent a broad class of chemically and biologically interesting natural 
and synthetic alkaloids, encompassing both constitutional isomers and hydrogenated 
derivatives.1–3 Structurally, carbolines contain a fused indole and pyridine fragment, with 
location of the pyrido nitrogen determining its identity as an α-, β-, γ-, or δ-carboline (Figure 
4-1A).1,2 In addition to the fully aromatic species, dihydro-, tetrahydro-, and hexahydro-
variants abound (Figure 4-1B).  
Figure 4-1. Carboline Nomenclature 
 
Both β- and γ-carbolines have demonstrated broad biological activity,1,2,4 and γ-
carbolines have even outperformed their β-carboline counterparts in some cases;5,6 however, 
investigations of β-carboline scaffolds are made easier by their natural abundance and 
comparative ease of synthesis relative to γ-carbolines. An expansive array of aromatic and 
saturated β-carbolines are readily found in nature, including several bioactive compounds such 
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as reserpine, harmane, and ajmalicine (Figure 4-2A).7–17 In contrast, only three γ-carboline 
natural products have been reported to date, all of which are saturated variants (Figure 4-
2B).18,19 Synthetically, access to both tetrahydro-β- and γ-carbolines can be achieved in a single 
synthetic step via the Pictet-Spengler reaction;20–24 however, β-carbolines can be derived from 
naturally abundant sources such as tryptamine and tryptophan, while the synthesis of γ-
carbolines requires costly iso-tryptamines (Scheme 4-1). Consequently, the library of γ-
carbolines available for investigations of biological activity is quite small compared to β-
carbolines. 
Figure 4-2. Carboline Natural Products 
 
Scheme 4-1. Access to THβCs vs. THγCs 
 
 Despite the limited scope of known γ-carbolines, myriad drug discovery efforts have 
investigated this scaffold (Figure 4-3). In particular, tetrahydro-γ-carbolines (THγCs) display 
a wide array of biological activities.1,4 For example, tetrahydro-γ-carboline dimebon 
progressed through phase III clinical trials as a treatment for Alzheimer’s disease (AD), but 
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ultimately failed to sufficiently ameliorate memory loss.4 Significant effort has since been 
devoted to scaffold optimization and diversification, seeking to maximize neuroprotective 
activities such as acetylcholinesterase antagonism, radical scavenging, and regulation of 
mitochondria.6,25–30 Setipiprant, another THγC, was investigated in two different clinical trials, 
one of which is ongoing. Early work with Setipiprant identified it as a CRTH2 antagonist, 
leading to Phase II and Phase III trials for asthma and seasonal allergic rhinitis, respectively.31 
More recently, the compound has been revived by Allergan and placed in Phase II trials for 
androgenetic alopecia in males.32 Promising new THγC drug candidates include Tubastatin A, 
which has received significant attention in the literature as a selective inhibitor of histone 
deacetylases 6 and 10 (HDAC-6, HDAC-10).33,34 Finally, the 1-oxo-tetrahydro-γ-carboline 
Alosetron is one of many γ-carboline antagonists of 5-HT serotonin receptors28,35–38 and an 
FDA approved treatment for irritable bowel syndrome (IBS) in females.4  
Figure 4-3. Biologically Active Tetrahydro-γ-Carbolines 
 
These pharmacological hits suggest that increased accessibility to novel γ-carboline 
scaffolds could improve existing therapeutic activities, and enable new activity as well. In a 
2018 review of γ-carboline syntheses and biological activities, Dai and co-workers argued that 
work is needed to provide access to functionalized and diversifiable γ-carbolines.1 Specifically, 
while development of more active γ-carbolines is ongoing, there is an increasing demand for 
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greater target specificity. One potential approach to improving both target binding and 
selectivity is to incorporate stereogenic elements39, which are noticeably absent in the γ-
carbolines depicted above (Figure 4-3), as well as the broader medicinal chemistry literature.  
 
4.2 Background: Synthesis of Tetrahydro-γ-Carbolines 
The first synthesis of a tetrahydro-γ-carboline was accomplished using a classic organic 
chemistry reaction: the Fischer indole synthesis.4,40,41 This transformation was applied to the 
synthesis of indoles as early as 1883,42 and applied to the synthesis of THγCs in 1924 by 
Robinson and Thornley (Scheme 4-2).43 Combination of hydrazine 4.1 and piperidone 4.2 in 
acetic acid generated hydrazone 4.3, and subsequent addition of dilute sulfuric acid provided 
the desired THγC (4.4).  
Scheme 4-2. Synthesis of 1,1,3,3,5-Pentamethyl-Tetrahydro-γ-Carboline 
 
The Fischer indole synthesis has been a robust method for generating an array of γ-
carbolines; however, the transformation suffers from two limitations when considering its 
application to the synthesis of more diverse, densely substituted tetrahydro-γ-carbolines: (1) 
The reaction is highly sensitive to functionalities on the piperid-4-one. Non-symmetrical 
substitution of the piperid-4-one can result in mixtures of regioisomers (Scheme 4-3A), while 
substituents like phenyl or benzyl groups adjacent to the carbonyl generate side products 
(Scheme 4-3B).3,44,45 (2) If any stereogenic centers are desired for the final carboline product, 
they must be preset on the piperid-4-one starting material.3 Moreover, even if the 
enantioenriched piperid-4-one can be obtained, the mechanism of the transformation prohibits 
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stereogenic centers adjacent to the carbonyl, as they would likely undergo racemization under 
the reaction conditions. Consequently, the synthesis of stereochemically and structurally 
complex THγCs typically requires alternative methods. 
Scheme 4-3. Regioselectivity Challenges with the Fischer Indole Synthesis of Carbolines 
 
Although the Fischer indole reaction is not amenable to the asymmetric synthesis of 
tetrahydro-γ-carbolines, other enantioselective approaches have been reported.1,3 In 2006, the 
first asymmetric synthesis of THγCs was accomplished via a palladium-catalyzed, 
intramolecular asymmetric allylic alkylation (AAA) (Scheme 4-4).46 More recently, [3+3] 
cycloadditions have been employed to generate densely functionalized products with 
stereogenic centers. In 2016, Shi reported a chiral phosphoric acid (CPA)-catalyzed 
cycloaddition of 2-indolylmethanols to provide THγCs with a stereogenic center at the β-
position (Scheme 4-5A).47 Yang published a copper-catalyzed [3+3] cycloaddition between 
azomethine ylides and 2-indolylnitroethylenes to afford products containing three stereogenic 
centers in high stereoselectivity and yield (Scheme 4-5B).48 Three years later, Wang extended 
this methodology to a cascade reaction, using an iridium catalyst for a stereodivergent AAA, 
followed by stereospecific iso-Pictet-Spengler reaction (Scheme 4-5C).49 Like the Fischer 
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indole synthesis, this latter transformation is an essential method for generating tetrahydro-γ-
carbolines. 
Scheme 4-4. Synthesis of THγCs via AAA (Bandini, 2006) 
 
Scheme 4-5. Asymmetric Synthesis of THγCs via Aza-Ylides 
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In 1911, Pictet and Spengler transformed β-phenethylamine and aldehydes to generate 
quinolines under acidic conditions.50 Tatsui then extended this methodology to indoles in 1928, 
employing aldehydes and tryptamine to generate tetrahydro-β-carbolines (THβCs).51,52 The 
first reported Pictet-Spengler approach to generating tetrahydro-γ-carbolines was not reported 
until 1976, when iso-tryptamine analog 4.10 and opianic acid 4.11 were combined with sulfuric 
acid to provide THγC 4.12 (Scheme 4-6).53 This 50-year gap between the synthesis of β- and 
γ-carbolines via the Pictet-Spengler reaction is partially attributed to the difficulty of 
synthesizing the requisite iso-tryptamine starting material. 
Scheme 4-6. Iso-Pictet-Spengler Synthesis of an Opianic Acid-Derived THγC  
 
Access to iso-tryptamines has, and continues to be, a limiting factor in generating novel 
tetrahydro-γ-carbolines. In 1957, Schindler reported the first synthesis of iso-tryptamine in 5 
steps from indole 2-carboxylic acid.54 Homologation was achieved via sodium cyanide and an 
in situ generated 2-indolyl trimethylmethanammonium. The transformation proceeded in 
moderate yield, and subsequent reduction to the primary amine required forcing conditions, 
including stoichiometric Raney-Nickel heated to 190 °C under 120 atm. of hydrogen gas 
(Scheme 4-7A). The synthesis has since been modified on several occasions, with most 
contemporary investigations using an approach published in 1998 by Tarzia and co-workers.55 
Redox manipulations generated the requisite benzylic indole aldehyde which is homologated 
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by condensation of nitromethane. Subsequent reduction of the vinyl nitroindole provides the 
primary amine (Scheme 4-7B).  
Scheme 4-7. Synthetic Approaches to Iso-Tryptamines 
 
a Yields represent those obtained from the Johnson lab synthesis of iso-tryptamine. Yields not reported by Tarzia 
et. al.  
 
Improved access to iso-tryptamines has helped to dramatically expand the scope of iso-
Pictet-Spengler products; however, asymmetric synthesis of THγCs via the Pictet-Spengler 
reaction remains underexplored1 relative to the vast body of literature on generating 
enantioenriched THβCs.52,56–59 In 2010, Fandrick and co-workers reported the first example of 
an iso-Pictet-Spengler reaction generating an enantioenriched THγC (Scheme 4-8A).60 After 
obtaining chiral iso-tryptamine 4.13 through use of a chiral auxiliary, exposure to aldehyde 
4.14 under dehydrating conditions enabled the diastereoselective iso-Pictet-Spengler reaction 
to provide enantioenriched carboline 4.15 in >10:1 dr. In 2016, Yus expanded the scope of 
products by employing diverse, chiral iso-tryptamines and aldehydes in the presence of TFA 
to generate enantioenriched THγCs (Scheme 4-8B).61 
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Scheme 4-8. Synthesis of Enantioenriched THγCs using Chiral Auxiliaries 
 
 In 2011, Jacobsen reported the sole extant enantioselective iso-Pictet-Spengler 
reaction.62 Employing chiral thiourea 4.16 and benzoic acid co-catalysts, the rapid synthesis of 
tetrahydro-γ-carbolines 4.17 was accomplished in high yield and enantioselectivity (Scheme 
4-9A). Further trituration or recrystallization of the Boc-protected carboline provided 
enantiopure material. This report also included the first example of a THγC bearing a 
quaternary stereogenic center at the δ-position (4.18), although this substrate required an 
extended reaction time and increased catalyst loadings (Scheme 4-9B).  
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Scheme 4-9. Enantioselective Iso-Pictet-Spengler Reaction 
 
 Jacobsen’s asymmetric iso-Pictet-Spengler reaction evolved out of a large body of 
work applying enantioselective thiourea organocatalysis to the synthesis of carbolines, as well 
as other stereochemically complex products.63 Between 1998 and 2002, Jacobsen published 
foundational studies revealing the utility of ureas and thioureas as asymmetric hydrogen bond 
donor catalysts.64–66 Jacobsen’s early investigations included an enantioselective acyl-Pictet-
Spengler catalyzed by thiourea 4.19 to generate acyl-protected THβCs (Scheme 4-10).67 
Although enantioselectivity depended greatly on the identity of the acylating reagent, the 
importance of the acetyl chloride was not fully realized until 2007 when subsequent 
investigations demonstrated the importance of an anion-binding mechanism in 
enantiodetermination.68,69 
Scheme 4-10. Thiourea-Catalyzed Enantioselective Acyl Pictet-Spengler 
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   Initial examples of enantioselective anion-binding focused on iminium or 
oxocarbenium halide complexes; however, in 2009, Jacobsen demonstrated that protioiminium 
intermediates could be employed in a similar capacity for an asymmetric Pictet-Spengler 
reaction (Scheme 4-11A).70 Thiourea 4.20 and benzoic acid catalyzed the transformation 
between aldehydes and activated tryptamines in good yield and high enantioselectivity. 
Although this report heavily informed Jacobsen’s subsequent iso-Pictet-Spengler publication, 
the original method required activated substrates and long reaction times. In an effort to 
increase the electrophilicity of the protioiminium species, Seidel employed his bifunctional 
thiourea/Brønsted acid catalysis 4.21 to enable use of unactivated tryptamines in the 
asymmetric Pictet-Spengler reaction.71 Seidel proposed that catalyst acidity would increase 
and promote reactivity due to stabilization of the conjugate carboxylate base. Stabilization is 
achieved via intramolecular thiourea anion-binding. The reaction successful provided 
enantioenriched THβCs, although aliphatic aldehydes failed to provide the product in high 
yield or enantioselectivity (Scheme 4-11B). 
Scheme 4-11. Asymmetric Protioiminium Iso-Pictet-Spengler Reactions 
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With this precedent in mind, we sought to expand the library of synthetic THγCs by 
adapting enantioselective thiourea/Brønsted acid co-catalysis to a dynamic kinetic resolution 
(DKR) iso-Pictet-Spengler reaction (Scheme 4-12A). Dixon reported the sole examples of 
DKR Pictet-Spengler reactions in 2009 and 2010 using a chiral phosphoric acid-catalyzed N-
acyliminium cyclization cascade.72,73 Their first publication employed tryptamines and enol 
lactones to provide enantioenriched fused tetracycles bearing two contiguous stereocenters. A 
follow-up study applied γ-keto acids to the same transformation, generating fused pentacycles 
(Scheme 4-12B). We hypothesized that enantioconvergent reaction of iso-tryptamine with α-
substituted β-formyl and β-keto carbonyls could provide enantioenriched tetrahydro-γ-
carbolines bearing two contiguous stereocenters, including one exocyclic stereogenic center 
and a carbonyl functional handle for downstream diversification (Scheme 4-12C). Moreover, 
our approach would provide immediate access to the unprotected indole and piperidine, which 
are critical sites for manipulation in SAR studies.1,27,74  
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Scheme 4-12. Prior Art and Current Work 
 
4.3 Results and Discussion 
4.3.1 Preliminary Studies with α-Substituted β-Formyl Morpholine Amides 
Motivated by the ongoing demand for diverse, enantioenriched THγCs, we initiated 
development of an enantioconvergent iso-Pictet-Spengler reaction using configurationally 
labile aldehydes. In 2015, our lab published an enantioconvergent 2-aza-Cope reaction using 
α-substituted β-formyl morpholine amides.75 Morpholine amides provided superior results 
relative to the analogous α-substituted β-formyl ester due to the allylic strain imposed by the 
morpholine amide during enamine formation (Figure 4-4). This strain shifted the 
imine/enamine equilibrium towards the reactive species, the imine. Given these insights, we 
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opted to apply the same substrate to our system. When iso-tryptamine 4.23 and α-methyl β-
formyl morpholine amide 4.24 were mixed in deuterated chloroform, we observed complete 
conversion to the tetrahydro-γ-carboline product 4.25 in 30 min with quantitative yield 
(Scheme 4-13). Identical results were observed using dry DCM, and the background reaction 
even proceeded in C6D6, albeit at a much slower rate (47% conversion after 1.5 h).  
Figure 4-4. Conformational Effects on the Reactivity of α-Substituted β-Formyl Esters and 
Morpholine Amides 
 
Scheme 4-13. Uncatalyzed Iso-Pictet-Spengler Reaction with α-Substituted β-Formyl 
Morpholine Amides 
 
These preliminary results suggested that β-formyl amides could be competent in this 
reaction, but a variety of analytical issues arose due to both the background reaction and 
product polarity. These analytical challenges were compounded by an inability to quickly and 
effectively quench the reaction and evaluate stereoselectivity. Aqueous quenching was 
problematic due to the high solubility of both product and reactants in aqueous solution under 
a range of pH conditions. Reductive quenching with LiAlH4 or DIBAL-H provided complex 
product mixtures. Finally, attempts to obtain a racemic HPLC trace of the highly polar amide 
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proved extremely challenging, even after N-protection of the carboline. While this latter issue 
could likely be overcome with reverse phase chromatography or mobile phase additives76,  the 
perceived advantage of high reactivity was quickly becoming a barrier to success. 
 
4.3.2 Reaction Development and Optimization with α-Substituted β-Formyl Esters 
Considering the reactivity and analytical issues outlined above, we sought to 
investigate an alternative substrate for the enantioconvergent iso-Pictet-Spengler reaction. 
Specifically, we wanted to slow or eliminate the background reaction observed with the β-
formyl amides, and reduce polarity of the THγC product by exchanging the morpholine ring. 
As previously discussed, our 2015 aza-Cope rearrangement75 revealed that β-formyl 
morpholine amides were significantly more reactive than β-formyl esters. We hypothesized 
that if β-formyl esters participated in the iso-Pictet-Spengler reaction, the rate of the 
background reaction would be diminished significantly. Additionally, substitution of the 
morpholine amide for an aliphatic ester would decrease the polarity of the THγC product. 
 A control study combining iso-tryptamine 4.23, α-isopropyl β-formyl ethyl ester 4.26a 
and CDCl3 confirmed our hypothesis, with a considerably slower background reaction relative 
to the morpholine amide (Table 4-1). In contrast to the fast-reacting morpholine amide, we 
exclusively observed enamine 4.27a after 2 h (entry 1), and only trace product after 19 h (entry 
2). Even after nearly 3 d, only a 66:34 ratio of enamine:THγC was observed (entry 3). 
Subsequent Boc-protection of THγC 4.28a provided a significantly less polar product relative 
to the analogous morpholine amide, enabling analysis via chiral HPLC. 
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Table 4-1. Control Studies with α-Substituted β-formyl Esters vs. Amides 
 
entry time (h) 4.27a : 4.28a 
1 2 100:0 
2 19 97:3 
3 67 66:34 
a Ratio of enamine to THγC is determined by 1H 
NMR peak integrations. 
 
The preliminary studies suggested that use of α-substituted β-formyl esters enabled 
improved control of the background reaction and access to less polar THγCs (Table 4-2). 
Therefore, we began investigating the enantioconvergent iso-Pictet-Spengler reaction 
employing these new substrates. The addition of catalytic quantities of acids accelerated the 
reaction in DCM and PhMe (entries 1-4), lending credence to the hypothesis that these less 
reactive esters could participate as active iminium electrophiles under general acid catalysis. 
Exposure of iso-tryptamine and β-formyl ester 4.26a to valine-derived thiourea 4.20 and 
benzoic acid in DCM at room temperature yielded THγC 4.28a in 76% NMR yield, >16:1 dr 
and 90:10 er (entry 5). X-ray diffraction analysis of the Boc-protected product provided the 
absolute and relative stereochemistry (Figure 4-5).  
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yielda dr erb 
1 4.29 (10) - DCM 23 91% 3.2:1 - 
2 4.29 (10) - PhMe 23 82% 3.7:1 - 
3 - BzOH (20) DCM 23 67% 4.7:1 - 
4 - BzOH (20) PhMe 23 41% 5.0:1 - 
5 4.20 (20) BzOH (10) DCM 23 76% >16:1 90:10 
6 4.20 (20) BzOH (10) PhMe 23 32% - - 
7 4.20 (20) BzOH (10) PhMe 35 83% >16:1 91:9 
8 4.20 (20) BzOH (10) DCM 35 78% >16:1 88:12 
9 4.30 (20) BzOH (10) PhMe 35 91% 20:1 95:5 
10 4.16 (20) BzOH (10) PhMe 35 92% 17:1 96:4 
11 4.31 (20) BzOH (10) PhMe 35 89% 17:1 96:4 
aDetermined by 1H NMR analysis of the crude reaction mixture using an internal standard. bDetermined by chiral 




Figure 4-5. X-Ray Crystal Structure of Boc-Protected THγC 4.28a* 
    
Subsequent optimization of the reaction conditions revealed that use of toluene as a 
solvent delivered poor product yields at room temperature (entry 6); however, increasing the 
temperature to 35 °C generated THγC 4.28a in 83% yield and similar stereoselectivities as 
those obtained with DCM at room temperature (entry 7). Product 4.28a was obtained in 
diminished enantioselectivity when the reaction was conducted in refluxing DCM (entry 8). 
 A survey of catalyst structures resulted in further improvements to yield and 
stereoselectivity. Generally, stereocontrol for these thiourea catalysts is dictated by substitution 
on the terminal amide and the amino acid from which the catalyst is derived.62,70 Consequently, 
we began by exchanging the valine-derived isopropyl group for tert-butyl substitution, 
providing catalyst 4.30. This exchange significantly increased enantioselectivity, and 
dramatically improved yields by reducing the formation of side products (entry 9). We also 
probed the effect of adding a second phenyl group to the benzyl substituent (4.16), as well as 
the impact of fusing those aryl groups (4.31). The former catalyst provided a modest increase 
to enantioselectivity and yield (entry 10), while we observed slightly diminished yields with 
the latter catalyst (entry 11). 
                                                 
* CCDC 2005290 contains the supplementary crystallographic data for this structure. These data can be obtained 
free of charge from the Cambridge Crystallographic Centre via www.ccdc.cam.ac.ui/data_request/cif. 
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 With optimized yields and stereoselectivities in hand, we next investigated lower 
catalyst loadings (Table 4-3). Gratifyingly, we found that with catalyst 4.16, we could decrease 
the loading of both catalysts to 5 mol % without any loss of stereoselectivity, and only slightly 
diminished yield (entry 1). Increasing the loadings of the thiourea and benzoic acid to 20 mol 
% increased the yield (entry 2); however, the same yield could be achieved by reducing the 
thiourea loading to 5 mol % while maintaining a 20 mol % loading for benzoic acid (entry 3). 
Finally, we found that heating the reaction further to 65 °C had little effect on stereoselectivity, 
but slightly diminished yields relative to results at 35 °C (entry 4). Ultimately, given the low 
cost of benzoic acid and higher yields we selected the reaction conditions employed in entry 3 
for substrate scope investigations. 











yielda dr erb 
1 5 5 35 89% 21:1 95.5:5.5 
2 20 20 35 96% 16:1 96:4 
3 5 20 35 97% 19:1 95:5 
4 5 5 65 85% 23:1 95.5:5.5 
a Determined by 1H NMR analysis of the crude reaction mixture using an internal 
standard. b Determined by chiral HPLC analysis after Boc-protection. Represents the 
enantiomeric ratio of the major diastereomer. 
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Upon initiating investigations into the substrate scope for this transformation we 
quickly found that unbranched substrates performed quite differently from α-isopropyl 
substrate 4.26a (Table 4-4). Using α-methyl β-formyl ester 4.26b we obtained THγC 4.28b in 
33% yield, 1.7:1 dr, and 85:15 er. Hoping the α-methyl aldehyde 4.26b was an outlier, we also 
synthesized the octanoic acid- and hydrocinnamic acid-derived β-formyl esters. α-Substituted 
β-formyl esters 4.26c and 4.26d provided the desired THγC products 4.28c and 4.28d in 
slightly improved diastereoselectivities and yields relative to the methyl case, but even further 
diminished enantioselectivities.  
Table 4-4. Initial Substrate Scope 
 
aDetermined by 1H NMR analysis of the crude reaction mixture using an internal standard. bDetermined by chiral 
HPLC analysis after Boc-protection. Represents the enantiomeric ratio of the major diastereomer.  
 
 Given these poor yields and stereoselectivities, we re-initiated optimization using α-
benzyl β-formyl ester 4.28d (Table 4-5). Increasing the thiourea loading to 20 mol % slightly 
improved stereoselectivity (entry 1), but the most substantial improvement arose from 
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switching back to DCM at room temperature (entry 2). Under those conditions, THγC 4.28d 
was obtained in 6.3:1 dr and 92:8 er with 95% conversion, but only 59% NMR yield. Close 
examination revealed two side products: double condensation product 4.32 and an unidentified 
compound.  
Seeking to limit formation of these undesired products and maintain stereoselectivity, 
we began screening alternative acid co-catalysts with varying pKa values. Specifically, we 
hypothesized acid strength could play a role in inhibiting over-condensation product formation. 
In general, yield decreased as acidity increased, and improved yields were obtained using 
acetic acid or p-methoxy benzoic acid (entries 3 and 4). Diastereoselectivity was maximized 
with benzoic acid, and suffered greatly when p-nitro benzoic acid or trifluoroacetic acid were 
employed (entries 5 and 6); however, impurities were still observed in all cases, and yields 
remained good to moderate.  
Acid co-catalyst identity appeared to only minimally affect yield, so we instead looked 
to new thiourea catalysts to improve yield and stereoselectivity.  Catalyst 4.33 had previously 
resulted in improved stereoselectivities for Jacobsen’s iso-Pictet-Spengler reaction, 
presumably due to an increased barrier to amide bond rotation. Thioureas 4.16 and 4.33 
generated THγC 4.28d with nearly identical enantioselectivity and diastereoselectivity was 
diminished; however, catalyst 4.33 increased the yield from 59% (entry 2) to 90% (entry 7). 
We synthesized an even bulkier thiourea (4.34) to further explore the impact of steric bulk on 
catalyst selectivity, but observed diminished yields and enantioselectivities (entry 8). Finally, 
we employed a bifunctional catalyst developed by Seidel71 (4.21) that successfully provided 
THγC product 4.28d in 77% yield, but without any diastereocontrol (entry 9). Additional 
optimization efforts are ongoing, but 4.33 appears to be the ideal catalyst. 
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Table 4-5. Re-Optimization of Iso-Pictet-Spengler Reaction for Non-Branched Substrates 
 
entry thiourea acid (pKa) conversiona yieldb dr erc 
1d 4.16 BzOH (4.20) 92% 68% 5.4:1 87:13 
2 4.16 BzOH (4.20) 95% 59% 6.3:1 92:8 
3 4.16 AcOH (4.76) 82% 69% 4.3:1 92:8 
4 4.16 4-MeO-BzOH (4.47) 92% 74% 5.9:1 91:9 
5 4.16 4-NO2-BzOH (3.44) 95% 62% 3.8:1 n.d.
e 
6 4.16 CF3CO2H (-0.25) 63% 48% 2.0:1 73:27 
7 4.33 BzOH (4.20) 89% 90% 5.3:1 91.5:8.5 
8 4.34 BzOH (4.20) 90% 85% 6.2:1 89.5:10.5 
9 4.21 - 77% n.d. 1:1 n.d. 
a Conversion estimates determined by 1H NMR peak integrations. bDetermined by 1H NMR analysis of the 
crude reaction mixture using an internal standard. cDetermined by chiral HPLC analysis after Boc-protection. 
Represents the enantiomeric ratio of the major diastereomer. dRun with PhMe as solvent at 35 °C. 
 
 
4.3.3 Preliminary Investigations into Generating Quaternary Stereogenic Centers 
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 While the bulk of our efforts have focused on employing configurationally labile 
aldehydes in the enantioconvergent iso-Pictet-Spengler reaction, preliminary studies suggest 
ketones may also be viable. Under co-catalytic conditions with thiourea 4.16 and benzoic acid 
in toluene, α-methyl β-keto ester 4.35 provided THγC 4.36 in 69% yield and 3.4:1 dr (Scheme 
4-14A). Increasing the temperature to 75 °C improved the yield, but lowered 
diastereoselectivity. α-Keto ester 4.37 also participated in the iso-Pictet-Spengler reaction 
under these conditions, generating THγC 4.38 in 79% yield and 3.2:1 dr at 35 °C, with similar 
results obtain at 75 °C (Scheme 4-14B). Unfortunately, our attempts to Boc-protect these 
products have been unsuccessful thus far, and as a result, the product remains too polar for 
HPLC analysis. Still, these preliminary results suggest we can provide access to an array of 
THγCs bearing a quaternary stereogenic center, and efforts to N-protect the substrate, analyze 
enantioenrichment, and optimize the reaction are ongoing. 




  In conclusion, we have developed an enantioconvergent protioiminium iso-Pictet-
Spengler reaction using Brønsted acid‒thiourea co-catalysis. Using α-substituted β-formyl 
ethyl esters, the transformation provides access to enantioenriched and unprotected tetrahydro-
γ-carbolines bearing two contiguous stereocenters, including an exocyclic stereogenic center 
and an orthogonal ester functional handle for downstream diversification. Future work will 
include further optimization of the scope of α-substituted β-formyl ethyl esters, as well as 
efforts to enantioselectively establish a quaternary stereogenic center in the iso-Pictet-Spengler 
reaction with α- and β-keto esters. 
 
4.5 Experimental Details 
Methods: Proton magnetic resonance spectra (1H NMR) were recorded on a Bruker model 
DRX 400, 500, or 600 (1H NMR at 400 MHz, 500 MHz, or 600 MHz). 1H NMR data are 
reported as follows: chemical shift, multiplicity (s = singlet, app s = apparent singlet, br s = 
broad singlet, d = doublet, dd = doublet of doublet, t = triplet, m = multiplet), coupling 
constants (Hz), and integration. Analytical thin layer chromatography was carried out using 
Whatman 0.25 mm silica gel 60 plates, Sorbent Technologies 0.20 mm Silica Gel TLC plates. 
Visualization was allowed by UV light, phosphomolybdic acid in ethanol, aqueous ceric 
ammonium nitrate solution, ninhydrin solution, or KMnO4. HPLC analysis was performed on 
a Perkin Elmer flexar photodiode array (PDA) system equipped with a Daicel Chiralpak IC 
column. Aluminum bead baths were used to heat reaction vessels. Purification of the reaction 
products was carried out by using Siliaflash-P60 silica gel (40-63μm) purchased from 
Silicycle. Yields refer to isolated yields after flash column chromatography. NMR yields were 
obtained using phenanthrene as an internal standard. The relative and absolute 
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stereoconfiguration of Boc-protected 4.28a was determined using X-ray diffraction analysis, 
and the stereochemistry of products 4.28 was assigned by analogy. 
 
Materials: Solvents were used as received, unless noted otherwise as dry. Dry solvents were 
passed through a column of neutral alumina under a stream of nitrogen prior to use. Reagents 
were obtained from Millipore Sigma, Fischer Scientific, or Oakwood Chemical Supply and 




dimethylbutanamide (4.20): The title compound was 
synthesized as reported by Jacobsen, et al.70 1H NMR 
spectroscopic data matches those reported.  
 
(S)-N-Benzyl-2-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-N,3,3-
trimethylbutanamide (4.30): The title compound was 
synthesized as reported by Jacobsen, et al.68 1H NMR 
spectroscopic data matches those reported. 
 
(S)-N-Benzhydryl-2-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-N,3,3-
trimethylbutanamide (4.16): The title compound was 
synthesized as reported by Jacobsen, et al.68,77 1H NMR 





trimethylbutanamide (4.33): The title compound was 
synthesized as reported by Jacobsen, et al.62,68 1H NMR 
spectroscopic data matches those reported.62 
 
1-((1R,2R)-2-Aminocyclohexyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea: The title 
compound was synthesized as reported by Kang, et al.,64 and purified 
according to Falck, et al.78,79 (1R,2R)-Cyclohexane-1,2-diamine was 
prepared as reported by Rawal, et al.80 1H NMR spectroscopic data matches those reported.79 
 
2-(((1R,2R)-2-(3-(3,5-Bis(trifluoromethyl)phenyl)thioureido)cyclohexyl)carbamoyl)-
3,4,5,6-tetrabromobenzoic acid (4.21): The title compound 
was synthesized as reported by Seidel, et al.71,81 1H NMR 





N-Methyl-9H-fluoren-9-amine: The title compound was prepared via a 
modified procedure from Bhattacharyya, et al.82 A solution of methanamine (8.4 
M in EtOH, 33.0 mmol, 3 equiv) was dissolved in MeOH (37 mL). Titanium (IV) isopropoxide 
(4.3 mL, 14.5 mmol, 1.32 equiv) was added, followed by 9H-fluoren-9-one (1.98 g, 11.0 mmol, 
1.0 equiv). The reaction mixture was stirred for 5 h at room temperature, then NaBH4 (416 mg, 
11.0 mmol, 1.0 equiv) was added and the mixture was stirred for another 2 h. The reaction was 
quenched with water, and the inorganic precipitate was filtered through Celite and washed with 
Et2O. The layers were separated, then the aqueous layer was extracted with Et2O (2x). The 
combined organics were washed with 2 M HCl (2x), and the aqueous layers were basified to 
pH = 10 by slow addition of 2.5 M NaOH. The aqueous mixture was extracted with Et2O (2x) 
and the combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. 
The crude material was purified via flash column chromatography to provide pure product. 1H 
NMR (400 MHz, Chloroform-d) δ 7.74 (dt, J = 7.5, 1.0 Hz, 2H), 7.62 (dq, J = 7.3, 0.8 Hz, 
2H), 7.41 (tdd, J = 7.4, 1.3, 0.6 Hz, 2H), 7.35 (td, J = 7.4, 1.2 Hz, 2H), 4.94 (s, 1H), 2.23 (s, 
3H), 1.91 (s, 1H). 
 
tert-Butyl (S)-(1-((9H-fluoren-9-yl)(methyl)amino)-3,3-dimethyl-1-
oxobutan-2-yl)carbamate: The title compound was prepared via a 
modified procedure from Jacobsen, et al.83 A flame-dried flask under a 
stream of N2 was charged with (S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoic acid 
(1.39 g, 6.0 mmol, 1.0 equiv) and dissolved in DCM (12 mL). Then, HBTU (2.5 g, 6.6 mmol, 
1.1 equiv), N-methyl-9H-fluoren-9-amine (1.63 g, 8.4 mmol, 1.4 equiv), and DIPEA (2.1 mL, 
12.0 mmol, 2.0 equiv) were added sequentially. The reaction was stirred at room temperature 
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for 3 days, then the resulting orange mixture was diluted with Et2O and washed with 1 M HCl 
(2x), satd. aq. NaHCO3, and brine. The combined organic extracts were dried over Na2SO4, 
filtered, and concentrated in vacuo. The crude material was purified via flash column 
chromatography (10% to 30% EtOAc:Hex) to provide the desired product (2.2 g, 88% yield). 
The title compound appeared as a 5:1 mixture of rotamers in the NMR spectrum. Major 
Rotamer: 1H NMR (600 MHz, Chloroform-d) δ 7.80 – 7.70 (m, 2H), 7.49 – 7.37 (m, 4H), 7.37 
– 7.30 (m, 2H), 6.93 (s, 1H), 5.45 (d, J = 9.9 Hz, 1H), 4.62 (d, J = 9.9 Hz, 1H), 2.53 (s, 3H), 
1.57 (s, 9H), 1.16 (s, 9H). 
 
(S)-2-(3-(3,5-Bis(trifluoromethyl)phenyl)thioureido)-N-
(9H-fluoren-9-yl)-N,3,3-trimethylbutanamide (4.31): The 
title compound was prepared via a modified procedure from 
Jacobsen, et al.68,83 A flask was flame dried, cooled under a stream of N2, and charged with 
tert-butyl (S)-(1-((9H-fluoren-9-yl)(methyl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate 
(2.16 g, 5.28 mmol, 1.0 equiv) and 4 M HCl in dioxane (8.6 mL, 34.3 mmol, 6.5 equiv). The 
reaction was stirred at rt for 2 h, then the solution was concentrated in vacuo. The crude primary 
amine was subsequently dissolved in DCM (26 mL), followed by addition of TEA (2.21 mL, 
15.8 mmol, 3 equiv) and 1-isothiocyanato-3,5-bis(trifluoromethyl)benzene (1.1 mL, 5.81 
mmol, 1.1 equiv). The reaction was stirred at rt for 4 h, then the mixture was concentrated in 
vacuo. The crude material was purified via flash column chromatography (30% EtOAc:Hex) 
to provide pure product. The title compound appeared as an 8.3:1 mixture of rotamers in the 
NMR spectrum. Major Rotamer: 1H NMR (400 MHz, Chloroform-d) δ 9.33 (s, 1H), 8.03 – 
7.92 (m, 2H), 7.84 – 7.68 (m, 3H), 7.62 (s, 1H), 7.42 – 7.32 (m, 3H), 7.24 – 7.17 (m, 1H), 7.17 
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– 7.09 (m, 1H), 6.82 (s, 1H), 5.69 (d, J = 9.0 Hz, 1H), 2.69 (s, 3H), 1.28 (d, J = 1.8 Hz, 9H). 
 
 
Bis(3,5-di-tert-butylphenyl)methanone: The title compound was 
prepared via modified procedures from Liu and Marchese.84,85 A two-
necked flask was charged with magnesium turnings (1.35 g, 55.5 mmol, 
3.0 equiv), flame-dried under vacuum, and cooled under a stream of N2. Enough THF was 
added to cover the magnesium turnings, followed by addition of an iodine crystal. A small 
portion of 1-bromo-3,5-di-tert-butylbenzene (1.2 g, 4.4 mmol, 0.24 equiv) was added 
portionwise until the yellow reaction mixture turned colorless, indicating initiation of the 
Grignard reaction. Alternating portionwise additions of THF (90 mL) and 1-bromo-3,5-di-tert-
butylbenzene (11.95g, 44.4 mmol, 2.4 equiv total) were completed, then the reaction was 
stirred at 70 °C for 4 h before cooling to rt. In a separate flask CDI (3.00 g, 18.5 mmol, 1 equiv) 
was dissolved in THF (90 mL, 0.5 M) and cooled to -78 °C. The Grignard reagent was added 
dropwise via syringe, then stirred at -78 °C for 30 min and room temperature for 1 h. The 
mixture was quenched with 1 M HCl, then extracted with EtOAc (3x). The combined organic 
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extracts were dried over Na2SO4, filtered, and concentrated in vacuo. Baseline impurities 
removed via flash column chromatography (100% Hex to 10% EtOAc:Hex) to provide product 
with sufficient purity for the subsequent step. 1H NMR (500 MHz, Chloroform-d) δ 7.71 – 
7.69 (m, 4H), 7.69 – 7.66 (m, 2H), 1.38 (s, 36H). 
 
1,1-Bis(3,5-di-tert-butylphenyl)-N-methylmethanamine: The title 
compound was prepared via a modified procedure from Bhattacharyya, 
et al.82 A solution of methanamine (8.4 M in EtOH, 1.8 mL, 15.0 mmol, 
3.0 equiv) was dissolved in MeOH (5.6 mL). Titanium (IV) isopropoxide (2.0 mL, 6.6 mmol, 
1.32 equiv) was added, followed by bis(3,5-di-tert-butylphenyl)methanone (2.03 g, 5.0 mmol, 
1.0 equiv). The reaction mixture was stirred for 16 h at room temperature, then NaBH4 (189 
mg, 5.0 mmol, 1.0 equiv) was added and the mixture was stirred for another 2 h, then additional 
NaBH4 (189 mg, 5.0 mmol, 1.0 equiv) was added and the reaction mixture was stirred for an 
additional 3 h. The reaction was quenched with water, and the precipitate was filtered through 
Celite and washed with Et2O. The layers were separated, then the aqueous layer was extracted 
with Et2O (2x). The combined organics were washed with 2 M HCl (2x), and the aqueous 
layers were basified to pH = 10 by slow addition of 2.5 M NaOH. The aqueous mixture was 
extracted with Et2O (2x) and the combined organic extracts were dried over Na2SO4, filtered, 
and concentrated in vacuo. The crude material was purified using flash column 
chromatography (0% to 2.5% MeOH:DCM) to provide a fluffy white solid (1.19 g, 56% yield). 
1H NMR (500 MHz, Chloroform-d) δ 7.31 – 7.30 (m, 4H), 7.28 – 7.26 (m, 2H), 4.69 (s, 1H), 




oxobutan-2-yl)carbamate: The title compound was prepared via a 
modified procedure from Jacobsen, et al.83 A flame-dried flask under 
N2 was charged with (S)-2-((tert-butoxycarbonyl)amino)-3,3-
dimethylbutanoic acid (435 mg, 1.9 mmol, 1.0 equiv) and dissolved in DCM (3.8 mL). Then, 
HBTU (784 mg, 2.1 mmol, 1.1 equiv), 1,1-bis(3,5-di-tert-butylphenyl)-N-methylmethanamine 
(1.19 g, 2.8 mmol, 1.5 equiv), and DIPEA (0.66 mL, 3.8 mmol, 2.0 equiv) were added 
sequentially. The reaction was stirred at rt for 3 days, then the resulting orange mixture was 
diluted with Et2O and washed with 1 M HCl (2x), satd. aq. NaHCO3, and brine. The combined 
organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. The crude 
material was purified via flash column chromatography (column 1: 5% to 25% Et2O:Hex, 
column 2: 0% to 2% MeOH:DCM) to provide a white solid (1.12 g, 94% yield). The product 
appeared as a 4.2:1 mixture of rotamers in the NMR spectrum. Major Rotamer:  1H NMR (500 
MHz, Chloroform-d) δ 7.36 – 7.31 (m, 2H), 7.18 (s, 1H), 7.06 – 7.03 (m, 2H), 7.03 – 7.00 (m, 
2H), 5.40 (d, J = 9.8 Hz, 1H), 4.64 (d, J = 9.9 Hz, 1H), 2.90 (s, 3H), 1.45 (s, 9H), 1.30 (s, 18H), 
1.29 (s, 18H), 1.06 (s, 9H). 
 
(S)-2-Amino-N-(bis(3,5-di-tert-butylphenyl)methyl)-N,3,3-trimethylbutanamide: The 
title compound was prepared via a modified procedure from Jacobsen, 
et al.83 A flame-dried flask under N2 was charged with tert-butyl (S)-
(1-((bis(3,5-di-tert-butylphenyl)methyl)(methyl)amino)-3,3-dimethyl-
1-oxobutan-2-yl)carbamate (1.12 g, 1.73 mmol, 1.0 equiv) and dry DCM (8.7 mL) was added. 
Then, TEA (0.48 mL, 3.47 mmol, 2.0 equiv) was added, and the reaction was cooled to 0 °C 
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before dropwise addition of TMSOTf (1.9 mL, 10.4 mmol, 6 equiv). The solution was stirred 
at 0 °C for 1 h, then the mixture was treated slowly with satd. aq. NaHCO3. The mixture was 
transferred to a separatory funnel and diluted with satd. aq. NaHCO3  and DCM. The layers 
were mixed with venting, then separated. The aqueous layer was extracted with DCM, then 
the combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The 
residue was dissolved in DCM and filtered through a silica plug (1:1:0.4 DCM:Et2O:MeOH) 
to remove baseline impurities, providing the primary amine (877 mg, 1.73 mmol, 95% yield) 
in sufficient purity for the next step. The product appeared as a 3:1 mixture of rotamers in the 
NMR spectrum. Major Rotamer:  1H NMR (400 MHz, Chloroform-d) δ 7.34 – 7.32 (m, 1H), 
7.31 – 7.30 (m, 1H), 7.16 (s, 1H), 7.07 – 7.04 (m, 2H), 7.03 – 7.01 (m, 2H), 5.30 (s, 1H), 2.85 




trimethylbutanamide (4.34): The title compound was 
prepared via a modified procedure from Jacobsen, et 
al.68,83 A flask was flame dried, cooled under a stream of N2, and charged with (S)-2-amino-N-
(bis(3,5-di-tert-butylphenyl)methyl)-N,3,3-trimethylbutanamide (877 mg, 1.64 mmol, 1.0 
equiv). DCM (5.1 mL) was added, followed by 1-isothiocyanato-3,5-
bis(trifluoromethyl)benzene (0.30 mL, 1.66 mmol, 1.0 equiv). The reaction was stirred at rt for 
2 h, then the mixture was concentrated in vacuo. The crude material was purified via flash 
column chromatography to provide pure product (1.16 g, 88% yield). The product appeared as 
a 7:1 mixture of rotamers in the NMR spectrum. Major Rotamer:  1H NMR (400 MHz, 
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Chloroform-d) δ 9.28 (s, 1H), 7.96 (s, 2H), 7.62 (s, 1H), 7.37 – 7.34 (m, 1H), 7.28 – 7.26 (m, 
1H), 7.08 (s, 1H), 7.07 – 7.03 (m, 2H), 6.96 – 6.90 (m, 2H), 5.66 (d, J = 9.3 Hz, 1H), 3.04 (s, 
3H), 1.29 (s, 18H), 1.25 (s, 18H), 1.10 (s, 9H). 
 
Starting Material Synthesis 
See Scheme 4-7 for synthetic route to iso-tryptamine. 
(1H-Indol-2-yl)methanol: The title compound was synthesized as reported by 
Jaitak, et al. starting from ethyl 1H-indole-2-carboxylate.86 1H NMR 
spectroscopic data matches those reported. 
 
(E)-2-(2-Nitrovinyl)-1H-indole: The title compound was synthesized as reported by Tarzia, 
et al. starting from (1H-indol-2-yl)methanol.55 1H NMR spectroscopic data 
matches those reported.87 
 
2-(1H-Indol-2-yl)ethan-1-amine (4.23): The title compound was synthesized as reported by 
Cossy, et al.88 1H NMR spectroscopic data matches those reported. Note that if 
reaction time is extended, over-reduction to the indoline can occur. 
 
2-Methyl-3-morpholino-3-oxopropanal (4.24): The title compound was 
synthesized as reported by Johnson, et al.75 1H NMR spectroscopic data 
matches those reported. 
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Ethyl 2-oxo-3-phenylbutanoate (4.37): The title compound was synthesized 
as reported by Johnson, et al.89 1H NMR spectroscopic data matches those 
reported. 
 
General procedure A ‒ Synthesis of α-substituted β-formyl ethyl esters: The title 
compounds were synthesized according to an adapted procedure from Tius, et al.90 A flame-
dried flask was cooled under a stream of N2 and charged with ester (1.0 equiv), ethyl formate 
(30 equiv), and dry DCM (0.6 M). The solution was cooled to 0 °C, then TiCl4 (2.0 equiv) and 
TEA (2.4 equiv) were added dropwise. The reaction mixture was stirred at 0 °C for 1 h, then 
warmed to room temperature and stirred for another 1 h. The mixture was then poured onto 
ice-cold water and the aqueous layer was extracted with DCM (3x). The combined organic 
layers were washed with water and brine, then dried over Na2SO4, filtered, and concentrated 
in vacuo. The crude material was purified via flash column chromatography. 
 
Ethyl 2-formyl-3-methylbutanoate (4.26a): The title compound was 
synthesized according to General Procedure A from ethyl 3-methylbutanoate 
(3.00 mL, 19.9 mmol, 1.0 equiv).  The product was obtained as a 1.4:1 mixture of 
aldehyde:enol. Aldehyde: 1H NMR (400 MHz, Chloroform-d) δ 9.73 (d, J = 3.9 Hz, 1H), 4.31 
– 4.25 (m, 2H), 2.99 (dd, J = 8.0, 3.9 Hz, 1H), 2.52 – 2.39 (m, 1H), 1.31 (t, J = 6.1 Hz, 3H), 
1.05 (dd, J = 6.8, 1.6 Hz, 7H). Enol: 1H NMR (400 MHz, Chloroform-d) δ 11.64 (d, J = 12.3 
Hz, 1H), 7.06 (d, J = 12.3 Hz, 1H), 4.28 – 4.21 (m, 2H), 2.68 – 2.56 (m, 1H), 1.33 (t, J = 6.8 
Hz, 3H), 1.11 (d, J = 6.9 Hz, 6H). 
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Ethyl 2-methyl-3-oxopropanoate (4.26b): The title compound was 
synthesized according to General Procedure A using ethyl propionate (0.8 mL, 
6.93 mmol, 1.0 equiv). Removal of baseline impurities removed via flash column 
chromatography (20% Et2O:Pet Ether) provided the product in approximately 81% purity after 
flash column chromatography. The product was isolated as a 2.2:1 mixture of enol:aldehyde. 
Enol: 1H NMR (500 MHz, Chloroform-d) δ 11.36 (d, J = 12.5 Hz, 1H), 7.03 (d, J = 12.4 Hz, 
1H), 4.27 (q, J = 7.2 Hz, 3H), 1.70 (d, J = 1.2 Hz, 3H), 1.40 – 1.27 (m, 3H). Aldehyde: 1H 
NMR (500 MHz, Chloroform-d) δ 9.82 (d, J = 1.5 Hz, 1H), 4.06 (q, J = 7.0 Hz, 2H), 3.41 (qd, 
J = 7.2, 1.5 Hz, 1H), 1.76 (d, J = 1.2 Hz, 4H), 1.41 – 1.25 (m, 6H). 
 
Ethyl 2-formyloctanoate (4.26c): The title compound was synthesized 
according to General Procedure A using ethyl octanoate (0.80 mL, 4.00 mmol, 
1.0 equiv). The product was obtained as a 1.5:1 mixture of enol:aldehyde. Enol: 1H NMR (500 
MHz, Chloroform-d) δ 11.47 (d, J = 12.4 Hz, 1H), 7.02 (d, J = 12.4 Hz, 1H), 4.32 – 4.22 (m, 
2H), 2.07 (t, J = 7.5 Hz, 2H), 1.45 – 1.23 (m, 9H), 0.91 (td, J = 7.0, 2.8 Hz, 5H). Aldehyde: 1H 
NMR (500 MHz, Chloroform-d) δ 9.72 (d, J = 2.6 Hz, 1H), 4.32 – 4.23 (m, 2H), 3.27 (td, J = 
7.2, 2.5 Hz, 1H), 1.95 – 1.85 (m, 2H), 1.46 – 1.24 (m, 9H), 0.96 – 0.84 (td, J = 7.0, 2.8 Hz, 
4H). 
 
Ethyl 2-methyl-3-oxopropanoate (4.26d): The title compound was synthesized 
according to General Procedure A using ethyl 3-phenyl propanoate (0.69 mL, 
8.42 mmol, 1.0 equiv). The crude material was purified via flash column chromatography 
(2.5% to 5% EtOAc:Hex) to provide the product an oil (333 mg, 58% yield). The product was 
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isolated as a 3:1 mixture of enol:aldehyde. Enol: 1H NMR (500 MHz, Chloroform-d) δ 11.56 
(d, J = 12.5 Hz, 1H), 7.33 – 7.28 (m, 3H), 7.24 – 7.19 (m, 2H), 7.10 (d, J = 12.5 Hz, 1H), 4.20 
(q, J = 7.0 Hz, 2H), 3.43 (s, 2H), 1.25 (t, J = 7.1 Hz, 3H). Aldehyde: 1H NMR (500 MHz, 
Chloroform-d) δ 9.78 (d, J = 1.9 Hz, 1H), 7.34 – 7.31 (m, 3H), 7.28 – 7.24 (m, 2H), 4.24 – 
4.17 (m, 3H), 3.26 (dd, J = 14.2, 6.7 Hz, 1H), 3.21 (dd, J = 14.2, 8.0 Hz, 1H), 1.30 – 1.25 (m, 
3H). 
 
Enantioconvergent iso-Pictet Spengler Reaction 
1-morpholino-2-(2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-
yl)propan-1-one (4.25): A one-dram vial was charged with iso-tryptamine 
(147 mg, 0.10 mmol, 1.0 equiv),  2-methyl-3-morpholino-3-oxopropanal 
(138 mg, 0.10 mmol, 1.0 equiv), and CHCl3 (1.0 mL). The reaction was stirred for 1 h at rt 
then concentrated in vacuo. Analysis by 1H NMR spectroscopy showed 100% conversion to 
product. The diastereomeric ratio was calculated using proton resonances at 4.50 ppm (major) 
and 4.79 ppm (minor). 1H NMR (500 MHz, Chloroform-d) δ 8.23 (bs, 1H), 7.42 (d, J = 7.9 
Hz, 1H), 7.34 (d, J = 8.0 Hz, 1H), 7.14 (t, J = 7.6 Hz, 1H), 7.08 (t, J = 7.5 Hz, 1H), 4.50 (d, J 
= 5.3 Hz, 1H), 3.63 – 3.49 (m, 6H), 3.50 – 3.41 (m, 1H), 3.40 – 3.35 (m, 1H), 3.34 – 3.22 (m, 
2H), 3.22 – 3.15 (m, 1H), 2.98 – 2.87 (m, 1H), 2.87 – 2.77 (m, 1H), 1.20 (d, J = 6.8 Hz, 3H). 
 
General procedure B ‒ Enantioconvergent iso-Pictet-Spengler reaction: A 1-dram vial 
was charged with iso-tryptamine (0.08 mmol, 1.0 equiv) and a thiourea catalyst,a, b then the 
solids were dissolved in DCM or PhMe (0.60 mL). Acidc (0.5 M in PhMe) was subsequently 
added, followed by addition of α-substituted β-formyl ester or amide (0.4 M in DCM or PhMe, 
176 
0.088 mmol, 1.1 equiv). The vial was capped and stirred overnight at room temperature for 16-
26 h then quenched with satd. aq. NaHCO3 and diluted with DCM or EtOAc. The layers were 
separated and aqueous layer was extracted (3x). The combined organic extracts were dried 
over Na2SO4, filtered, and concentrated. The crude material was purified via flash column 
chromatography. 
 
General procedure C ‒ One-pot enantioconvergent iso-Pictet-Spengler reaction and Boc-
protection: A 1-dram vial was charged with iso-tryptamine (0.08 mmol, 1.0 equiv) and a 
thiourea catalyst,a, b then the solids were dissolved in DCM or PhMe (0.60 mL). An acidc (0.5 
M in PhMe) was subsequently added, followed by addition of α-substituted β-formyl ester or 
amide (0.4 M in DCM or PhMe, 0.088 mmol, 1.1 equiv). The vial was capped and stirred 
overnight at room temperature. After 16-26 h, satd. aq. NaHCO3 (150 μL) and Boc2O (25 μL, 
0.11 mmol, 1.33 equiv) were added and the reaction was stirred at room temperature for 1 h. 
The layers were separated, and the aqueous layer was extracted with DCM or EtOAc (3x). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated. The crude 
material was purified via flash column chromatography. 
a For catalyst loadings and reaction times see tables in section 4.4.  
b Racemic reactions accomplished using either diphenylphosphinic acid (10 mol %) or benzoic 
acid (10 mol %) and Schreiner’s thiourea (N,N′−bis[3,5−bis(trifluoromethyl)phenyl]−thiourea) 
(20 mol %). 
c BzOH, AcOH, and TFA were added as a solution. p-NO2 and p-OMe benzoic acids were 
added neat due to poor solubility in DCM or PhMe. See Table 4-5 for acid screen.   
 
177 
General Procedure D ‒ Boc-protection: Tetrahydro-γ-carboline (0.08 mmol, 1.0 equiv) was 
dissolved in a 2:1 mixture of EtOAc:satd. aq. NaHCO3 (0.45 mL). Boc2O (25 μL, 0.11 mmol, 
1.33 equiv) was subsequently added and the reaction was stirred at rt for 1 h. The layers were 
separated, and the aqueous layer was extracted with EtOAc (3x). The combined organic 
extracts were dried over Na2SO4, filtered, and concentrated in vacuo. The crude material was 
purified via flash column chromatography. 
 
Ethyl 3-methyl-2-(2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-
yl)butanoate (4.28a): The title compound was synthesized according to 
General Procedure B from iso-tryptamine (12.8 mg, 0.080 mmol, 1.0 equiv) 
and ethyl 2-formyl-3-methylbutanoate (0.088 mmol, 15.5 mg, 1.10 equiv). The product was 
purified using flash column chromatography (100% DCM to 30% MeOH:DCM). The product 
was recrystallized for X-ray diffraction analysis by dissolution in minimal hot ethyl acetate, 
followed by vapor diffusion with pentanes for at least 48 h. The diastereomeric ratio was 
calculated using proton resonances at 0.63 ppm (major) and 0.88 ppm (minor). 1H NMR (500 
MHz, Chloroform-d) δ 8.49 (bs, 1H), 7.58 – 7.52 (m, 1H), 7.31 – 7.25 (m, 1H), 7.17 – 7.06 
(m, 2H), 4.57 (app s, 1H), 3.86 – 3.78 (m, 1H), 3.76 – 3.68 (m, 1H), 3.53 – 3.40 (m, 1H), 3.17 
– 3.02 (m, 2H), 2.94 – 2.85 (m, 1H), 2.77 – 2.67 (m, 1H), 2.59 (d, J = 15.8 Hz, 1H), 2.50 – 
2.39 (m, 1H), 1.23 (d, J = 6.6 Hz, 3H), 1.05 (d, J = 6.6 Hz, 3H), 0.63 (t, J = 7.1 Hz, 3H). The 




2H-pyrido[4,3-b]indole-2-carboxylate: The title compound was 
synthesized according to General Procedure D from ethyl 3-methyl-2-
(2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-yl)butanoate (32.0 mg, 0.08 mmol, 1.0 equiv). 
The crude material was purified using flash column chromatography (100% DCM then 10% 
to 30% EtOAc:Hex). The product appeared as a 1.3:1 mixture of rotamers in the 1H NMR 
spectrum. Major: 1H NMR (400 MHz, Chloroform-d) δ 8.20 (s, 1H), 7.57 (t, J = 8.4 Hz, 1H), 
7.37 – 7.30 (m, 1H), 7.22 – 7.01 (m, 2H), 5.73 (d, J = 8.9 Hz, 1H), 4.48 (dd, J = 14.0, 6.7 Hz, 
1H), 4.19 – 3.91 (m, 2H), 3.48 (td, J = 12.8, 4.8 Hz, 1H), 3.02 – 2.83 (m, 2H), 2.64 (d, J = 4.6 
Hz, 1H), 2.26 (dp, J = 13.3, 6.7 Hz, 1H), 1.49 (s, 9H), 1.35 – 1.24 (m, 6H), 1.16 (t, J = 7.1 Hz, 
3H). Minor: 1H NMR (400 MHz, Chloroform-d) δ 8.09 (s, 1H), 7.57 (t, J = 8.4 Hz, 1H), 7.34 
– 7.29 (m, 1H), 7.21 – 7.05 (m, 2H), 5.88 (d, J = 9.1 Hz, 1H), 4.27 (dd, J = 14.1, 6.5 Hz, 1H), 
4.22 – 3.89 (m, 2H), 3.63 (td, J = 13.1, 4.6 Hz, 1H), 3.02 – 2.85 (m, 2H), 2.60 (d, J = 4.7 Hz, 
1H), 2.26 (dp, J = 13.3, 6.7 Hz, 1H), 1.11 – 1.00 (m, 9H). HPLC (91:9 hexanes:iPrOH, Daicel 
Chiralpak IC Column, flow rate = 1.0 mL/min, λ = 210 nm): tR (major diastereomer) = 13.5, 
14.5 min, tR (minor diastereomer) = 10.5 min, 12.2 min.  
 
Ethyl 2-(2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-yl)propanoate 
(4.28b): The title compound was synthesized according to General Procedure 
B using iso-tryptamine (12.9 mg, 0.08 mmol, 1.0 equiv) and ethyl 2-methyl-
3-oxopropanoate (12.7 mg, 0.088 mmol, 1.1 equiv). The crude material was purified using 
flash column chromatography (0% to 5% MeOH:DCM). The purified material was taken 




pyrido[4,3-b]indole-2-carboxylate: The title compound was synthesized 
according to General Procedure D from ethyl 2-(2,3,4,5-tetrahydro-1H-
pyrido[4,3-b]indol-1-yl)propanoate (29.8 mg, 0.08 mmol, 1.0 equiv). The crude material was 
purified using flash column chromatography (100% DCM then 10% to 20% EtOAc:Hex). The 
product was isolated as a 1.6:1 mixture of diastereomers, and appeared as a 1.3:1 mixture of 
rotamers in the 1H NMR spectrum. For the 1H NMR spectrum, all peaks are reported as 
observed (as opposed to ratio-resolved) due to numerous overlapping peaks. 1H NMR (400 
MHz, Chloroform-d) δ 8.05 (s, 1H), 8.01 (s, 1H), 7.98 (s, 1H), 7.62 – 7.54 (m, 2H), 7.54 – 7.45 
(m, 2H), 7.36 – 7.26 (m, 3H), 7.22 – 7.02 (m, 6H), 5.80 (d, J = 6.9 Hz, 1H), 5.67 (d, J = 9.3 
Hz, 1H), 5.58 (d, J = 8.6 Hz, 1H), 5.53 (d, J = 8.5 Hz, 1H), 4.59 (dd, J = 13.7, 6.4 Hz, 1H), 
4.53 (dd, J = 13.9, 6.6 Hz, 1H), 4.39 (dd, J = 13.6, 6.0 Hz, 1H), 4.32 (dd, J = 14.0, 6.3 Hz, 1H), 
4.23 – 4.00 (m, 6H), 4.00 – 3.87 (m, 1H), 3.63 – 3.51 (m, 1H), 3.51 – 3.33 (m, 2H), 3.24 (td, J 
= 12.8, 4.6 Hz, 1H), 3.12 – 3.00 (m, 3H), 3.00 – 2.83 (m, 3H), 2.76 – 2.60 (m, 3H), 1.50 (s, 
11H), 1.47 (s, 11H), 1.45 – 1.40 (m, 1H), 1.38 (d, J = 7.0 Hz, 2H), 1.33 – 1.25 (m, 5H). HPLC 
(91:9 hexanes:iPrOH, Daicel Chiralpak IC Column, flow rate = 1.0 mL/min, λ = 210 nm): tR 
(diastereomer 1) = 9, 10 min, tR (diastereomer 2) = 11, 12 min. 
 
Ethyl 2-(2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-yl)octanoate 
(4.28c): The title compound was synthesized according to General Procedure 
B using iso-tryptamine (12.9 mg, 0.08 mmol, 1.0 equiv) and ethyl 2-
formyloctanoate (19.6 mg, 0.088 mmol, 1.1 equiv). The crude material was purified using flash 
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column chromatography (0% to 5% MeOH:DCM). The diastereomeric ratio was calculated 
using proton resonances at 4.47 ppm (major) and 4.63 ppm (minor). Major: 1H NMR (400 
MHz, Chloroform-d) δ 8.17 (s, 1H), 7.61 – 7.49 (m, 1H), 7.37 – 7.27 (m, 1H), 7.22 – 7.05 (m, 
2H), 4.47 (d, J = 6.4 Hz, 1H), 4.22 – 4.11 (m, 1H), 4.06 – 3.87 (m, 2H), 3.57 – 3.43 (m, 1H), 
3.31 – 3.22 (m, 1H), 3.12 – 3.00 (m, 1H), 2.79 – 2.63 (m, 1H), 2.08 (s, 1H), 1.93 – 1.73 (m, 
2H), 1.46 – 1.22 (m, 7H), 0.97 – 0.85 (m, 4H). 
 
tert-Butyl 1-(1-ethoxy-1-oxooctan-2-yl)-1,3,4,5-tetrahydro-2H-
pyrido[4,3-b]indole-2-carboxylate: The title compound was synthesized 
according to General Procedure D from ethyl 2-(2,3,4,5-tetrahydro-1H-
pyrido[4,3-b]indol-1-yl)octanoate (35.4 mg, 0.08 mmol, 1.0 equiv). The crude material was 
purified using flash column chromatography (100% DCM then 10% to 20% EtOAc:Hex). The 
product was isolated as a 5:1 mixture of diastereomers, and appeared as a 1.4:1 mixture of 
rotamers in the 1H NMR spectrum. Major rotamer: 1H NMR (400 MHz, Chloroform-d) δ 7.92 
(s, 1H), 7.59 (t, J = 7.6 Hz, 1H), 7.40 – 7.30 (m, 1H), 7.24 – 7.02 (m, 2H), 5.51 (d, J = 9.0 Hz, 
1H), 4.51 (dd, J = 13.8, 6.6 Hz, 1H), 4.21 – 3.99 (m, 2H), 3.54 – 3.42 (m, 1H), 3.07 – 2.84 (m, 
2H), 2.71 – 1.67 (s, 1H), 2.09 – 1.86 (m, 2H), 1.46 (s, 9H), 1.34 – 1.07 (m, 11H), 0.85 (t, J = 
6.7 Hz, 3H). Minor rotamer: 1H NMR (400 MHz, Chloroform-d) δ 7.86 (s, 1H), 7.59 (t, J = 
7.6 Hz, 1H), 7.39 – 7.30 (m, 1H), 7.24 – 7.02 (m, 2H), 5.68 (d, J = 9.3 Hz, 1H), 4.35 – 4.25 
(m, 1H), 4.21 – 3.98 (m, 2H), 3.65 – 3.55 (m, 1H), 3.08 – 2.78 (m, 2H), 2.67 – 2.60 (m, 1H), 




yl)propanoate (4.28d): The title compound was synthesized according to 
General Procedure C using iso-tryptamine (12.9 mg, 0.08 mmol, 1.0 equiv) 
and ethyl 2-formyloctanoate (20.1 mg, 0.088 mmol, 1.1 equiv). The crude material was 
purified using flash column chromatography (0% to 0.2% to 5% MeOH:DCM). The 
diastereomeric ratio was calculated using proton resonances at 4.52 ppm (major) and 4.63 ppm 
(minor). 1H NMR (400 MHz, Chloroform-d) δ 8.01 (s, 1H), 7.63 – 7.60 (m, 1H), 7.33 – 7.12 
(m, 9H), 4.52 (d, J = 6.6 Hz, 1H), 3.94 – 3.77 (m, 2H), 3.60 – 3.54 (m, 1H), 3.51 – 3.45 (m, 
1H), 3.37 – 3.28 (m, 1H), 3.25 – 3.17 (m, 1H), 3.15 – 3.04 (m, 1H), 2.81 – 2.61 (m, 2H), 2.33 
(s, 1H), 0.77 (t, J = 7.1 Hz, 3H). 
 
tert-Butyl 1-(1-ethoxy-1-oxo-3-phenylpropan-2-yl)-1,3,4,5-tetrahydro-
2H-pyrido[4,3-b]indole-2-carboxylate: The title compound was 
synthesized according to General Procedure D from ethyl 3-phenyl-2-
(2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-yl)propanoate (35.8 mg, 0.08 mmol, 1.0 equiv). 
The crude material was purified using flash column chromatography (100% DCM then 10% 
to 20% EtOAc:Hex). The product appeared as a 1.3:1 mixture of rotamers in the 1H NMR 
spectrum. When General Procedure C was used, the diastereomeric ratio was calculated by 
adding peaks at 4.54 and 4.34, then dividing by the summation of peaks at 4.66 and 4.44. For 
the 1H NMR data, all peaks are reported as observed (as opposed to ratio-resolved) due to 
numerous overlapping peaks. 1H NMR (400 MHz, Chloroform-d) δ 8.14 (s, 1H), 8.05 (s, 1H), 
7.69 (d, J = 7.4 Hz, 1H), 7.65 (d, J = 6.0 Hz, 1H), 7.40 – 7.28 (m, 2H), 7.28 – 7.06 (m, 12H), 
5.75 – 5.57 (m, 1H), 4.54 (dd, J = 14.0, 6.7 Hz, 1H), 4.34 (dd, J = 14.3, 6.3 Hz, 1H), 4.05 – 
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3.79 (m, 4H), 3.68 – 3.57 (m, 1H), 3.56 – 3.43 (m, 1H), 3.33 – 3.20 (m, 4H), 3.14 (t, J = 10.2 
Hz, 1H), 3.07 – 2.86 (m, 2H), 2.71 (d, J = 4.7 Hz, 1H), 2.67 (d, J = 4.7 Hz, 1H), 1.48 (s, 14H), 
1.01 – 0.82 (m, 8H). HPLC (93:7 hexanes:iPrOH, Daicel Chiralpak IC Column, flow rate = 
1.0 mL/min, λ = 210 nm): tR (diastereomer 1) = 9, 15 min, tR (diastereomer 2) = 11, 13 min. 
 
Ethyl 3-phenyl-2-(2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-
yl)propanoate (4.36): A 1-dram vial was charged with iso-tryptamine (10.0 
mg, 0.062 mmol, 1.0 equiv) and ethyl 2-methyl-3-oxobutanoate (7.3 mg, 
0.0124 mmol, 0.20 equiv) then the solids were dissolved in PhMe (0.60 mL). Benzoic acid (0.5 
M in PhMe, 12.5 μL, 6.25 μmol, 0.10 equiv) was subsequently added, followed by ethyl 2-
methyl-3-oxobutanoate (0.4 M in PhMe, 0.20 mL, 0.075 mmol, 1.2 equiv). The vial was 
capped and stirred overnight at the appropriate temperature for 26 h (see Scheme 4-14). The 
reaction was quenched with satd. aq. NaHCO3 and diluted with EtOAc. The layers were 
separated and aqueous layer was extracted with EtOAc (3x). The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated in vacuo. The crude material was purified 
via flash column chromatography (5% to 15% EtOAc:Hex). The diastereomeric ratio was 
calculated using proton resonances at 0.58 ppm (major) and 1.00 ppm (minor). Major: 1H 
NMR (400 MHz, Chloroform-d) δ 8.08 (s, 2H), 7.56 (d, J = 7.9 Hz, 1H), 7.36 – 7.26 (m, 1H), 
7.18 – 7.06 (m, 2H), 4.21 (q, J = 7.1 Hz, 1H), 3.84 – 3.73 (m, 1H), 3.72 – 3.61 (m, 1H), 3.48 
– 3.39 (m, 2H), 3.15 – 3.05 (m, 1H), 2.73 (dd, J = 9.6, 5.6 Hz, 1H), 2.69 – 2.65 (m, 1H), 1.63 




yl)propanoate (4.38): A 1-dram vial was charged with iso-tryptamine (10.0 
mg, 0.062 mmol, 1.0 equiv) and ethyl 2-oxo-3-phenylbutanoate (7.3 mg, 
0.0124 mmol, 0.20 equiv) then the solids were dissolved in PhMe (0.60 mL). Benzoic acid (0.5 
M in PhMe, 12.5 μL, 6.25 μmol, 0.10 equiv) was subsequently added, followed by addition of 
ethyl 2-oxo-3-phenylbutanoate (0.4 M in PhMe, 0.20 mL, 0.075 mmol, 1.2 equiv). The vial 
was capped and stirred overnight at the appropriate temperature for 26 h (Scheme 4-14). The 
reaction was quenched with satd. aq. NaHCO3 and diluted with EtOAc. The layers were 
separated and aqueous layer was extracted with EtOAc (3x). The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated in vacuo. The crude material was purified 
via flash column chromatography (5% to 15% EtOAc:Hex). The diastereomeric ratio was 
calculated using proton resonances at 1.07 ppm (major) and 1.38 ppm (minor). Major: 1H 
NMR (600 MHz, Chloroform-d) δ 8.19 – 8.11 (m, 1H), 7.97 (s, 1H), 7.39 (d, J = 8.2 Hz, 2H), 
7.37 – 7.32 (m, 3H), 7.27 – 7.14 (m, 3H), 4.24 (q, J = 7.0 Hz, 1H), 4.15 – 4.07 (m, 1H), 4.04 
– 3.94 (m, 1H), 3.28 – 3.21 (m, 1H), 3.21 – 3.14 (m, 2H), 3.03 – 2.93 (m, 1H), 2.58 (dd, J = 
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